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ABSTRACT 
Perkinsus marinus is an alveolate protozoan parasite of the eastern oyster 
(Crassostrea virginica) which is responsible for much of the decline in United States 
oyster populations. Perkinsus marinus can be cultured in vitro, but is rapidly attenuated 
in the process. Supplementation of a protein-free medium with products of P. marinus-
susceptible (C. virginica) and tolerant (C. gigas, C. ariakensis) oysters altered 
proliferation, changed protease expression profiles in the parasite extracellular products 
(ECP), induced morphological fonns typically seen in vivo, and partially reversed in vitro 
attenuation. Increased infectivity was not consistently associated with changes in cell 
size, cell morphology, or protease secretion, and was not related to the susceptibility of 
the oyster used as the supplement source. Supplements derived from dissected oyster 
tissues were used to detennine if these changes could be differentially elicited. These 
supplements, with the exception of adductor muscle, reduced proliferation. Whole oyster 
and digestive gland/gonad supplements favored palintomic, rather than binary, fission. 
The total ECP protease activity was generally decreased in supplemented cultures, though 
gill/mantle supplemented cultures may have undergone protease induction. Zymograms 
indicated that the low molecular weight subset of proteases were upregulated most 
effectively by heart- and adductor muscle-derived supplements. 
Serine proteases and other ECP proteins may be virulence factors. Attempts to 
create antibodies to study P. marinus cells and ECP have been largely unsuccessful due 
to poor immune responses and crossreactivity with host oyster antigens. In this study, 
ultrafiltration-concentrated culture supernatants containing the P. marinus ECP were both 
poorly immunogenic and toxic to experimental animals. Immunogenicity was not 
substantially affected by heat denaturation or proteolytic inhibition. Co-administration of 
ECP with oyster plasma caused a suppression in the anti-plasma antibody response with 
restriction of epitope recognition. Analysis of medium constituents revealed that a 
surfactant, Pluronic F-68 (PF68), was immunosuppressive. Although isolated protein 
antigens from P. marinus ECP remained immunosuppressive, separation of the antigens 
from PF68 enabled production of monoclonal antibodies. It also allowed subtractive 
immunization for attempted production of antibodies specific to proteins upregulated by 
oyster supplement exposure; however, the changes in ECP from supplemented media 
were either not associated with generation of novel epitopes, or those epitopes were in 
sub-immunogenic concentrations. Five monoclonal antibodies were created using ECP 
from unsupplemented medium and were used to study ECP function, regulation, and 
mechanism of storage and release. ECP are secreted by several pathways, including 
release from the cell wall and from two morphologically distinct intracellular 
compartments. A sandwich ELISA format allowed sensitive and precise quantification of 
an ECP protein with significantly reduced expression in supplemented cultures. Another 
antibody, which specifically bound to trophozoite and tomont walls, was used to 
investigate the morphological and antigenic changes during thioglycollate-induced 
fonnation of prezoosporangia, and confinn supplement-induced fonnation of 
prezoosporangia. This antibody also labeled P. marinus cells in fixed oyster tissue in a 
species-specific manner. 
X1V 
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Chapter 1 
Introduction 
The eastern oyster, Crassostrea virginica, is a bivalve mollusc of commercial, 
ecological, and historical importance. The species occurs in natural populations from the 
Canadian Maritime provinces to Texas, as well as in Panama and the Caribbean (Carlton 
and Mann, 1996). It is also present in introduced populations on the Pacific coast of the 
United States and in Hawaii (Carlton and Mann, 1996; Munoz et al., 2003). Over the 
past one hundred years, the historically large populations have undergone significant 
decline, initially due to fishing and, later, disease pressures (Andrews, 1988; Hargis and 
Haven, 1988; Rothschild et al., 1994). In the 1880s, harvests of oysters in Virginia's 
portion of the Chesapeake Bay amounted to nearly 10 million bushels per year (Hargis 
and Haven, 1988; MacKenzie, 1997). Landings fell steadily over 75 years to 
approximately 3 million bushels per year by 1955 (Hargis and Haven, 1988; MacKenzie, 
1997). This decline was likely due to depletion of existing natural oyster beds and 
subsequent siltation and fouling of the small amount of residual shell (Rothschild et al., 
1994; MacKenzie, 1997). 
During the last half of the twentieth century, oyster landings have fallen below 
500,000 bushels per year due in large part to two parasitic diseases, commonly referred to 
as MSX and Dermo (Andrews, 1979; Andrews, 1988; Hargis and Haven, 1988; 
MacKenzie, 1997). MSX is caused by the haplosporidian parasite Haplosporidium 
nelsoni and has been responsible for epizootics in the mid-Atlantic states. It was initially 
reported as the cause of mortalities in 1957 in Delaware Bay, and two years later 
appeared in the Chesapeake Bay (Haskin et al., 1966; Andrews and Wood, 1967; 
Andrews and Castagna, 1978; Ford and Haskin, 1982). Through screening 
2 
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of natural populations and selective breeding techniques, strains of oysters have since 
been developed with decreased susceptibility to the disease (Haskin and Ford, 1979; Ford 
and Haskin, 1987). Since the late 1980s, MSX has been replaced by Denno as the most 
significant oyster disease (Craig et al., 1989; Burreson, 1991; Burreson and Ragone-
Calvo, 1996; Chu and Volety, 1997). Dermo is caused by the protozoan parasite 
Perkinsus marinus. 
Perkinsus marinus was first described by Mackin et al. (1950) and named 
Dermocystidium marinum, due to its perceived resemblance to fungal parasites of fish. It 
was later renamed Labyrinthomyxa marina based on observation of labyrinthulid 
protistan forms which were later felt to be cultural contaminants (Mackin and Ray, 1966; 
Perkins, 1996). In 1978, Levine proposed its placement into a new genus, Perkinsus, in 
the phylum Apicomplexa based on the observation by Perkins of a partial apical complex 
in the motile zoospore stage (Perkins, 1976b; Levine, 1978). Recent phylogenetic 
analysis using small-subunit ribosomal RNA and actin sequences has indicated that 
Perkinsus is phylogenetically basal to the apicomplexans and dinoflagellates, though it is 
likely more closely related to the latter (Fong et al., 1993; Goggin and Barker, 1993; 
Siddall et al., 1995; Reece et al., 1997; Noren et al., 1999; De La Herran et al., 2000). In 
1993, it was suggested that Perkinsus be placed in a new subphylum, Apicomonada, 
under the phylum Apicomplexa (Cavalier-Smith, 1993). This was later revised, with 
Perkinsus being a member of the infrakingdom Alveolata, superphylum Miozoa, phylum 
Dinozoa, subphylum Protalveolata (Cavalier-Smith, 1998). Phylum Dinozoa also 
contains, within subphylum Dinoflagellata, the dinoflagellates (Cavalier-Smith, 1998). 
Noren et al. ( 1999) have proposed that Perkinsus be placed into a new phylum, 
Perkinsozoa. 
Though P. marinus has likely been present in oyster populations since at least the 
early 1900s, in the past 15 years it has caused major oyster mortalities in Atlantic 
populations south of Delaware Bay (Burreson and Ragone-Calvo, 1996; Ford, 1996). 
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Perkinsus marinus occurs with highest prevalence and intensity in areas of high salinity 
and temperature, and the occurrence of P. marinus prior to the late 1980s was primarily 
restricted to high-salinity coastal bays south of Delaware Bay and in the Gulf of Mexico 
(Craig et al., 1989; Paynter and Burreson, 1991; Burreson and Ragone-Calvo, 1996). 
This is in agreement with laboratory findings that P. marinus is most infective under 
conditions ofhigh salinity and temperature (Chu and Greene, 1989; Chu and LaPeyre, 
1993; Chu et al., 1993; Ragone and Burreson, 1993; Chu et al., 1996; Chu and Volety, 
1997). During the late 1980s, there was a range extension into the upper reaches of 
Chesapeake Bay associated with four consecutive years of drought and warm winter 
temperatures (Burreson and Ragone-Calvo, 1996). In 1990, there was another sudden 
range extension into the northern side of the Delaware Bay, and from 1991 to 1995 the 
range extended further to its current northern limit in Maine (Ford, 1996). These 
extensions were postulated to have resulted from an introduction of diseased oysters to 
non-endemic sites, a change in either the parasite or host populations, a change in 
environmental conditions favorable for the parasite, or some combination thereof (Ford, 
1996). The severity of disease in this new range appears to be similar to that found in the 
south, with decreased growth and condition index, and death in the second or third year 
of infection (Ford et al., 2000). 
Perkinsus marinus occurs in vivo primarily as an unicellular trophozoite that 
develops a large vacuole which eccentrically displaces the nucleus, giving the cells a 
signet ring-like appearance (Perkins, 1996). In contrast with the replication solely by 
binary fission seen in vitro in ODRP-3 medium, trophozoites can multiply in vivo by 
budding or binary fission, or they can form multicellular tomonts surrounded by the 
parent trophozoite cell wall by palintomic fission (Fig. 1) (Perkins, 1996; Sunil a et al., 
2001). Tomonts may contain from 2 to 64 cells that are released by rupture of the 
parental cell wall (Perkins, 1996). Tomonts occur in all host tissues, but are most 
frequently observed intercellularly in the connective tissues, the epithelium ofthe gut, 
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gill, and digestive gland, and in hemocyte phagosomes (Perkins, 1996). Trophozoites can 
also differentiate into zoosporangia which, when released into seawater, undergo 
palintomic sporulation to yield small biflagellate zoospores that exit the zoosporangium 
through a discharge tube (Perkins, 1996). Trophozoites can be induced to form 
zoosporangia in vitro by incubation in thioglycollate medium. Incubation causes cell 
enlargement and alterations cell wall structure which allow it to be stained with 
Lugol' s iodine. This method is routinely used for P. marinus diagnosis (Ray, 1952). 
These enlarged trophozoites, or hypnospores, are functionally prezoosporangia, and if 
exposed to seawater will zoosporulate and release viable zoospores (Perkins and Menzel, 
1966; Perkins and Menzel, 1967; Perkins, 1976b). For unknown reasons, however, this 
zoosporulation technique has failed in recent years, limiting the ability to study zoospores 
(Perkins, 1996). All P. marinus life stages are capable of initiating infection, though 
trophozoites may be more infective than hypnospores or zoospores (Chu, 1996; Chu and 
Volety, 1997). The mechanisms and regulation of differentiation into these various 
morphological forms are not understood, nor is it known whether the formation of 
zoospores represents a sexual reproductive stage. 
Dermo disease is a chronic wasting syndrome that leads to slowing or cessation of 
growth and eventual mortality (Paynter and Burreson, 1991; Newell et al., 1994). 
Oysters typically acquire infections in mid- to late summer, and mortalities in the first 
year of growth are normally low. This is especially true in smaller oysters, presumably 
due to the reduced volume of water filtered and, thus, lower exposure to parasites 
(Burreson and Ragone-Calvo, 1996). During winter, the intensity of infection is greatly 
decreased, though there is evidence of a high prevalence of overwintering infections of 
very low intensity (Ragone-Calvo and Burreson, 1994). In the summer of the second 
year of infection, oyster mortality typically exceeds 90% (Paynter and Burreson, 1991; 
Burreson and Ragone-Calvo, 1996). 
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Figure 1. Life cycle of Perkinsus marinus during in vitro culture in ODRP-3 medium and 
during in vivo infection. Stage names are as described by Perkins (1996), with additional 
commonly used names for each stage and replicative mode listed in parentheses. The 
dashed line in the in vivo life cycle represents stages which may be external to the oyster. 
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Infections begin the gill, gut, or mantle epithelium, and parasite cells are found 
both between host cells and within phagosomes ofhemocytes. Parasite cells may be 
transported throughout the organism by mobile hemocytes. Alvarez (1992) demonstrated 
that abiotic particles introduced into the oyster digestive tract are phagocytosed and over 
a period of days are distributed throughout the oyster by hemocytes. In late infections, 
foci of P. marinus cells are found in all tissues. In the connective tissue and epithelium, 
large foci of P. marinus cells can cause extensive tissue lysis, abscess formation and, in 
heavy infections, occlusion ofhemolymph sinuses (Perkins, 1976a). The exact cause of 
death in the oyster is not known. It is unlikely that it is due to a systemic toxin, due to the 
chronic nature of the disease, and the large parasite burdens that can build up prior to 
death (Perkins, 197 6b ). Death may be due to long-term energetic drain by the parasites. 
Oyster feeding rates and nutrient assimilation rates have been found to be identical 
between infected and non-infected oysters, and the calculated energy requirements ofthe 
parasite may be sufficient to account for both decreased growth rate and mortality (Choi 
et al., 1989; Newell et al., 1994). The metabolic costs to the oyster may also be increased 
by the ongoing need to repair tissue damage caused by the parasite (Choi et aL, 1989). 
There is evidence that C. virginica is able to effect limited killing of P. marinus 
cells. LaPeyre et al. (1995) found that approximately 10% of phagocytosed P. marinus 
cells viewed by electron microscopy were partially degraded 12 hours after exposure to 
hemocytes. The mechanism of killing is not known. It is apparent that the oyster is 
capable of some defensive activity toward P. marinus, however, it does not appear to be 
sufficient to effectively combat infection. This may be due to (1) the inability of extant 
defense mechanisms to kill P. marinus, (2) the parasites ability to overwhelm moderately 
effective oyster defenses by rapid proliferation, or (3) the ability of P. marinus to 
circumvent or downregulate relevant defense mechanisms by one or more virulence 
factors. 
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Crassostrea virginica defenses include both cellular and humoral mechanisms. 
The hemolymph is clear, devoid of respiratory pigments, and contains hemocytes within 
a complex mixture of plasma proteins. These are distributed throughout the oyster by an 
open circulatory system that conveys hemolymph through sinuses and intracellular spaces 
in direct contact with tissue cells (Ebel and Scro, 1996). Hemolymph contains three 
types of cells, the granulocytes, hyalinocytes, and the serous, or brown, cells. 
Granulocytes account for the majority of circulating hemocytes and contain a mixture of 
acidophilic, basophilic and refractile granules and form filopodial extensions when 
adhered to surfaces (Foley and Cheng, 1972; Auffret, 1988; Cheng, 1996). Hyalinocytes 
contain few to no granules and tend to form broad cytoplasmic extensions, or lobopodia 
(Foley and Cheng, 1972; Cheng, 1996). Serous cells are found predominantly in the 
excretory Keber's glands in the atria and mantle and, though they are capable of 
migration, are not considered to be true hemocytes (Cheng, 1996). They are believed to 
play a role in removal of products of parasite metabolism and degradation (Cheng, 1996). 
The primary defensive role ofhemocytes is phagocytosis and intracellular 
degradation of pathogens, though they also appear to be responsible for production of 
many of the humoral defense molecules (Cheng and Roderick, 1975; Cheng, 1976; 
Mohandas and Cheng, 1985; Mohandas et al., 1985; Chu, 1988; LaPeyre, Chu and 
Meyers, 1995; LaPeyre, Chu and Vogelbein, 1995; Cheng, 1996). In vitro, granulocytes 
are more actively phagocytic toward both bacteria and P. marinus than are hyalinocytes 
{Foley and Cheng, 1975; LaPeyre, Chu and Meyers, 1995; LaPeyre, Chu and Vogelbein, 
1995). Oyster hemocytes chemotactically respond to Gram positive and negative 
bacteria, as well as toward P. marinus cells and cell lysate (Cheng and Howland, 1979; 
Howland and Cheng, 1982; Garreis et al., 1996). The receptor or receptors driving these 
chemotactic responses are not known. 
Phagocytosis requires initial surface attachment of the particle to the hemocyte, 
and thus some ability to detect and discriminate self from non-self particles. Some non-
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self recognition is based on physical properties of both the hemocyte and the particle (e.g. 
hydrophobicity, charge); however, there is evidence that there is recognition in 
invertebrates which goes beyond simple detection ofbulk physical traits (Anderson, 
197 5; Bigger, 1984; Cheng, 1987). Self/non-self discrimination and pre-phagocytic 
binding in the oyster may be based on carbohydrate recognition by lectins, which are 
glycoproteins that specifically bind the carbohydrate moieties of other glycoproteins 
(Sminia and van der Knapp, 1986). Invertebrate lectins may be integral in the hemocyte 
membrane, free in hemolymph, bound to cell-surface lectin receptors, or stored within 
hemocytes (Yeaton, 1981 b; Vasta et al., 1982; Vasta et al., 1984; Sminia and van der 
Knapp, 1985; Vasta and Marchalonis, 1985; Arizza et al., 1991). They can exist singly or 
as non-covalently bound multimers of single or combined specificities and can function 
as opsonins or, in their multivalent form, as agglutinins (Yeaton, 1981a; Chu, 1988; 
Fisher and DiNuzzo, 1991; Kawabata and Iwanaga, 1999). Integral membrane lectins 
may be capable of signal transduction upon binding their ligand (Kwaik et al., 1998). 
Thus, lectins may play a major role in both cellular and humoral defenses in the oyster by 
providing a potential mechanism for self/non-self recognition and cellular activation, and 
through their functions as agglutinins and opsonins. 
Crassostrea virginica has at least two serum lectins of differing carbohydrate 
specificity, as well as a membrane-bound lectin on hemocytes which bears the same 
specificity as one of the serum lectins (McDade and Tripp, 1967b; Vasta et al., 1982; 
Vasta et al., 1984). Fisher and DiNuzzo (1991) tested the agglutinating capability of 
oyster serum against 94 bacterial isolates as well as red blood cells from seven vertebrate 
species and found that oyster serum agglutinated all red blood cell types, as well as 64 of 
the 94 bacterial isolates tested. There was some specificity in the agglutination reaction, 
with variations in agglutination intensity between different isolates of the same species, 
for example all 01-serotype Vibrio cholerae were agglutinated, while non-01-serotype 
were not (Fisher and DiNuzzo, 1991 ). The agglutinating molecule or molecules were 
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heat labile, but were not isolated nor further characterized; the assumption was made that 
they were multivalent lectins. 
The role of agglutinating or opsonic 1ectins in P. marinus infection is not known. 
Chintala et al. (1994) found no correlation between parasite density or survival time and 
serum agglutination titer to Vibrio cholerae or horse or human red blood cells. Given the 
possibility of involvement oflectins of differing specificity, however, the role oflectins 
in P. marinus defense cannot be excluded. The exact mechanisms by which C. virginica 
hemocytes distinguish pathogens, including P. marinus, have not been elucidated. While 
oyster hemocytes clearly recognize and phagocytose P. marinus cells, the occurrence of 
up to half of infecting P. marinus cells free in tissues and hemolymph suggests a masking 
of the parasite from recognition by oyster hemocytes (Cheng and Dougherty, 1994), or 
inactivation of hemocyte phagocytic function. 
Following phagocytosis, C. virginica hemocytes are capable ofboth oxygen-
dependent and oxygen-independent killing and degradative mechanisms within 
phagosomes (Anderson, 1996). The initiation of oxygen-dependent killing mechanisms, 
the respiratory burst, is marked by a rapid use of oxygen in creation of toxic reactive 
oxygen species (ROS) (Anderson, 1994). The progenitor of all ROS is the superoxide 
anion (02), which is produced by the univalent reduction of molecular oxygen by a 
membrane-bound NADPH-oxidase. The superoxide anion may then spontaneously 
dismute, or be dismuted by the enzyme superoxide dismutase (SOD), to hydrogen 
peroxide. Further enzymatic processing of hydrogen peroxide may yield other reactive 
species such as hydroxyl radicals, singlet oxygen and, in the presence of myeloperoxidase 
enzyme and halide species, hypohalous acids (Klebanoff, 1968; Pipe, 1992; Anderson et 
al., 1995). Torreilles and Guerin (1999) have documented production of another highly 
toxic ROS product, peroxynitrite in the hemocytes of the mussel Mytilus 
galloprovincialis. Using a variety of chemiluminescent probes (e.g.lucigenin for 
superoxide anion; luminol for myeloperoxidase activity) and ROS inhibitors and 
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scavengers (e.g. superoxide dismutase, catalase, taurine, mannitol, azide), Austin and 
Paynter (1995) showed that hemocytes of C. virginica are capable of producing 
superoxide anion, hypochlorous acid (HOCl), and probably hydrogen peroxide in 
response to phagocytosis of zymosan, a particulate yeast cell wall preparation, or 
treatment with the protein kinase C activator, phorbol myristate acetate. They also found 
a positive relationship between the level of ROS production on exposure to zymosan or 
PMA and the underlying P. marinus infection intensity. Anderson et al. (1995) similarly 
found that zymosan-induced chemiluminescence was higher in oysters with moderate to 
heavy P. marinus infections. Phagocytosis of P. marinus trophozoites does not, however, 
induce a chemiluminescent response in oyster hemocytes, implying a priming effect on 
ROS production coupled with non-activation or suppression of activation of actual ROS 
generation, or a scavenging ofROS (Volety and Chu, 1995; Anderson, 1999). Bramble 
and Anderson (1999) question the significance of the ROS response in oyster defense 
based on a low level of response, in comparison with striped bass phagocytes, to 
challenge with Bacillus megaterium or Pseudomonas fluorescens. 
Volety and Chu (1995) found that the luminol-enhanced chemiluminescence 
measurement of zymosan-induced ROS response was suppressed by introduction of live, 
but not heat-killed, P. marinus trophozoites. Anderson (1999) demonstrated the same 
effect using live and osmotically killed P. marinus. He further quantified the inhibition 
using lucigenin to specifically detect superoxide anion. These results indicate a possible 
up-regulation or release of inhibitory or scavenging molecules in the extracellular 
products (ECP) of P. marinus upon phagocytosis. Scavenging of ROS by molluscan 
parasites has been demonstrated in the gastropod mollusc Biomphalaria glabrata. The 
sporocyst of Schistosoma mansoni secretes an antioxidant molecule which suppresses the 
effectiveness of the hemocyte ROS response in the snail (Connors and Yoshino, 1990; 
Connors et al., 1991). In humans, a phosphatase secreted by Leishmania blocks 
superoxide anion production in neutrophils (Remaley et al., 1984). 
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The oxygen-independent cellular defense mechanisms in the oyster overlap 
significantly with many of the humoral defense mechanisms. The presence of several 
lysosomal enzymes, including acid and alkaline phosphatases, ~-glucuronidase, a-
mannosidase, lipase, and lysozyme occurs both in hemocytes as well as free in oyster 
serum (Roderick and Cheng, 1974; Cheng and Roderick, 1975; Cheng, 1976; Chu and 
LaPeyre, 1989; Cheng, 1992; LaPeyre, Chu and Meyers, 1995). Fusion of cytoplasmic 
granules with the phagosomes releases lysosomal enzymes which can kill and degrade 
pathogens phagocytosed by the cell. There is evidence that hemocyte granules may also 
be the source of some components of molluscan humoral immunity. Lysosomal enzymes 
contained in granules in the hemocytes of Mercenaria mercenaria, for example, are 
released into the serum within a dual-membrane vesicle that degrades in the serum 
(Mohandas and Cheng, 1985; Mohandas et al., 1985). Oysters also show inducible 
release oflysosomal enzymes into the serum. Cheng (1992) measured the serum levels 
of two lysosomal enzymes, acid phosphatases and a-mannosidase following exposure to 
four bacterial species. Oyster hemocytes apparently selectively released lysosomal 
enzymes to the serum upon exposure to Escherichia coli and Salmonella sp., but not on 
exposure to Klebsiella oxytoca or Micrococcus roseus (Cheng, 1992). The association of 
enzyme release with hemocyte recognition and/or phagocytosis ofthe bacteria was not 
addressed. Lysozyme, a lytic lysosomal enzyme capable of catalyzing the cleavage of 
the ~-1 ,4 linkage between N-acetylmuramic acid and N-acetylglucosamine in bacterial 
cell walls, has been extensively studied as a mechanism of humoral defense in C. 
virginica (McDade and Tripp, 1967a; Roderick and Cheng, 1974; Chu and LaPeyre, 
1989; LaPeyre, Chu and Meyers, 1995). Wnile oyster lysozyme is effective against 
numerous Gram positive and Gram negative bacterial isolates, it does not appear to play a 
role in Perkinsus defense (Chu and LaPeyre, 1989). 
In addition to the agglutinating and lysosomal proteins described above, oysters 
have humoral defense mechanisms mediated by low molecular weight proteins. Oysters 
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have been reported to have a <1 0 k:Da molecule active against P. marinus, however, it 
was of very limited effect in vitro, and is of questionable significance (Anderson and 
Beaven, 2001). Oysters also have a peptide(< 10 kDa) serum component that acts as a 
protease inhibitor (Oliver et aL, 1999). The level of protease inhibition in the serum was 
positively correlated with the susceptibility of oyster lines selectively bred for decreased 
P. marinus susceptibility (Oliver et al., 2000). 
The particular molecular determinants of virulence in P. marinus are not known, 
though there is growing evidence that proteolytic enzymes in the ECP of P. marinus may 
play an important role in parasite virulence and modulation of host defenses (Garreis et 
al., 1996; LaPeyre et al., 1996; Oliver et al., 1999). Proteases have been shown to be 
virulence factors in several protozoan pathogens (McKerrow et al., 1993 ). Pathogenicity 
is associated with total protease production in the apicomplexan parasite Babesia bovis 
(Wright et al., 1981). While still infective, strains that do not produce protease fail to 
cause the fatal disease normally associated with infection (Wright et al., 1981 ). The 
cercarial proteases of schistosomes play a direct role in parasite virulence; their 
inhibition, while not interfering with parasite motility or attachment processes, prevents 
skin penetration (McKerrow and Doenhoff, 1988; McKerrow et aL, 1993). Amastigote 
and promastigote forms of Leishmania mexicana secrete cysteine proteases crucial to 
their survival within phagosomes of mammalian macrophages (Coombs, 1982; Pupkis 
and Coombs, 1984). One leishmania! protease, leishmanolysin or gp63, is a virulence 
factor involved in host macrophage binding and complement inactivation; its 
upregulation leads to higher infectivity of the parasite (Ramamoorthy et al., 1992; 
McKerrow et al., 1993; McGwire et al., 2002). Trypanosoma cruzi, the causative agent 
of Chagas' disease, secretes the cysteine protease cruzipain which is required for parasite 
replication and differentiation (McKerrow et al., 1993). In the Plasmodium malarial 
parasites, sets of proteases variously involved in erythrocyte penetration, hemoglobin 
digestion, and erythrocyte rupture are differentially expressed during trophozoite, 
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schizont and merozoite life stages (Rosenthal et al., 1987; Braun-Breton and Pereira da 
Silva, 1988; McKerrow et al., 1993). Other protozoan parasites, including Trypanosoma 
brucei, Trichomonas vagina/is, and Giardia Iamblia, secrete proteases which are of 
unknown significance in virulence (McKerrow et al., 1993). 
The study of protease secretion by P. marinus began with assessment of relative 
amounts of protease contained within ECP by casein hydrolysis (LaP eyre and Faisal, 
1995b ). The proteases were further investigated and categorized as serine proteases 
based on protease inhibitor studies (LaP eyre, Schafhauser et al., 1995). One or more 
constituents of P. marinus ECP appears to be involved in virulence, as oysters fed P. 
marinus ECP encapsulated in liposomes had a sevenfold increase in P. marinus body 
burden after experimental infection (LaPeyre et al., 1996). The mechanism behind this 
increase is not known, but may be due to a protease-mediated disruption of the gut 
epithelium favoring parasite invasion, increased availability of nutrients leading to 
increased parasite replication, or a disruption of oyster defense mechanisms. Oliver et al. 
(1999) demonstrated that a 35 kilodalton C. virginica hemolymph protein ofunknown 
function was degraded in the presence of ECP. Subsequent studies have demonstrated 
that nearly all oyster hemolymph proteins are susceptible to degradation by P. marinus 
ECP pro teases (Earnhart, unpublished results). Only limited attempts have been made to 
isolate and purify individual proteases for structural investigation, and there have been no 
experiments designed to elucidate specific functional roles for these proteases. The DNA 
sequence of one P. marinus protease has been determined, and bears sequence homology 
with the subtilisin class of serine proteases; however, the function of the protease is not 
known, nor is it clear if this protease is secreted extracellularly (Brown, 2001). There 
currently exists no adequate means of quantification or functional analysis of individual 
proteases either in vitro or in vivo, nor have there been genetic analyses specifically 
targeting the secreted pro teases for assessment of their classification and relatedness to 
known virulence factors. 
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The study of the excretory products and, in particular, pro teases of P. marin us has 
been greatly facilitated by the development of methods of in vitro culture. There are 
several media for in vitro P. marinus culture, ranging from a chemically defined protein-
free medium to media containing such supplements as yeastolate, cod liver oil, bovine 
serum albumin, fetal bovine serum (FBS), and fetuin (Gauthier and Vasta, 1993; 
Kleinschuster and Swink, 1993; LaPeyre et al., 1993; Dungan and Hamilton, 1995; 
Gauthier et al., 1995; LaPeyre and Faisal, 1997). The effects ofsupplementingP. 
marinus media with oyster tissue homogenates and hemolymph from both P. marinus-
susceptible and tolerant oyster species have also been studied. This supplemented media 
produces marked changes in cell proliferation as well as morphology and differentiation 
(Gauthier and Vasta, 2002; Macintyre et al., 2003). In addition, there are significant 
changes in the pattern of protease expression when P. marinus cells are exposed to C. 
virginica homogenates. Those changes are not seen when cells are exposed to 
homogenates from the more tolerant oyster species C. gigas and C. ariakensis (Macintyre 
et al., 2003). The ECP of cells grown in chemically defined medium displays only the 
apparently constitutively-expressed higher molecular weight proteases. Supplementation 
of this media with oyster products causes dose-responsive changes in intensity of 
proteolytic bands, and alteration in protease profile including both apparent 
downregulation of high molecular weight, and upregulation oflow molecular weight 
proteases (Macintyre et al., 2003). 
In order to address their significance in P. marinus virulence, pro teases have been 
purified as a class from the ECP of P. marinus cells grown in defined and supplemented 
media using affinity chromatography. This purification technique relies on the affinity of 
a protease active site for either a substrate or for a specific or non-specific reversible 
enzyme inhibitor. Proteases, including P. marinus serine proteases, can be purified using 
the cyclopeptide antibiotic bacitracin (van Noort et al., 1991; Faisal et al., 1999). Both 
whole ECP and purified ECP proteases have been shown to affect several important 
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defense parameters in vitro. The normal chemotactic response of oyster hemocytes 
across a microporous filter toward P. marinus cells or P. marinus cell lysate was 
significantly reduced when P. marinus ECP or bacitracin-purified protease was co-
located with the cells or lysate (Garreis et al., 1996). Perkinsus marinus ECP and 
purified protease also decreased the level of random, non-stimulated migration across the 
a microporous filter (Garreis et al., 1996). Coincubation of C. virginica serum with ECP 
also decreased the level of lysozyme activity and reduced the titer of agglutinins toward 
sheep red blood cells (Garreis et al., 1996). As has been discussed previously, P. marinus 
ECP may also contain products that scavenge or downregulate production ofROS upon 
phagocytosis by oyster hemocytes (Volety and Chu, 1995; Anderson, 1999). 
Assessment of induction, expression levels, elaboration, and function of possible 
virulence factors in the ECP of P. marinus requires specific and sensitive methods of 
detection and purification. Attempts have been made to create antibodies against both P. 
marinus whole cells and ECP. Choi et al. (1991) produced a rabbit polyclonal antiserum 
to lysed hypnospores created by incubation of infected oyster tissues in fluid 
thioglycollate medium. While hypnospore protein could be sensitively detected both by 
enzyme-linked immunosorbant assay (ELISA) and immunofluorescent staining of whole 
hypnospores, the antiserum failed to react with any other form of the parasite (Choi et al., 
1991). There was also significant crossreactivity of the antiserum with uninfected oyster 
tissue, requiring adsorption of crossreactive antibody with acetone-dried oyster tissue and 
oyster egg powder. This crossreactivity was attributed to either antigenic similarity 
between oyster and P. marinus proteins, or to embedded oyster cell membranes within 
the hypnospore wall (Choi et al., 1991). While not explicitly stated, the immunization 
regimen utilized in that study implied that the hypnospores may have been poorly 
immunogenic, as the initial immunization of 1 mg of protein was followed by five 0.5 mg 
immunizations prior to antiserum collection. 
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Dungan and Roberson (1993) created rabbit polyclonal antibodies using four 
injections of 3.0 x 106 parafonnaldehyde-fixed whole hypnospores created in fluid 
thioglycollate media. By ELISA, there was some minor crossreactivity with oyster 
proteins. The polyclonal antiserum recognized all life stages of P. marinus and was 
successfully used for fluorescent immunostain detection of P. marinus cells in tissue 
section. Reactive cells were clearly visible in infected epithelial and connective tissues, 
as well as within the lumen of the digestive tract. The tissues surrounding the P. marinus 
cells displayed a diffuse fluorescence that may have been due to secreted ECP detected 
by the polyclonal antiserum. The antibodies crossreacted with other members of the 
genus Perkinsus as well as other dinoflagellate species (Dungan and Roberson, 1993; 
Dungan et al., 2000). Bushek et al. (2002) tested the reactivity of this polyclonal 
antiserum against nineteen free-living and eight parasitic dinoflagellates. They found 
reactivity with seven of the parasitic dinoflagellates and three of the free-living species. 
Polyclonal antiserum against one of the reactive parasitic dinoflagellates, Hematodinium 
sp., also crossreacted with those same parasitic dinoflagellates and with P. marinus, 
indicating shared epitopes among these species. When crossreactive binding occurred, it 
was not confined to surface determinants, but was often found in the cytoplasm and 
nucleus as well. The identity of the crossreactive immunogen or immunogens is not 
known. 
Monoclonal antibody production was also attempted by Dungan and Roberson 
(1993) using mice immunized with hypnospores of P. marinus. Mice initially immunized 
with 105 cells in Freund's complete adjuvant (CFA), then boosted twice with 1.0 to 3.0 x 
105 cells failed to produce an adequate serum titer. Only after repeated subcutaneous 
immunizations with and without CF A was the titer satisfactory to allow fusion. Of the 26 
ELISA-positive hybridomas created, most were of the IgM isotype, and none bound in 
vivo cells immunostaining assays. 
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Monoclonal antibodies to whole P. marinus cells were produced by Romestand, 
et al. (200 1) by three immunizations of 3 x 106 previously frozen trophozoites. Two 
hybridomas were selected and were incorporated into a competitive ELISA format 
capable of measuring proliferation of P. marinus in vitro culture. The antibodies 
bound to all life stages of P. marinus, but were cross-reactive with P. at/anticus (now 
synonymized with P. olseni (Murrell et al., 2002)). 
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Montes et aL (2002) prepared a polyclonal rabbit antiserum against several 
proteins from lysed hypnospores of Perkinsus at/anticus which had been excised from a 
preparative SDS-P AGE gel. An antiserum recognizing a 233 kDa protein was selected 
for further study and that protein was found to be a major cell wall component of P. 
atlanticus. The polyclonal antiserum bound to all walled life stages, and was cross-
reactive on immunoblot with a P. marinus protein of similar size. 
Ottinger et al. (2001) used the ECP of P. marinus grown in a chemically defined 
medium to create polyclonal rabbit antiserum. This antiserum was used for comparison 
of in vitro with in vivo ECP protein secretion, for development of a quantitative ELISA 
for measurement of ECP production, and to attempt correlation of in vivo ECP levels 
with infection intensity. Immunoblots of negative, lightly, and heavily infected oysters 
were used to assess binding of the antiserum to putative in vivo components of ECP. 
Seventeen in vitro-produced ECP proteins were recognized by the antiserum by 
immunoblot. Three of these were identical to those found in infected oysters. There 
were two additional proteins detected that did not correspond to any in vitro produced 
protein. 
The intensity of infection, as assessed by ELISA, was in disagreement with the 
fluid thioglycollate assay for P. marinus infection from 40% to 45% of the time. The 
majority of the disagreement was due to ELISA-positive, FTM-negative findings, which 
could have been caused by the greater sensitivity of the ELISA assay. There was a 
blocking effect of oyster homogenate, and a low level of crossreactivity with oyster 
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tissues that hampered detection of low ECP concentrations. During attempts to 
reproduce and expand on the findings of Ottinger et al. (200 1 ), new batches of polyclonal 
rabbit antisera were produced, which proved to be crossreactive with non-infected oyster 
tissue and hampered efforts to reproduce the ELISA and immunoblot results. 
Furthermore, the anti-ECP titer in each of two identically treated rabbits was low, despite 
repeated boosts (Earnhart, unpublished results). 
Given the magnitude of the decline in oyster populations due toP. marinus, there 
is a critical need for directed research into the specific mechanisms by which the 
differentiation and virulence of this parasite are regulated. Recently, Ford et al. (2002) 
confirmed a multitude of anecdotal evidence regarding the rapid loss of parasite virulence 
during in vitro culture. This may provide a useful tool for the study of critical virulence 
factors, especially if a reliable mode of restitution of virulence for in vitro cultures can be 
uncovered. Evidence to date suggests that ECP, and especially the ECP proteases, may 
play a significant role in virulence. Despite a number of technical hurdles to be 
overcome, creation of antibodies specific to ECP components will allow a needed 
understanding of their regulation and role in virulence. 
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Chapter 2 
Supplementation of Perkinsus marinus cultures with host plasma or tissue 
homogenate enhances their infectivity 
Abstract 
The protozoan oyster parasite, Perkinsus marinus, can be cultured in vitro in a 
variety of media; however, this has been associated with a rapid attenuation of infectivity. 
Supplementation of defined media with products of P. marinus-susceptible ( Crassostrea 
virginica) and tolerant (C. gigas, C. ariakensis) oysters alters proliferation and protease 
expression profiles, and induces differentiation into morphological forms typically seen 
in vivo. It was not known if attenuation could be reversed by host extract 
supplementation. To investigate correlations among these changes as well as their 
association with infectivity, the effects of medium supplementation with tissue 
homogenates from both susceptible and tolerant oyster species were examined. The 
supplements markedly alter both cell size and proliferation, regardless of species; 
however, upregulation of low molecular weight protease expression is most prominent 
with susceptible oysters extracts. Increased infectivity occurs with the use of oyster 
product-supplemented media, but is not consistently associated with changes in cell size, 
cell morphology, or protease secretion, and is not related to the susceptibility of the 
oyster species used as the supplement source. 
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lnt:roduction 
Perkinsus marinus is a protozoan parasite of the eastern oyster, Crassostrea 
virginica. Mortalities caused by this parasite typically occur in the second summer of 
infection, and have been responsible for much of the recent decline in the oyster fishery 
along the eastern seaboard of the United States (Burreson and Ragone-Calvo, 1996; Ford, 
1996). The molecular mechanisms of parasite infectivity, virulence, and interaction with 
the host defense system are largely unknown. The development of media formulations 
allowing axenic culture of Perkinsus marinus has provided new opportunities to assess 
the effects of host components on parasite growth, physiology, and infectivity. There are 
several media formulations for in vitro P. marinus culture that employ commercial base 
formulations (e.g. Dulbecco modified Eagle's medium with Ham's Fl2 nutrient mixture) 
supplemented with such constituents as cod liver oil, bovine serum albumin, yeastolate, 
fetal bovine serum (FBS), or its a-fetoprotein constituent, fetuin (Gauthier and Vasta, 
1993; Kleinschuster and Swink, 1993; LaPeyre et al., 1993; Dungan and Hamilton, 1995; 
Gauthier et al., 1995; Gauthier and Vasta, 1995). There is also a chemically defined, 
protein-free medium (ODRP-3; LaPeyre and Faisal, 1997) which has proven to be of 
particular value for the production of antibodies against P. marinus extracellular products 
(Earnhart and Kaattari, 2003). 
The in vivo P. marinus life cycle begins with a small, immature trophozoite, that 
enlarges over time into a "signet ring" form, so named for its large vacuole and offset 
nucleus. This mature trophozoite may then undergo palintomic fission in which 4 to 64 
or more immature trophozoites are formed within, then exit from, the parental cell, or 
tomont, wall (Perkins, 1996). Perkinsus marinus can also form motile zoospores, again 
by palintomic fission, with exit of the zoospores through a discharge tube and pore 
structure formed on the wall of the enlarged parental trophozoite, the zoosporangium 
(Perkins, 1996). During in vitro culture in ODRP-3 medium, cellular proliferation is 
apparently solely by binary fission, and no zoosporulation is seen. In an effort to more 
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closely simulate, vitro, the milieu to which P. marinus is exposed in vivo, oyster tissue 
homogenate and plasma from P. marinus-susceptible and tolerant oyster species have 
been employed as culture supplements (Gauthier and Vasta, 1995; Gauthier and Vasta, 
2002; Macintyre et al., 2003). Compared with growth in unsupplemented ODRP-3, 
Perkinsus marinus cells grown in the presence of plasma supplements from Crassostrea 
gigas, Crassostrea ariakensis, or infected C. virginica oysters show reduced in vitro 
proliferation (Gauthier and Vasta, 2002). Uninfected C. virginica plasma 
supplementation, however, results in only minimal inhibition of proliferation (Gauthier 
and Vasta, 2002; Macintyre et al., 2003). Oyster tissue homogenate supplemented media 
produces marked changes in cell proliferation, morphology, and differentiation, including 
enlargement of trophozoites and induction of tomont stages, which are rarely seen in 
unsupplemented ODRP-3 medium, but commonly observed during infection (Macintyre 
et al., 2003). 
Several studies have implicated proteases as contributing factors in P. marinus 
virulence (Garreis et al., 1996; LaPeyre et al., 1996; Oliver et al., 1999; Oliver et al., 
2000). The extracellular products of P. marinus cells grown in ODRP-3 contain only 
high molecular weight (>50 kDa) proteases (Macintyre et al., 2003). However, when C. 
virginica plasma or homogenate is used as a media supplement, there is significant 
alteration in P. marinus protease expression patterns, including a simultaneous down-
regulation of high molecular weight, and upregulation of low molecular weight (<50 
kDa) proteases. These changes are not seen when cells are exposed to homogenates from 
C. gigas and C. ariakensis oysters (Macintyre et al., 2003), both of which have been 
reported to be more tolerant of P. marinus infection than is C. virginica (Meyers et al., 
1991; Barber and Mann, 1994; Calvo et al., 2000; Calvo et al., 2001). 
It is not clear if there is an association between the observed changes in cellular 
morphology and the shifts the secreted protease profiles in supplemented cultures, or 
whether either is associated with parasite infectivity. In order to better understand these 
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relationships, protease production, in vitro cell size and morphology, and infectivity were 
assessed under various conditions. Observations were made of variations in these factors 
among donal P. marinus isolates, then one isolate was selected for investigation of 
alterations in the presence of various host-derived media supplements. A detailed 
observation of the effects of tissue-based supplements derived from susceptible and 
tolerant oysters was then assessed, and a selected dosage level was used to investigate 
infectivity using a variety of oyster populations and species. 
Materials and methods 
Animals 
Experimental oysters were maintained in 1 !liD filtered York River (Virginia, 
USA) water and fed commercially produced algae (Reed Mariculture, San Jose, CA). 
Water changes were performed twice weekly, and all effluent water was chlorinated prior 
to release. Perkinsus marinus-free C. virginica oysters from Maine (C. virginica ME; 
Pemaquid Oyster Company, Waldoboro, ME) were initially employed, but the 
occurrence of P. marin us infections in those oysters over the course of this study 
necessitated the importation of disease-free C. virginica oysters from Washington state 
(C. virginica W A; Taylor Shellfish Farms, Shelton, W A). Crassostrea gigas oysters 
were purchased from Taylor Shellfish Farms. Crassostrea virginica oysters originally 
from populations in Louisiana (C. virginica LA), Tangier Sound (C. virginica TG) in the 
Chesapeake Bay, Virginia, and the CROSBreed program (C. virginica XB; selectively 
bred for P. marin us resistance) were all gathered from a single deployment site in the 
Yeocomico River, a tributary of the Potomac River (Virginia, USA) near its entrance to 
the Chesapeake Bay. Crassostrea ariakensis oysters were provided by the Virginia 
Institute of Marine Science oyster hatchery. A subsample of both the C. virginica ME 
and C. virginica WA oysters used in infection trials was confirmed to be P. marinus-free 
by body burden analysis (see below). 
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Infection trials and analysis of P. marinus body burden 
Oysters were infected by injection of parasites into the mantle cavity through a 
small hole in the shell made with a lapidary saw. Each oyster was injected with 106 
parasite cells suspended in 1 00 J..LL of artificial sea water (20 ppt; Forty Fathoms Marine 
Mix, Marine Enterprises International, Baltimore, MD) on days 1, 3 and 5, and a sham 
group was injected with artificial sea water. The oysters were maintained at a density of 
ten to fifteen per 35 L aquarium and sacrificed after four weeks for analysis of P. marinus 
infection level. 
In order to most accurately and sensitively quantify the infection level following 
experimental infection, P. marinus cells were enumerated using the whole body burden 
technique (Choi et al., 1989; Fisher and Oliver, 1996). Briefly, the oyster soft tissues 
were finely minced and incubated at room temperature for seven days in 20 mL fluid 
thioglycollate medium (2.9% FTM, T-9032, Sigma-Aldrich, Inc., St. Louis, MO; 2% 
NaCl) supplemented with penicillin/streptomycin solution (5% (v/v); P-0781, Sigma-
Aldrich, Inc.). Following incubation, the tissue was pelleted by centrifugation, 
resuspended in 20 mL 2M NaOH, and held at 60°C for three to four hours to dissolve the 
oyster tissue. The enlarged P. marinus prezoosporangia (hypnospores) were then 
pelleted, washed three times in distilled water, stained with a 1:5 dilution ofLugol's 
iodine, immobilized on a 0.45 J..Lm filter by vacuum, and enumerated by light microscopy. 
When necessary, dilutions of the hypnospores were made in distilled water, counted in 
triplicate, and the mean count extrapolated to the volume of the sample. The resultant 
counts were loge transformed for analysis of variance and for Tukey's multiple 
comparisons test, using a 5% error rate. 
Analysis of proteolytic enzyme expression 
Supernatants from P. marinus cultures and their respective media controls were 
analyzed for protease production by zymography. Twenty J..LL of media or culture 
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supernatant were electrophoresed under non=reducing conditions by SDS-P AGE 
(Laemmli, 1970) using an 8% polyacrylamide separating gel copolymerized with 0.1% 
porcine gelatin (G-8150, Sigma-Aldrich, Inc.), and a 4% stacking gel. Following 
electrophoresis, the gels were washed three times for ten minutes in 2.5% Triton-X-1 00 
(BP151, Fisher Scientific, Fairlawn, NJ) to renature the proteins, then once in 0.1 M Tris 
HCl (BP152, Fisher Scientific), pH 8.0. The gels were then incubated at 37°C in a fresh 
change ofTris HCl, pH 8.0 buffer. While use ofbuffers from pH 4.0 to pH 9.0 have 
previously been shown not to alter the P. marinus zymographic profile, pH 8.0 is 
optimum for detection of P. marinus proteolytic activities by zymogram (LaPeyre et al., 
1995), and has been specifically used for the study of the modulation of protease 
expression under varying media supplementation schemes (Macintyre et al., 2003). 
Following incubation, the gels were stained overnight in Coomassie brilliant blue G-250 
(0.1 %; 161-0406, Biorad, Hercules, CA) in 40% methanol, 10% acetic acid. The gels 
were destained in the same solution, without the stain. The gels were then assessed for 
the presence of cleared bands corresponding to the location of gelatinolytic proteases. 
Since the gels were, by necessity, run under non-reducing conditions, no attempt was 
made to assign absolute molecular weights to them. The proteases are, for convenience, 
referred to as high (>SOkDa) and low (<SOkDa) molecular weight species. 
Assessment of differences in infectivity among several isolates of P. marinus 
Perkinsus marinus clonal isolates LAl0-1 (ATCC#50906; genotype #4), MA2-11 
(ATCC#50896; genotype #1), SC3-2 (genotype #3) (Bushek et al., 2000), and P-1 
(genotype #9) (Faisal et al., 1999), and the isolate HVA-18 (ATCC#50764; genotype #8) 
(Bushek et al., 2000) were cultured for use in an infection trial, and were selected based 
on previous genotype identification at eight polymorphic loci (Reece et al., 2001 ). The 
HV A-18 isolate was not initially cloned; however, genetic analysis of this isolate at three 
loci showed little genetic variability, supporting the possibility that it has become clonal 
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by serial passage (unpublished data). All cultures were seeded at 106 cells per in 75 
cm
2 flasks containing 50 mL of a supplemented DMEM-Ham's medium with 5% fetal 
bovine serum commonly known as "Dungan's medium" (Dungan and Hamilton, 1995; 
Ford et al., 2002). Cultures were maintained in a humidified incubator at 27°C under 5% 
C02 for three weeks, harvested for oyster challenge, and the culture supernatants assayed 
by zymography. Prior to challenge, cells were enumerated by hemacytometer and their 
mean size was estimated using an ocular micrometer. Twenty C. virginica ME oysters 
per group were subjected to experimental infection. 
Assessment of the effects of oyster plasma and tissue homogenate supplementation on P. 
marinus infectivity 
The P-1 isolate of P. marinus was chosen for further study based on its 
demonstrated potential to alter its secretion profile of high and low molecular weight 
proteases following media supplementation. Both plasma and tissue homogenate 
supplemented media induce similar changes in P-1 protease expression, but only 
homogenate alters cell size and morphology, allowing the opportunity to distinguish 
correlations between these alterations and parasite infectivity. Hemolymph was 
withdrawn from the adductor muscle through a shell notch in three C. virginica ME 
oysters, using a syringe fitted with a 25 gauge needle. The hemocytes were removed by 
centrifugation (500 x g, 5 minutes), and the plasma was pooled and filtered through a 
0.22 J.lm filter (J!Star LB, Costar, Coming, Inc., Acton, MA). The oyster tissues were 
pooled and processed for homogenate basically in the manner described in Macintyre et 
al. (2003). Briefly, the oyster soft tissue was finely minced, suspended in 10 mL of cold 
artificial sea water, and homogenized using a glass Tenbroek homogenizer. This 
homogenate was centrifuged for 30 minutes at 2,500 x g at 4 °C, and the supernatant 
withdrawn and centrifuged at 12,000 x g for an additional30 minutes at 4°C. This 
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partially clarified homogenate was then filtered to 0.22 Jlm by syringe filters, and the 
protein content assayed by the bicinchoninic acid technique (BCA, Pierce, Rockford, IL). 
Cultures of the P-1 isolate of P. marinus were seeded at 106 cells per mL in 75 
cm2 flasks containing 50 mL ofODRP-3 media without supplementation, or 
supplemented with 0.3 mg/mL of plasma or 0.3 mg/mL of tissue homogenate. The P. 
marinus cells used in this experiment had been cultured on a long term basis in 
unsupplemented ODRP-3 prior to exposure to the media supplements. Cultures were 
maintained in a humidified incubator at 27°C under 5% C02 for four weeks. Cells were 
then harvested for oyster challenge, and the culture supernatants assayed by zymography. 
Prior to challenge, cells were enumerated by hemacytometer and their mean size 
estimated using an ocular micrometer. Thirty C. virginica ME oysters per group were 
subjected to experimental infection. 
Assessment of the effects of homogenate supplementation on P. marinus cell size, 
morphology, and life stages 
In view of the restitution of infectivity and superior induction of proteases by 
oyster homogenate (see results below), it was elected to investigate in greater detail the 
effects of homogenate supplementation on the P. marinus P-1 isolate. Cells were 
cultured in ODRP-3 medium supplemented with homogenates oftissues from five 
individual C. virginica WA, C. gigas, and C. ariakensis oysters. Fetal bovine serum 
(FBS) and fetuin were used as control supplements. ODRP-3 medium was supplemented 
at 1.0, 0.33, 0.11, 0.037, 0.012, and 0.004 mg/mL on a protein basis, or was left 
unsupplemented. Each well was seeded with 106 P. marinus cells in one mL of media in 
duplicated 48-well tissue culture plates. An additional set of unseeded plates were 
maintained as media controls. All plates were held in a humidified incubator at 27°C 
under 5% C02 for six weeks. 
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Following incubation, the cells were resuspended (30 x 100 j.!L passages through 
a 200 j.!L pipette tip) prior to hemacytometer counts of single and clustered trophozoites. 
The exact enumeration of the cells within clusters was not possible, as they were 
extremely adherent, thus clusters were ranked as groups of two to three, four, five to 16, 
and greater than 16 cells. Additionally, measurement of cell diameters of ten 
trophozoites were completed for each culture well using an ocular micrometer, at a 
magnification of 400X. In order to simultaneously compare changes in both cell volume 
and count, a "pellet volume" was calculated as the average cell volume ((4/3)m3) 
multiplied by the estimated total cell number, with cell numbers in clusters estimated by 
multiplying by 2.5, 4, 10.5, and 32 times the number of clusters of2-3, 4, 5-16, and 16+ 
cells, respectively. The volume of the ODRP-3 controls was then subtracted from all 
groups to assess deviation from the control culture. Culture supernatants from all 
treatments were analyzed for protease activity by zymography. 
Assessment of the effects of homogenate supplementation from different Crassostrea 
species and C. virginica populations on P. marinus infectivity 
Oyster tissue homogenates were produced from pooled tissues of three oysters 
from each of the test groups, C. virginica LA, C. virginica TO, C. virginica XB, C. 
virginica W A, C. gigas, and C. ariakensis. Cultures of the P-1 isolate of P. marinus were 
seeded at 106 cells per mL in 75 cm2 flasks containing 50 mL ofODRP-3 medium 
without supplementation, or supplemented at 0.25 mg/mL with homogenates from each 
of the oyster groups. This supplementation level was chosen based on prior observations 
of alterations in P. marinus culture cell count, morphologic characteristics protease 
production. Cultures were maintained in a humidified incubator at 27°C under 5% C02 
for four weeks. Cells were then harvested for oyster challenge, and the culture 
supernatants retained for zymography. Prior to challenge, cells were enumerated by 
hemacytometer and their mean size was estimated by measurement of ten cells per 
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subjected to experimental infection. 
Results 
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Perkinsus marinus clonal isolates display a range of infectivity and protease expression 
Perkinsus marinus clonal isolate cell diameters were consistent within each 
group, ranging from 2 j.!m (SC3-2) to 4 j.!m (LAl0-1, MA2-11, P-1). The cell size ofthe 
HV A-18 isolate was more variable, ranging from 2 to 6 j.!m. All cells in the cultures 
were single trophozoites, with little to no clustering of cells. There were significant 
differences in the oyster P. marinus body burdens four weeks after experimental infection 
(Fig. 1a), with all groups significantly greater than SC3-2. The LAl0-1, P-1, and HVA-
18 isolates were not significantly different. The MA2-11 isolate was significantly more 
infective than both the P-1 and the HVA-18 isolates. There were no mortalities, and all 
sham injected oysters were negative for P. marinus infection. 
Low molecular weight proteases were most strongly expressed in the culture supernatants 
ofHVA-18 and MA2-11 (Fig. lb). The LAl0-1 and P-1 isolates also showed some weak 
low molecular weight protease activity. High molecular weight proteases were most 
prominent in the HVA-18 and P-1 culture supernatants. The SC3-2 culture supernatant 
did not have any apparent protease activity. The FBS proteins, which can be visualized 
as dark bands on the zymogram, were degraded to some extent in the MA2-ll and P-1 
cultures, and were completely degraded in the HVA-18 culture. 
Infectivity ofP. marinus isolate P-1 is increased by media supplementation with oyster 
plasma or tissue homogenate 
Unsupplemented cells and cells supplemented with plasma were similarly sized, 
with most cells being 5 to 6 j.!m. The homogenate supplemented cells were larger, at ~ 10 
j.!m, and had frequent multicellular tomont structures, as well as numerous dusters of 
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adherent cells. These were not seen in the plasma-supplemented or the unsupplemented 
cultures. Gelatin zymograms demonstrated production oflow molecular weight 
proteases in supplemented cultures, with greater activity induced by homogenate 
supplementation (Fig. 2b ). The media controls did not demonstrate any proteolytic 
activity. 
Infection levels at four weeks were significantly higher in oysters challenged with 
P. marinus from supplemented cultures as compared with those grown in ODRP-3 
medium (Fig. 2a). Sham injected controls were all negative for P. marinus infection. 
There were seven, nine, ten, and three oyster mortalities in the homogenate, plasma, 
unsupplemented and sham injected groups through the course of the experiment. The 
cause of the mortalities could not be determined due to rapid degradation of the oyster 
tissues. 
Oyster tissue homogenate alters P. marinus proliferation, size, morphology, and protease 
expression 
Oyster homogenate supplements from all three oyster species resulted in the 
occurrence of multicellular clusters, which were resistant to disaggregation by pi petting 
(Figs. 3, 4). While no shared exterior wall could be visualized, these multicellular 
clusters were often compressed, and were similar in appearance to tomonts. P-1 isolate 
total cell counts were diminished by oyster homogenate supplementation, regardless of 
the oyster species (Fig. 3). This effect was dose-dependent, with some effect seen even at 
the lowest supplementation levels. Cells supplemented with C. ariakensis homogenate at 
1.0 mg/mL appeared to be non-viable, as assessed by neutral red uptake. 
Supplementation with fetuin was associated with minor diminishment in the number of 
cells at low and intermediate concentrations, and a moderate increase in cell count at the 
1.0 mg/mL supplementation level (Fig. 3). Cultures supplemented with FBS behaved 
similarly to fetuin; however, there was a large increase in proliferation at the highest 
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supplementation levels. When supplemented at 1.0 mg/mL with FBS, the P. marinus cell 
count was approximately 2.5-fold higher than in the ODRP-3 control. 
Most multicellular clusters observed in the homogenate supplemented medium 
consisted of 5-16 aggregated cells. The degree of cell clustering was dose-dependent, 
and was typically maximal at intermediate supplement concentrations. The C. virginica 
W A supplemented cultures had a peak in the number of clusters at 0.11 mg/mL and 
maintained clusters to the highest dose tested. Crassostrea ariakensis and C. gigas 
supplemented cultures had a peak in cell clustering at the lower supplementation level of 
0.037 mg/mL. There was a precipitous decline in the occurrence of these clusters at the 
0.33 mg/mL dose for C. ariakensis and at the 1.0 mg/mL dose for C. gigas. Neither 
fetuin nor FBS supplementation was associated with formation of multicellular clusters. 
Homogenate supplementation from all three oyster species also resulted in a dose-
dependent increase in the mean P. marinus cell size (Figs. 4, 5). Cells supplemented at 
1.0 mg/mL had an over threefold larger diameter than unsupplemented cells. Neither 
FBS nor fetuin supplementation resulted in a change in the cell size as compared with the 
ODRP-3 control. The calculated cell "pellet volume" was greater than unsupplemented 
cultures at the highest supplementation levels for FBS, fetuin, and C. virginica W A 
supplemented cultures (Fig. 5b ). Both C. ariakensis and C. gigas supplemented cultures 
had volumes greater than unsupplemented cultures only at the 0.33 mg/mL 
supplementation level. 
A dose-dependent increase in low molecular weight protease production was 
observed, as expected, in cultures supplemented with C. virginica W A oyster 
homogenate (Fig. 6). Homogenates from the P. marinus-tolerant C. gigas oysters did not 
induce low molecular weight proteases. The C. ariakensis oyster homogenate induced 
low molecular weight proteases only at the 1.0 mg/mL supplementation level, and these 
bands were faint and difficult to visualize on the zymogram. Both FBS and fetuin 
induced low molecular weight proteases at supplementation levels of 0.33 mg/mL and 
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above. Oyster supplement protease activity was seen at approximately 60 kDa in the 
homogenate supplemented cultures and media controls, especially at the highest dosage 
levels. This protease activity was fully inhibited by the addition of 10 mM EDTA to the 
incubation buffer, and is therefore assumed to represent oyster metalloprotease activity 
similar to that described by Ziegler et aL (Ziegler et aL, 2002). 
Oyster tissue homogenates from different oyster species and populations cause increased 
infectivity 
Perkinsus marinus isolate P-1 cell cultures were supplemented with 0.25 mglmL 
oyster homogenate from C. virginica LA, C. virginica W A, C. virginica TG, C. virginica 
XB, C. ariakensis, and C. gigas oysters. Cells from C. ariakensis, C. virginica LA, and 
C. virginica TG supplemented cultures had similar mean size of 7.6 to 7. 7 J.Lm. Cells 
supplemented with C. virginica XB were slightly larger, with a mean size of9.0 J.Lm, and 
those supplemented with C. virginica W A were smaller, at 5.2 J.!m. Unsupplemented 
cultures had a mean cell size of 4.1 Jlm. All homogenate supplemented cultures formed 
large clusters of cells resistant to disaggregation by pipetting. No clusters were noted in 
the unsupplemented culture. 
All homogenate supplements tested in the infection study resulted in increased 
body burdens; however, only those oysters infected with cells pulsed with C. ariakensis 
or C. virginica LA homogenate had body burdens significantly different than that of the 
ODRP-3 control (Fig. 7a). There was one mortality in the C. virginica LA group, two in 
the C. virginica XB group, and three each in the C. ariakensis and C. virginica W A 
groups. Sham injected oysters were negative for P. marinus infection, and experienced 
no mortalities. Cells grown in the C. gigas homogenate supplemented cultures were not 
viable at the time of infection, as assessed by neutral red uptake. The cause of this is not 
known, as concentrations of C. gigas homogenate both above and below this level were 
used in other experiments without loss of culture viability. Gelatin zymograms 
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Figure 1. Infectivity level and secreted protease profiles of selected P. marinus isolates. 
(a) Mean body burden± standard error of oysters infected with P. marinus isolates. Cells 
were grown for three weeks in Dungan's medium at 27°C in 5% C02, then injected at 106 
cells per oyster per day on days 1, 3, and 5 into twenty C. virginica ME oysters per 
group. After four weeks, the oysters were sacrificed and total P. marinus body burden 
assessed, and loge transformed for statistical analysis. Groups with different numbers 
were significantly different (p<O.OOl). 
(b) Gelatin zymograrn of 20 J..LL of culture supernatant from P. marinus isolate cultures 
used in the above infection trial. Non-reducing, 8% acrylarnide, 0.1% porcine gelatin 
SDS-PAGE were incubated 3 hours at 37°C in 0.1 M Tris HCl, pH 8.0, then stained with 
Coomassie brilliant blue G-250. Molecular weights are in kilodaltons. 
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Figure 2. Infectivity level and secreted protease profiles of P. marinus isolate P-1 in 
plasma and homogenate supplemented cultures. 
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(a) Mean body burden± standard error of oysters infected with P. marinus isolate P-1 
grown for four weeks in ODRP-3 medium without supplementation or supplemented 
with 0.3 mg/mL of oyster plasma or homogenate at 27°C in 5% C02, then injected at 106 
cells per oyster per day on days 1, 3, and 5 into thirty C. virginica ME oysters per group. 
After four weeks, the oysters were sacrificed, the total P. marinus body burden assessed 
and loge transformed for statistical analysis. Groups with different numbers were 
significantly different (p<O.OOl). 
(b) Gelatin zymogram of 20 JlL of culture supernatant from supplemented and 
unsupplemented P. marinus cultures from the above infection trial. Non-reducing, 8% 
acrylamide, 0.1% porcine gelatin SDS-P AGE were incubated 3 hours at 37°C in 0.1 M 
Tris HCl, pH 8.0, then stained with Coomassie brilliant blue G-250. Molecular weights 
are in kilodaltons. 
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Figure 3. Mean counts of single trophozoites, multi cell clusters, and calculated total cell 
number (see text) from P. marinus isolate P-1 cultures supplemented with a range of 
doses of tissue homogenate from five C. virginica WA (CvWA), C. ariakensis (Ca), C. 
gigas (Cg) oysters, or with fetal bovine serum (FBS) or fetuin. Cultures were incubated 
for six weeks at 27°C in 5% C02, resuspended by repeated pipetting and enumerated by 
hemacytometer. Counts are the mean of duplicate cultures from each of five separate 
oysters tested. FBS and fetuin were tested in duplicate. Standard error bars, ANOV A 
significance and multiple comparison results are shown for single trophozoites. Groups 
with different numbers were significantly different. 
Note: Homogenates from two of five C. gigas oysters were not in sufficient 
concentration to allow 1.0 mg/mL supplementation; therefore, this dose was omitted for 
these oysters. 
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Figure 4. Light micrograph (neutral red stain, lOOOX) of P. marinus isolate P-1 cultures 
supplemented with a range of tissue homogenate concentrations from five C. virginica 
WA (CvWA), C. ariakensis (Ca), C. gigas (Cg) oysters or with fetal bovine serum (FBS) 
or fetuin. Cultures were incubated for six weeks at 27°C in 5% C02, resuspended by 
repeated pipetting, and digitally photographed. 
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Figure 5. Supplemented culture cell size and deviation of pellet volume from 
unsupplemented control cultures. 
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(a) Cell size± standard deviation from P. marinus isolate P-1 cultures supplemented with 
a range of tissue homogenate concentrations from five C. virginica WA (CvWA), C. 
ariakensis (Ca), C. gigas (Cg) oysters or with fetal bovine serum (FBS) or fetuin. 
Cultures were incubated for six weeks at 27°C in 5% C02, resuspended by repeated 
pipetting and measured at 400X using an ocular micrometer. Sizes often trophozoites 
were measured in duplicated culture wells supplemented with homogenates of five 
separate oysters per group. C. gigas (Cg) measurements included only three oyster 
supplements at the 1.0 mg/mL dose. 
(b) Deviation of calculated pellet volume (see text) of P. marinus isolate P-1 grown in 
supplemented cultures from the mean unsupplemented pellet volume. 
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Figure 6. Gelatin zymogram of 20 IlL of culture supernatant from P. marinus isolate P-1 
cultures supplemented with 1.0 mg/mL (a), 0.33 mg/mL (b), 0.11 mg/mL (c), 0.037 
mg/mL (d), 0.012 mg/mL (e), or 0.004 mg/mL (f) oftissue homogenate from C. virginica 
W A (CvW A), C. ariakensis (Ca), C. gigas (Cg) oysters or with fetal bovine serum (FBS) 
or fetuin. ODRP-3 is the unsupplemented control. Cultures were grown for six weeks at 
27°C in 5% C02• Non-reducing, 8% acrylamide, 0.1% porcine gelatin SDS-P AGE were 
incubated 3 hours at 37°C in 0.1 M Tris HCl, pH 8.0, then stained with Coomassie 
brilliant blue G-250. Molecular weights are in kilodaltons. 
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Figure 7. Infectivity level and secreted protease profiles of P. marin us isolate P-1 grown 
in homogenate supplemented cultures. 
(a) Mean body burden± standard error of oysters infected with P. marinus isolate P-1 
grown for four weeks at 27°C in 5% C02 in ODRP-3 medium without supplementation or 
supplemented with 0.25 mg/mL ofhomogenate from C. ariakensis (Ca), or from C. 
virginica oysters from Louisiana (C. virginica LA), Tangier Sound, Chesapeake Bay, VA 
(CvTG), Washington state (CvWA), or from the CROSBreed program (CvXB). 106 cells 
per oyster per day were injected on days 1, 3, and 5 into thirty C. virginica W A (CvWA) 
oysters per group. After four weeks, the oysters were sacrificed and total P. marinus 
body burden assessed and loge transformed for statistical analysis. Groups with different 
numbers were considered significantly different (p=0.007). 
(b) Gelatin zymogram of20 !-!L of culture supernatant from P. marinus isolate P-1 grown 
for four weeks at 27°C in 5% C02 in ODRP-3 medium without supplementation or 
supplemented with 0.25 mg/mL ofhomogenate as described above. Non-reducing, 8% 
acrylamide, 0.1% porcine gelatin SDS-PAGE, incubated overnight at 37°C in 0.1 M Tris 
HCl, pH 8.0 with 10 mM EDTA included to limit oyster metalloprotease activity on the 
zymogram that obscured some of the lower intensity P. marinus serine proteases. The 
gels were stained with Coomassie brilliant blue G-250. Molecular weights are in 
kilodaltons. 
Reproduced with permission of the copyright owner.  Further reproduction prohibited without permission.
47 
Figure 7. 
a 
6.0 
5.5 r i ~ 1, 2 1, 2 5.0 1, 2 T I 1 I + 4.5 ~ 
J!!. t ! + a; I 0 .L I c: 4.0 1 
-' 2 
3.5 
f 3.0 
2.5 
ODRP-3 Ca CvlA CvTG CI!WA CvXB 
Supplement 
b 
~';? 
"?"" :'.6 ~"?"" Gp 0<:) C:j~>' G~ G"' C'' 
200 
116 
97 
66 
45 
31 
Reproduced with permission of the copyright owner.  Further reproduction prohibited without permission.
48 
demonstrated induction oflow molecular weight protease in the C. virginica LA culture 
only (Fig. 7b ). The unsupplemented ODRP-3 culture displayed the typical high 
molecular weight proteases. High molecular weight protease activity the C. ariakensis 
and the C. virginica XB cultures was greatly diminished. No protease activity was 
detected in the media controls. 
Discussion 
Neither the physical nor the biochemical mechanisms of P. marinus infectivity or 
virulence are understood; however, this parasite can be rapidly attenuated by in vitro 
culture (Ford et al., 2002). The mechanism of attenuation is not known, but may be due 
to the lack of critical growth, differentiation, or virulence-induction factors provided by 
the host. Previous attempts to restore virulence by passage of cultured parasites through 
a host oyster did not succeed, possibly due to the brief reculture required to produce an 
inoculum for challenge (Ford et al., 2002), suggesting attenuation occurs quite rapidly. 
Perkinsus marinus isolates 
Non-clonal P. marinus isolates have been shown to vary in virulence, with 
Atlantic coast isolates being more virulent than those from the Gulf of Mexico (Bushek 
and Allen, 1996a; Bushek and Allen, 1996b ). In this study, isolates of P. marinus that 
were chosen based on their assignment by genetic markers into distinct genotypes (Reece 
et al., 1997) displayed differences in infectivity as evidenced by the four week body 
burden (Fig. la). The South Carolina isolate, SC3-2, was associated with the lowest level 
of infection. Eight of the experimental oysters infected with SC3-2 were negative for P. 
marinus infection at week four, and the highest body burden in any oyster infected with 
SC3-2 was 96 cells. 
It is possible that the small size ofthe SC3-2 isolate (~2Jlm) rendered the cells 
less likely to be phagocytosed by mantle cavity hemocytes or ingested during feeding. 
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The efficiency of particle filtration by oysters varies directly with the size of the particle 
(Haven and Morales-Alamo, 1970; Palmer and Williams, 1980; Riisgard, 1988), and 
previous studies have demonstrated that ingestion of P. marinus is one probable route of 
parasitic infection (Alvarez et al., 1992). While it has also been suggested that 
hemocytes in the mantle cavity may be responsible for transport of P. marinus into the 
oyster (Perkins, 1976b; Chintala et al., 2002), it is not known whether there are size-
mediated differences in rates of phagocytosis and transport of P. marinus into the oyster 
by hemocytes. Given these results, there is an indication that P. marinus cell size could 
be a factor in its infectivity. 
Supplementation and infectivity 
The possibility that cell size is a determinant of infectivity was not supported, 
however, by the results of the other infection trials. When P. marinus P-1 isolate cells 
were grown in the presence of oyster plasma supplement, the cell size and morphology 
were similar to unsupplemented cultures. The body burden after experimental infection, 
however, was significantly higher, and was statistically similar to that seen with cells 
enlarged by culture in homogenate supplemented media. Additionally, despite inducing 
similar body burdens (Fig. 7a), P-1 cells from cultures supplemented with C. virginica 
WA or C. virginica XB homogenates had markedly different mean sizes (5.2J.Un and 
9.0jlm, respectively). The cells with the greatest infectivity were those supplemented 
with C. ariakensis homogenate, and they were very similar in size (mean~ 7.6 jlm) to two 
other groups oflesser infectivity, C. virginica LA and C. virginica TG. In this latter 
infection study, infections were initiated in C. virginica W A oysters, and it should be 
noted that the magnitude of the body burdens at four weeks was markedly lower than was 
seen in the earlier trials using C. virginica ME oysters. The cause of this is not known, 
but it is assumed that the C. virginica W A oysters may be more resistant to P. marinus 
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infection. This is particularly interesting because this population of oysters has been 
isolated from P. marinus numerous generations (Munoz et aL, 2003). 
The ability to increase parasite infectivity appears to be a property specific to host 
plasma and tissue homogenates. Supplementation of cell cultures with FBS in Dungan's 
medium did not cause the increases in infectivity seen with oyster homogenate or plasma 
supplementation. The mean four week body burden from C. virginica ME oysters 
infected with P-1 grown in Dungan's medium with FBS was 2,327 cells (Fig. la), while 
those from C. virginica ME oysters infected with P-1 grown in plasma and homogenate 
had mean burdens of 18,975 and 25,311, respectively (Fig. 2a). 
Morphology, size, and proliferation 
Oyster homogenate supplements were the most effective inducers of 
morphological changes, altered protease profiles, and increased infectivity. 
Supplementation of media with homogenates from either susceptible or tolerant oyster 
species resulted in a marked reduction in cell proliferation at increasing doses (Fig. 3). 
At the 1.0 mg/mL supplementation level for both C. ariakensis and C. gigas 
homogenates, there was a decrease in cell number below the seeding concentration, with 
the C. ariakensis cells appearing to be non-viable (Fig. 4). At high supplementation 
levels, the diminution was similar between all oyster species supplements. At the lowest 
two supplement doses, the suppressive effect was more pronounced in the disease 
tolerant C. ariakensis and C. gigas oysters (Fig. 3). The suppression of proliferation was 
only associated with oyster product supplementation. Fetuin supplementation caused a 
minor decrease in cell proliferation that was consistent at lower supplement doses. Both 
the 0.33 mg/mL and 1.0 mg/mL supplementation levels were similar to the ODRP-3 
control. FBS behaved similarly, except that there was a large increase in proliferation at 
the 0.33 mg/mL, and especially at the 1.0 mg/mL, supplementation levels. This is in 
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described the proliferative effects of FBS and fetuin on P. marin us cultures. 
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Since increasing supplementation levels with oyster homogenates are associated 
with decreasing cell counts (Fig. 3) and increasing cell size (Figs. 4, 5a), it was desirable 
to understand their combined effects using the calculated "pellet volumes." The results 
were not surprising for the FBS and fetuin cultures. Cell sizes did not change over the 
range of supplementation, and there are no cell clusters, thus the pellet volumes 
paralleled the cell counts. Supplementation with any oyster homogenate was associated 
with a reduced pellet volume at the three lowest dosage levels (Fig. Sb ). At 0.11 mg/mL, 
the C. virginica WA supplemented cells had a pellet volume in excess of the ODRP-3 
control. At 0.33 mg/mL, this effect was even more pronounced in the C. virginica W A 
oyster group, and was seen in both the C. gigas and C. ariakensis supplemented cultures, 
despite the continuing decrease in cell count. At 1.0 mg/mL, the C. virginica W A culture 
pellet volume was nearly 8 mm3 larger than the ODRP-3 control. At this highest 
supplementation level, the C. gigas pellet volume again fell below ODRP-3 control, as 
did that of the non-viable C. ariakensis culture. 
In vivo, P. marinus cells range in size from 3.9 to 11.6 ~'with a mean of 5.5 ~ 
(Perkins, 1996), similar to that elicited by media supplementation with oyster products. 
The association oflarger cell size with lower replication rate may indicate there is a 
regulation of mitosis by exposure to host products. Perkinsus marinus appears to 
regulate its replication, especially at high infection intensities, such that the parasite 
burden remains at non-lethal levels (Saunders et al., 1993). This regulation may be based 
on energy limitations (Choi et al., 1989). The decreased in vivo replication rate could 
also be mediated by an ability of P. marinus to sense cell density and decrease replication 
rate accordingly, as has been documented in certain quorum-sensing bacteria (Withers 
and Nordstrom, 1998). This does not seem likely, as previous studies have found that the 
presence of P. marinus cells and extracellular products has a positive effect on in vitro 
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replication rate (Gauthier and Vasta, 1995; Bushek et al., 2000). Alternatively, this 
change may represent a partial transition to the prezoosporangium life stage. fluid 
thioglycollate medium, trophozoite maturation to prezoosporangia (hypnospores) is 
associated with thickening of the cell waH and marked enlargement of the vacuole, 
resulting in cell enlargement to 30-80 J.Lm (Perkins, 1996). While this enlargement is 
considerably greater than is seen in supplemented cultures, it is nonetheless possible that 
supplementation results in the preliminary phases of transition to this life stage. 
The current data suggest that there may be a molecular signal present in all three 
oyster species tested which regulates P. marinus proliferation. Since this effect occurs 
only with tissue homogenates, the signaling molecule could be a product of tissue 
degradation. In that case, an increase in the number of P. marinus cells during infection 
and the associated tissue damage from proteolytic activity could signal P. marinus to 
decrease the replication rate and allow the oyster to survive longer in the parasitized state. 
This possibility is supported by the greater potency of the homogenate effect from the 
tolerant C. gigas and C. ariakensis oysters on P. marinus cell replication (Fig. 3). 
Protease induction 
The initial work investigating the induction of pro teases by oyster homogenate 
(Macintyre et al., 2003) was largely confirmed by the dose-response experiment, though 
there was some induction of low molecular weight pro teases by C. ariakensis 
homogenate, FBS, and fetuin at doses above those assessed in the earlier research. The 
induction oflow molecular weight proteases does correlate with infectivity in cultures 
supplemented with oyster plasma and homogenate (Figs. 3, 4). It is tempting to correlate 
increased infectivity with induction ofthese proteases under exposure to conditions that 
more closely mimic the in vivo environment. The strongest induction oflow molecular 
weight proteases and the highest body burdens were seen in the cells supplemented with 
homogenate. Similarly, the intermediate level of protease production by plasma 
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burden. Both were more virulent than the ODRP-3 control, which produced little to no 
low molecular weight protease. 
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The relationship between induction of low molecular weight pro teases and 
increased infectivity was not consistent in the other experiments. In the clonal isolates 
grown in Dungan's medium, the SC3-2 isolate was the least virulent, and demonstrated 
little to no protease activity in the culture supernatant (Figs. 1, 2). The LA1 0-1 and P-1 
isolate also had lower levels of protease expression in general, and weak low molecular 
weight protease expression in particular, and were more virulent than SC3-2. The HV A-
18 isolate had infectivity similar to LA10-1 and P-1, but had the greatest amount of low 
molecular weight protease expression. The most virulent isolate, MA2-ll, had a level of 
low molecular weight protease expression that was intermediate between HV A-18, and 
LA 1 0-1 and P -1. It is interesting to note that the two Virginia isolates, HV A -18 and P -1 
more strongly expressed the series of high molecular weight proteases. 
When the P-1 isolate was exposed to 0.25 mg/mL of various oyster homogenates, 
the C. virginica LA and C. ariakensis supplemented cultures were the most infective 
(Fig. 7a). While the C. virginica LA supplementation induced low molecular weight 
proteases, C. ariakensis supplementation did not. In addition, the C. ariakensis 
supplemented media elicited decreased level of high molecular weight protease activity 
(Fig. 7b ). Given these varied results, there does not appear to be a consistent correlation 
between the in vitro induction of low molecular weight pro teases by homogenate 
supplementation and infectivity as measured by week four body burden. 
The origin of the low molecular weight proteases and their relationship to the 
higher weight forms is not clear. There often appears to be a diminishment in high 
molecular weight protease activity associated with increases in the appearance of the low 
molecular weight forms. It is not known if these changes in the protease profile are due 
to changes at the transcriptional, translational, post-translational, or secretory level. 
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Previous research has demonstrated that the low molecular weight fonns can not be 
created from the high molecular weight fonns by incubation in the presence of host 
products (Macintyre et al., 2003), indicating that the low molecular weight fonns are 
likely not originated by proteolytic cleavage of a multimeric fonn. 
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The supplementation of P. marinus cultures with oyster products from either 
disease-tolerant or susceptible oysters modulates cell proliferation, size, and morphology, 
as well as protease expression and infectivity. Many of these effects cannot be 
reproduced using common bovine media supplements. None of these varied effects 
appear to be linked in all cases, indicating that exposure to oyster products likely causes a 
complex alteration in P. marinus physiology resulting in a multitude of phenotypic and 
functional changes. 
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Chapter 3 
Homogenates of selected Crassostrea wirginica organs and tissues differentially affect 
Perkinsus marinus in vitro proliferation, morphology, and protein expression 
Abstract 
Perkinsus marinus is an alveolate parasite of the eastern oyster, Crassostrea 
virginica. Marked phenotypic changes have been elicited in previous studies by culture 
medium supplementation with whole oyster homogenate. These changes include 
alteration in cell proliferation and size, induction of replication by palintomic fission, and 
alteration of the expression pattern of secreted serine proteases. To determine if specific 
tissues could differentially elicit some or all of these changes, a protein-free, defined 
medium was supplemented with homogenates from specific oyster organs or tissues. 
Generally, medium supplementation reduced proliferation; however, supplementation 
with low concentrations of adductor muscle tissue induced proliferation levels greater 
than is seen in the unsupplemented cultures. Supplementation with whole oyster 
homogenate and, more specifically, the homogenate of the digestive gland and gonad, 
reduced the total cell count, but favored reproduction by palintomic, rather than binary, 
fission. Protease activity in the parasite extracellular products was generally decreased in 
supplemented cultures, except in gill/mantle supplemented cultures, where there was 
apparent induction of proteolytic activity. Zymograms indicated that low molecular 
weight proteases were upregulated by heart- and adductor muscle-derived supplements. 
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lntroductio:n 
The protozoan parasite, Perkinsus marinus, causes a chronic wasting disease 
which is partially responsible for the decline of oyster (Crassostrea virginica) 
populations along the eastern seaboard of the United States (Burreson and Ragone-Calvo, 
1996; Ford, 1996). The exact mechanisms of parasite differentiation and virulence within 
the host are not known; however, P. marinus is known to exist in vivo primarily as a 
trophozoite, progressing from a small, immature to a mature "signet ring" form, so named 
for the microscopic appearance of its large vacuole and offset nucleus. Mature 
trophozoites can form a tomont, a reproductive structure that undergoes palintomic 
fission to form 4 to 64 immature trophozoites within the parental cell wall (Perkins, 
1996). Perkinsus marinus can also form motile zoospores, again by palintomic fission, 
which exit through a discharge tube and pore structure formed on the wall of the enlarged 
parental trophozoite, the zoosporangium (Perkins, 1996). 
In vitro, cellular proliferation of P. marinus in protein-free medium (ODRP-3; 
LaP eyre and Faisal, 1997) occurs solely by binary fission, and zoosporulation is not seen. 
Supplementation of that medium with oyster products is associated with changes in cell 
proliferation, and with the appearance of cellular morphologies and the tomont 
reproductive stage typically found in vivo (Gauthier and Vasta, 2002; Macintyre et al., 
2003; Earnhart et al., 2004). High supplement concentrations have also been associated 
with a partial transition to a prezoosporangium stage (Earnhart et al., 2004; See this 
dissertation, Chapter 6). 
Medium supplementation also causes changes in the expression pattern of P. 
marinus extracellular products (ECP), which may contain one or more virulence factors, 
including serine proteases (Garreis et al., 1996; LaPeyTe et al., 1996; Anderson, 1999; 
Oliver et al., 1999; Oliver et al., 2000). Medium supplementation changes the pattern of 
ECP serine protease expression, with upregulation of a set of low molecular weight (30-
45 kDa) proteases and concurrent downregulation of some higher molecular weight 
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proteases (Macintyre et al., 2003; Earnhart et al., 2004). ~t\nother ECP constituent, p107, 
is a potential virulence factor and is expressed at greatly reduced levels in the presence of 
whole oyster supplements (See this dissertation, Chapter 6). 
Medium supplementation also alters the interaction of the parasite with the host 
during artificial infection. The virulence of Perkinsus marinus cultures is rapidly 
attenuated during in vitro culture (Ford et al., 2002); however, this attenuation has been 
partially reversed by medium supplementation with either oyster plasma or whole oyster 
homogenate prior to infection (Earnhart et al., 2004). This reversal of attenuation is not 
consistently associated with alterations in cell size, morphology, or ECP protease 
expression (Earnhart et al., 2004). The complexity of the responses to oyster product 
supplementation in vitro may be due to an interplay of multiple regulatory signals (e.g. 
inductive/suppressive) provided by the complex mixture of host products. Efforts to 
refine or restrict these regulatory signals may lead to a clearer resolution of the molecular 
cues required for specific physiological or differentiative processes. In this study, we are 
observing alterations in proliferation and cell morphology as well as changes in ECP 
composition, induced by incubation with medium supplements derived from specific host 
organs and tissues. 
Materials and methods 
Animals 
Crassostrea virginica oysters from Washington state (Taylor Resources, Inc., 
Shelton, WA) were used for all experiments (Munoz et al., 2003). The oysters were 
maintained in 1 jlm-filtered water (York River, Virginia) and fed commercially produced 
algae (Shellfish Post-set Formula; Reed Mariculture, San Jose, CA). Water changes were 
performed twice weekly, and all effluent water was chlorinated prior to release. A 
subsample of the oysters was confirmed to be negative for Perkinsus marinus infection 
by the total body burden technique (Fisher and Oliver, 1996). 
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Dissection of oyster organs/tissues and preparation of medium supplements 
Using a lapidary saw, a small shell notch was made adjacent to the adductor 
muscle in ten oysters. Approximately 2 mL of hemolymph was removed from the 
adductor muscle sinuses of each oyster using a syringe fitted with a 25 ga needle. The 
hemolymph was pooled and centrifuged at 800 x g for 5 minutes to remove hemocytes. 
The right valve was then carefully removed to allow dissection of tissues into adductor 
muscle, heart, gill/mantle, labial palps, and digestive gland/ gonad. These tissues, as well 
as a single whole oyster, were separately homogenized in artificial sea water (20 ppt; 
Forty Fathoms Marine Mix, Marine Enterprises International, Baltimore, MD) using a 
glass Tenbroek homogenizer. The homogenates were then centrifuged for 30 minutes at 
2,500 x gat 4°C, and the supernatant withdrawn and centrifuged at 12,000 x g for an 
additional30 minutes at 4°C. These partially clarified homogenates and the cell-free 
plasma were filtered to 0.22J.l.m by syringe filters (J.LStar LB, Costar, Coming, Inc., 
Acton, MA), and the protein content assayed by the bicinchoninic acid technique (BCA, 
Pierce, Rockford, IL). 
Perkinsus marinus cultures 
Perkinsus marinus isolate P-1 cells (Faisal et al., 1999) which had been cultured 
for several years in a chemically-defined, protein-free medium (ODRP-3; LaPeyre and 
Faisal, 1997; Earnhart and Kaattari, 2003), were grown in the presence ofthe above 
described oyster homogenates. ODRP-3 medium was supplemented at 1.5, 0.75, 0.38 
and 0.19 mg/mL for each tissue supplement, as well as for plasma and whole oyster 
homogenate. The heart supplement was not tested at the 1.5 mg/mL concentration due to 
the small size of the organ. Control wells were not supplemented. Perkinsus marin us 
trophozoites were seeded at 106 cells/mL in two mL of each supplemented medium in 
duplicated 24-well tissue-culture plates (Costar 3524, Coming, Inc., Coming, NY). An 
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additional media control plate was not seeded. The cultures were incubated for six weeks 
at 27°C in 5% C02 in a humidified incubator. 
After six weeks, the cells were resuspended by pipetting and counted by 
hemacytometer, including those contained within tomont structures and in tightly 
adherent clusters. In addition, an estimate was made of the percentage of particles in the 
culture which were tomonts or clusters. A thirty-three J.LL aliquot of each culture was 
diluted to 200 J.LL in artificial sea water, applied to a glass slide (Superfrost plus, Fisher 
Scientific) by cytospin, air dried, methanol fixed, and stained using Hema-3 (Biochemical 
Sciences, Inc., Swedesboro, NJ) according to the manufacturer's instructions. Cell sizes 
were measured by ocular micrometer for ten cells per treatment. The remainder of the 
culture was harvested, centrifuged at 12,000 x g for 10 minutes to remove cells and 
debris, and used for zymographic and enzyme assays. 
Analysis of proteolytic enzymes 
Proteolysis of gelatin substrate was measured both by zymography and by the rate 
of hydrolysis of fluorescence-quenched gelatin substrate in order to examine protease 
expression pattern and total gelatinolytic activity, respectively. For zymography, 25 J.LL 
of P. marinus culture supernatant were electrophoresed under non-reducing conditions by 
SDS-P AGE (24) using an 8% polyacrylamide separating gel copolymerized with 0.1% 
porcine gelatin (G-8150, Sigma-Aldrich, Inc.), and a 4% stacking geL Following 
electrophoresis, the gels were washed three times for ten minutes in 2.5% Triton-X-100 
(BP151, Fisher Scientific, Fairlawn, NJ) to renature the proteins, then once in 0.1 M Tris 
pH 8.0 (BP152, Fisher Scientific). The gels were then incubated at 37°C in 0.1 M Tris, 
lOmM EDTA (BP118, Fisher Scientific), pH 8.0 buffer. Two sets of gels were run. One 
set was incubated for one hour to allow comparison of the relatively active high 
molecular weight bands, and the other for 16 hours to enable visualization of low 
molecular weight proteases. The gels were stained with Coomassie brilliant blue G-250 
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destained in the same solution, without the stain. 
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The gelatinolytic activity of proteases from P. marin us was also quantified using 
a fluorogenic gelatin substrate (DQ gelatin, Molecular Probes, Inc., Eugene, OR) 
(D'Angelo et al., 2001). Seventy jlL ofunseeded medium or culture supernatant from 
each treatment were combined with 10 JlL ofbuffer (0.5M Tris, 2mM NaN3, lOOmM 
EDTA) and 20 JlL ofDQ gelatin substrate (1.0 mg/mL). Each replicate was analyzed in 
duplicate wells. The rate of production of fluorescent product was measured using 
fluorescein filters on a fluorescence plate reader (GENios, Tecan, Durham, NC) while the 
reaction rate was constant. 
Quantification ofpl07 
The P. marinus ECP protein p 107 appears to be a target of supplement-induced 
regulation (Earnhart et al., 2004; See this dissertation, Chapter 6). In order to track 
changes in the expression of this ECP, it was quantified in each culture supernatant by 
sandwich ELISA as previously described (See this dissertation, Chapter 6). High-
protein-binding 96-well ELISA plates (Costar 3590, Coming, Inc., Coming, NY) were 
coated with 200 ng of purified monoclonal antibody 5G9 per well in 50 jlL of carbonate 
buffer (15mM Na2C03, 17.4mM NaHC03, pH 9.7), and residual unbound sites were 
blocked with 240 flL/well of 1% bovine serum albumin (BSA) in Tris-buffered saline 
with Tween-20 (TTBS; 50mM Tris, 150mM NaCl, 1mM EDTA, 0.1% Tween-20, pH 
7.5). Each culture supernatant was titered by serial twofold dilutions in 1% BSA in 
TTBS in duplicate wells and incubated for 1 hour at room temperature. Included on each 
plate were duplicated serial dilutions of a standard P. marinus culture supernatant which 
was previously determined to contain 200 ng/mL ofpl07, and a negative control of 
unseeded culture medium. Following incubation, the plates were washed three times, 
then incubated with 200 ng of purified, biotinylated monoclonal antibody 1B3 for one 
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hour at room temperature, followed by a one hour incubation with 1 OOf.!L of a 1:1000 
dilution of horseradish peroxidase-conjugated streptavidin (S5512, Sigma, Inc.). The rate 
of peroxidase-catalyzed conversion of 2,2' -azinobis(3-ethylbenzthiazoline-sulfonic acid) 
(ABTS) substrate was measured spectrophotometrically, and p107 was quantified by 
comparison of sigmoidal curves fitted to the rate data from each dilution series using a 
four-parameter logistic equation (SigmaPlot, SPSS, Inc., Chicago, IL). The amount of 
p 107 contained in each of the samples was calculated by interpolation at the rate 
corresponding to 30% ofthe reaction rate plateau of the standard for that plate (Arkoosh 
and Kaattari, 1990). 
Results 
Oyster tissue supplements differentially affect cell count and morphology 
With the exception of the adductor muscle supplement, oyster tissue product 
supplementation was associated with cell counts below that found in unsupplemented 
medium (Fig. la). The reduced proliferation was most significant above the 0.19 mglmL 
supplement level, and was relatively stable with increasing supplementation in all 
treatments except whole oyster homogenate and plasma. There was marked reduction of 
proliferation in cultures supplemented with whole oyster homogenate at 1.5 mg/mL. 
Plasma supplementation was not associated with the same reduction of proliferation with 
increasing dose. Adductor muscle cultures supplemented at 0.38 and 0.19 mglmL had 
cell counts above those in the unsupplemented control. 
There were morphological changes induced by supplementation, including 
increased cell size and the appearance of multicellular tomonts and adherent cell clusters 
likely representing tomonts that had recently ruptured the outer cell wall (Figs. 1 b, 1 c, 2). 
The size changes tended to parallel increases in supplementation level and occurred, to 
some extent, with all supplements (Fig. 1 b). The magnitude of cellular enlargement with 
increasing supplementation was similar among all tissue supplements, except in those 
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cultures supplemented with high levels ofwhole oyster homogenate (Figs. lb, 2). The 
diameters of cells supplemented at 1.5 mg!mL whole homogenate were frequently 
over three times that ofunsupplemented controls. Plasma supplementation was not 
associated with increased mean cell size. The proportion of tomonts and cell clusters was 
maximal at the 0.75 mglmL supplementation level in all treatments (Fig. lc). 
Unsupplemented cultures did not contain detectable numbers of tomonts or clusters. 
There were differences in the staining characteristics of the supplemented cultures. The 
cytoplasm of supplemented cells, particularly those which were in tomonts or clusters, 
staining considerably more basophilic than did the control cultures (Fig. 2). 
Oyster tissue supplements differentially affect protease expression pattern and activity 
Supernatants from both the adductor muscle- and heart-supplemented cultures 
contained low molecular weight proteases (30-45 kDa), with highest activity at the lowest 
supplement concentration for the adductor muscle and at the highest concentration for the 
heart (Fig. 3). The zymograms of the gill/mantle and labial palp had a decreasing level of 
high molecular weight protease activity with increasing supplementation. Both had very 
faint low molecular weight protease bands at all levels of supplementation. The digestive 
gland/gonad and the whole oyster homogenates had decreasing protease activity with 
increasing supplementation, with the 1.5 mglmL supplementation level of each having 
very little protease activity by zymogram. Both had very faint low molecular weight 
protease bands at the lowest supplementation levels only. Plasma-supplemented cultures 
had a protease expression pattern similar to unsupplemented control at low supplement 
levels, with a gradual diminishment in the intensity of digestion at higher 
supplementation levels, along with the appearance of faint low molecular weight protease 
bands. Unsupplemented cultures appeared to have the greatest high molecular weight, 
but no low molecular weight, protease activity. 
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The results of the quenched substrate protease activity assay did not consistently 
parallel the zymographic results. Unsupplemented cultures and cultures supplemented 
with 0.19 and 0.38 mg/mL plasma had similarly high activity (Fig. 3). Both the adductor 
muscle- and gill/mantle-supplemented cultures had decreasing protease levels with 
decreasing supplementation, though the gill/mantle-supplemented cultures had markedly 
higher activity. Labial palp- and digestive gland/gonad-supplemented cultures had very 
little protease activity at any supplementation leveL This was also true of plasma-
supplemented cultures at the 0.75 and 1.5 mg/mL supplement levels. Heart 
supplemented cultures had intermediate activity, with an increase in proteolysis at the 
lowest supplement level. Cultures supplemented with whole oyster homogenate had very 
low protease activity except at the highest supplement level. Unseeded supplemented 
media did not have any proteolytic activity (data not shown). 
Oyster tissue supplements differentially affect the quantity ofpl07 in the culture 
supernatants 
Culture supplementation decreased the level ofpl07 in the culture supernatant 
(Fig. 4). Unsupplemented cultures contained over 750 ng pl07 per mL of medium. 
Regardless of supplement type, the level of p 107 decreased with increasing supplement 
concentration up to 0.75 mg/mL. The pl07levels at 1.5 mg/mL were typically similar to 
those at the 0.75 mg/mL supplementation level. The p107levels in plasma- and adductor 
muscle-supplemented cultures were least affected, though the level was reduced by 
nearly half with each twofold increase in supplementation from 0.19 to 0.75 mg/mL. 
Labial palp supplemented cultures had a similar pattern, but levels were lower than with 
plasma or adductor muscle. In all other supplemented cultures, pl07levels were greatly 
reduced, with 100 ng/mL or less ofp107 in all treatments. Whole oyster-supplement 
caused the most significant change, with p 107 levels nearly fifty times less than the 
unsupplemented control cultures at the highest supplementation levels. 
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Figure 1. Cell count, percentage tomonts and cell size in supplemented cultures. 
Total cell count (a), mean cell diameter± standard deviation (b) , and percent of particles 
which were multicellular tomonts or adherent clusters (c) in P. marinus cultures 
supplemented with 1.5, 0.75, 0.38, or 0.19 mg/mL of supplements derived from oyster 
adductor muscle (Add), heart, gill and mantle (G/M), labial palps (LP), digestive gland 
and gonad (DG/G), whole body, or plasma. Duplicated cultures were seeded at 106 
cells/mL in two mL of each medium and incubated for six weeks at 27°C in 5% C02 in a 
humidified incubator. Cells and tomonts were enumerated with a hemacytometer, and 
ten cells per treatment were sized by ocular micrometer. The heart supplement was not 
tested at the 1.5 mg/mL concentration due to an inadequate amount of material. 
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Figure 2. Light micrograph of a representative field of P. marinus cultures supplemented 
at 1.5 mg/mL, 0.75 mg/mL, 0.38 mg/mL, and 0.19 mg/ml, orunsupplemented 
demonstrating size, morphologic, and stage differences, including trophozoites (a, b), 
adherent cell clusters (c), tomonts (d), and enlarged, prezoosporangium-like trophozoites 
(e). Thirty three j.!L of each supplemented P. marin us culture was diluted to 200 j.!L and 
applied to a glass slide by cytospin. The slides were air dried, methanol fixed, stained 
using Hema-3, and photographed on a phase contrast light microscope at 1 OOX. 
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Figure 3. Gelatinase activity of six week supplemented P. marinus culture supernatants. 
(a) Total gelatinase activity was measured by the rate of change in fluorescence of a 
quenched, floresceinated gelatin as a result of the proteolytic activity in 70 J..LL of each 
culture supernatant combined with 10 J..LL ofbuffer (0.5M Tris, 2mM NaN3, lOOmM 
EDTA) and 20 J..LL ofDQ gelatin substrate (1.0 mg/mL). Each supernatant was analyzed 
in duplicate. 
SDS-PAGE zymograms (b) (8% acrylamide, 0.1% porcine gelatin) of25 IlL of culture 
supernatant. Following electrophoresis, the gels were washed three times for ten minutes 
in 2.5% Triton-X-100, once in 0.1 M Tris pH 8.0, then incubated at 37°C in 0.1 M Tris, 
10mM EDTA pH 8.0 for either one (short incubation) or sixteen (long incubation) hours. 
The gels were stained with Coomassie brilliant blue G-250. 
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Figure 4. Quantification ofp107 in culture supernatants 
ELISA plates were coated with 200 ng of antibody 509 and blocked with 1% BSA in 
TTBS. Serial twofold dilutions of each culture supernatant sample were assessed in 
duplicate. The bound antigen was then detected by incubation with 200 ng/well of 
biotinylated antibody 1B3 followed by incubation with a 1:1000 dilution of peroxidase-
conjugated streptavidin. The titrated rates of conversion of ABTS were compared and 
p 107 was quantified by comparing the curves at 30% of the maximum rate plateau for 
the standard ECP (200 ng pl07/mL) on that plate. 
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Discussion 
The ability to selectively and independently modulate cell size, morphology, 
proliferation, and constituents ECP of this protozoan may offer tools for the investigation 
of modes of differentiation and virulence. In earlier studies, it was determined that 
addition of host-derived supplements to parasite cultures could modulate these 
phenotypic traits (Macintyre et al., 2003; Earnhart et al., 2004). Further, supplementation 
also partially reversed the in vitro virulence attenuation that occurs quite rapidly in this 
organism (Ford et al., 2002; Earnhart et al., 2004). The interrelationships and induction 
modes of these various phenotypic changes were quite complex, and could not be 
separately studied using whole oyster-derived supplements. In this study, medium 
supplements created by homogenization of organs and tissues were capable of eliciting 
the multiple phenotypic changes observed with whole oyster homogenate supplements, 
including altered cell proliferation, size and morphology, and ECP composition. 
Cell counts could be altered either positively or negatively, as compared with 
unsupplemented cultures, depending on the origin of the supplement. While nearly all of 
the supplements resulted in lower cell counts compared with unsupplemented control 
cultures, there was a striking increase in cell count that occurred with the lower 
concentrations of adductor muscle supplement (Fig. la), and none of the plasma 
supplemented cultures had the same degree of suppressed proliferation seen with other 
tissues. In vivo, P. marinus cells exist both within phagosomes of the hemocytes and free 
in oyster plasma (Perkins, 1996). The adductor muscle is highly vascular, and 
proliferation may be altered in plasma and adductor muscle supplemented cultures by 
similar mechanisms. In contrast, cultures supplemented with whole oyster homogenate 
showed very little proliferation. This confirms what has been previously described 
(Earnhart et al., 2004), and while it does not offer new insight into a more specific 
mechanism of suppression of replication, when combined with cell data, it 
emphasizes the remarkable changes that can be elicited by high concentrations of whole 
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oyster homogenate supplement (Figs. 1 a, 1 b). The very large cells produced in these 
cultures are likely a partial transition to prezoosporangia (Figs. lb, 2) (Earnhart et al., 
2004; See this dissertation, Chapter 6). Differentiation into this stage has formerly been 
induced in vitro by prolonged incubation in a fluid thioglycollate medium (Ray, 1952; 
Ray, 1966; Choi et aL, 1989; Bushek et al., 1994; Fisher and Oliver, 1996). Historically, 
transfer of these prezoosporangia to sea water resulted in maturation and release of motile 
zoospores (Perkins and Menzel, 1966). Over the past several years, for unknown 
reasons, P. marinus prezoosporangia induced by this technique have failed to 
zoosporulate (Kleinschuster et al., 1994; Perkins, 1996), though small numbers of 
zoospores have been produced using FBS supplemented medium (Sunila et al., 2001) and 
in thioglycollate supplemented with lipids (Chu and Lund, 2004). The production of 
zoospores in vivo is thought to occur in moribund oysters (Ford and Tripp, 1996), though 
this has not been well demonstrated. Culture supplementation with high doses of whole 
oyster homogenate, or possibly with higher doses of individual tissues than were tested in 
this study, may provide a means to investigate the inductive mechanism of cell 
enlargement into prezoosporangia, and possibly the mechanisms by which zoosporulation 
is triggered. 
In addition to the changes in cell proliferation, supplementation resulted in 
reproduction by palintomy in tomonts, rather than by the binary fission normally seen in 
unsupplemented cultures (Fig. lc). Previous studies indicated that whole oyster 
supplement was an efficient inducer of this replicative form (Macintyre et aL, 2003; 
Earnhart et al., 2004); however, supplementation with homogenate of dissected digestive 
gland/ gonad was even more effective. During active infection, P. marinus cells are 
frequently found, and often as tomonts, in the connective tissues and epithelium of the 
gut, digestive gland, gill, and mantle, and in hemocyte phagosomes (Perkins, 1996). In 
this experiment, the gill/mantle- and digestive gland/gonad-supplemented media were 
found to have the largest proportion oftomonts (Fig. lc), possibly indicating a greater 
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concentration of an inducer of this replicative stage. The presence of replicative stages 
did not, however, predict the culture cell count. For example, despite the elevated 
number of cells found in plasma-supplemented cultures, these cultures had very few 
tomonts. While this could indicate that the cells rapidly dissociated following rupture of 
the tomont wall, it is more likely that the increase in cell counts in those cultures was due 
to binary division, as occurs in unsupplemented cultures. These results imply that 
parasite proliferation may be regulated by at least two factors. 
Supplementation of cultures with tissue homogenates variably altered the pattern 
of protease secretion by P. marinus cells. The use of both gelatin zymography and a 
flourogenic gelatin substrate allowed an understanding of the protease activity both in the 
presence of potential protease inhibitors and following their electrophoretic dissociation 
from the proteases, and also allowed quantification of protease activity not detectable by 
zymography. Zymographic evidence of elevated low molecular weight protease activity 
in the presence of heart and adductor muscle supplementation indicates the presence of 
inductive components in muscle tissue. Low molecular weight protease activity varied 
directly with heart supplementation, but indirectly with adductor muscle 
supplementation, indicating that the inducing factor may operate within a range bounded 
by the concentrations present in the two supplements. This dose-dependent induction of 
low molecular weight proteases has been reported from cultures supplemented with both 
whole oyster homogenate and oyster plasma (Macintyre et al., 2003). The failure of 
whole oyster homogenate to induce low molecular weight proteases in this study 
indicates that the presence of these prot eases is not simply due to specific induction by a 
certain tissue or molecule, but must also be co-regulated by other factors. This could 
involve protease destruction or inactivation by oyster proteases or inhibitory molecules 
(Oliver et al., 1999; Oliver et al., 2000; Ziegler et al., 2002; Munoz et al., 2003). If the 
downregulation is due to inhibition it is likely not due to a reversible non-covalently 
bound inhibitor, as that type of inhibitor would be expected to dissociate from the 
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molecule during SDS treatment and/or electrophoresis. The possibility of protease 
destruction or inhibition is supported by the reduced high molecular weight protease 
activity in cultures supplemented with high levels of whole oyster or digestive 
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gland! gonad homogenates. The reduction is similar in both cultures, and does not appear 
to be related to the cell count (Fig. la, 3). While the pattern of protease expression by P. 
marinus prior to experimental infection has not been demonstrated to be a reliable 
predictor of increased virulence (Earnhart et al., 2004), the regulation of a subset of 
proteases in the presence of a specific host tissue makes them an interesting target for 
further functional study. Alteration in protease expression has been demonstrated to 
occur in Plasmodium falciparum in association with erythrocyte invasion, hemoglobin 
degradation, processing of parasite proteins, and release of the parasite from the host cell 
(Lyon and Haynes, 1986; Rosenthal et al., 1987; Braun-Breton and Pereira da Silva, 
1988; Greenbaum et al., 2002; Wickham et al., 2003). 
The results of the fluorogenic gelatin assay indicate that there are likely multiple 
factors regulating total protease activity within the cultures. Plasma supplemented 
cultures appear to have inhibited proteolytic activity at the highest levels of 
supplementation. Protease inhibitors present in oyster plasma which are active against P. 
marinus proteases have been previously described (Faisal et al., 1998; Oliver et al., 1999; 
Oliver et al., 2000), so these findings are not altogether surprising. There was 
suppression of proteolytic activity in all other supplemented cultures at all doses, except 
those supplemented with gill/mantle. With increasing gill/mantle supplementation, there 
was a marked increase in rate of proteolysis, which was not retlected in the zymograms. 
Taken together, these results indicate that there may be induction of pro teases not 
detectable zymographically, possibly in combination with inhibition or downregulation of 
the detectable pro teases. The genome of the protozoan parasite Entamoeba histolytica 
contains at least 20 potentially functional cysteine protease genes; however, 90% of the 
protease activity found during in vitro culture is mediated by only three proteases 
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(Bruchhaus et al., 2003). Perkinsus marinus may also have the potential to secrete 
numerous proteases in vivo, or under specific culture conditions, of which only a subset 
may be detectable zymographically. 
The extracellular product protein, p 107, was found in all supplemented cultures, 
though in a wide range of concentrations. The general reduction in the p107level with 
supplementation is in agreement with previous findings (See this dissertation, Chapter 6), 
and may indicate that various tissues are able to regulate the levels of this potential 
virulence factor to various degrees. The highest levels of p 107 in supplemented cultures 
were with plasma and adductor muscle supplements, implying that the factor or factors 
involved in modulation of p 107 expression may be present to a lesser degree in these 
supplements. 
The varied physiological and morphological changes brought about by specific 
medium supplements may have some relevance to the in vivo disease process, and may 
conceivably represent requisite differentiative changes that must occur during normal 
infection. The large proliferative response seen in cells exposed to plasma and the 
vascular adductor muscle may, for example, parallel the initial rapid replication seen in 
early infection in vivo (Saunders et al., 1993). Similarly, the transition to 
prezoosporangia in the presence of whole oyster tissue homogenate may parallel that 
same transition seen in vivo in moribund oysters. That supplement may replicate 
conditions found in terminally infected oysters by releasing large amounts of tissue 
proteins, lipids, and enzymes, and by altering such medium conditions as the reduction-
oxidation potential. While the alterations in protease and other protein production does 
not have a dear in vivo correlate, additional information regarding the function of these 
molecules may help elucidate the mechanism and purpose of their regulation under 
various medium conditions. 
In addition to its importance as an oyster parasite, the phylogenetic position of P. 
marinus potentially makes it a useful model organism. Perkinsus occupies the proposed 
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phylum Perkinsozoa (Noren et al., 1999), within the alveolates (Cavalier-Smith, 1993), in 
a position apparently basal to the apicomplexans and dinoflagellates (Fong et al., 1993; 
Goggin and Barker, 1993; Siddall et aL, 1995; Reece et al., 1997; Siddall et al., 1997). 
Culture techniques are not available for many of the alveolates, though where available, 
they have been an important tool for understanding nutritional requirements, metabolic 
pathways, virulence factors, and triggers for life stage differentiation. Culture of many of 
the alveolates requires use of a host cell line, such as with Cryptosporidium (Upton et al., 
1995; Hijjawi et al., 2001; Arrowood, 2002; Hijjawi et al., 2002), Toxoplasma (Hughes et 
al., 1986; Chatterton et al., 2002; Sreekumar et al., 2003), Babesia (Levy and Ristic, 
1980; Goff and Yunker, 1988; Schuster, 2002a), Theileria (Preston et al., 2001; Schuster, 
2002a; Zweygarth et al., 2002), and Plasmodium (Trager and Jensen, 1997; Schuster, 
2002b; Hurd et al., 2003). Few extracellular alveolate parasites are axenically culturable. 
These include the crustacean dinoflagellate parasite Hematodinium (Appleton and 
Vickerman, 1998) and the molluscan parasite Perkinsus (Gauthier and Vasta, 1993; 
Kleinschuster and Swink, 1993; LaPeyre et al., 1993; Dungan and Hamilton, 1995; 
Gauthier et al., 1995; Gauthier and Vasta, 1995; LaPeyre and Faisal, 1995a; LaPeyre and 
Faisal, 1997). Given the relative ease of isolation and culture and the ability to 
manipulate virulence as well as several phenotypic traits by medium supplementation, 
Perkinsus represents a potentially useful organism in which to investigate shared 
metabolic, inductive, and pathogenic mechanisms of the dinoflagellates and 
apicomplexans. 
In this study, marked changes in P. marinus were induced by supplements derived 
by homogenization of distinct oyster tissues. Morphological changes include enhanced 
proliferation in the absence of multicellular tomont structures by adductor muscle 
supplements, reproduction by palintomic fission by whole oyster digestive gland/gonad 
supplementation, and possible partial transition to the prezoosporangia stages at the 
highest levels of whole oyster supplementation. Biochemical changes include 
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downregulation of zymographic protease activity by supplemented cultures, but with 
evidence of induction of proteolytic activity by gilVmantle which is not evident on the 
zymograms, as well as upregulation oflow molecular weight proteases by 
supplementation with homogenized heart or adductor muscle, and alteration of the 
concentration of a protein extracellular product, p 107. This fractionation method was 
capable of inducing marked changes in this parasite with surprising specificity. Further 
refinement of these supplements may allow a better understanding of this parasite as well 
as potential shared regulatory mechanisms of the alveolates. 
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The humoral response to in vitro generated parasite antigens is enhanced by the 
removal of a defined media component p:rio:r to immumization 
Abstract 
Concentrated culture supernatants containing the extracellular products (ECP) of 
the protozoan oyster parasite Perkinsus marinus were used to immunize mice. This 
preparation, produced by ultrafiltration, was found to be both poorly immunogenic and 
toxic to experimental animals. The possibility that these effects were due to toxic 
parasite products and/or medium constituents was examined. Co-administration of this 
material with highly immunogenic oyster hemolymph caused a substantive suppression 
of the specific antibody response to hemolymph, as well as a decrease in the number of 
epitopes recognized. Potential protein/protease toxin-mediated causes of the 
immunosuppression were addressed by heat denaturation and proteolytic inhibition of the 
concentrate; neither substantially enhanced immunogenicity. Analysis of media 
constituents revealed that the known immunomodulatory surfactant, Pluronic F-68 
(PF68), used in the defined lipid concentrate supplement, was capable of eliciting 
significant immunosuppression. Although isolated protein antigens from P. marinus ECP 
remain highly immunosuppressive, separation of the protein antigens from the PF68 has 
enabled production of polyclonal antisera with a broader recognition of antigens. 
79 
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Introduction 
Extracellular products (ECP) elaborated by parasites amenable to in vitro culture 
can be of particular value in the study of potential virulence factors, enabling, for 
example, the production of highly useful and specific poly- and monoclonal antibodies 
(Bates et al., 1987; Langer et al., 2002). The oyster parasite Perkinsus marinus is an 
axenically culturable protozoan that causes a chronic wasting disease in the eastern 
oyster, Crassostrea virginica, and has been responsible for much of the decline in that 
fishery along the eastern seaboard of the United States (Burreson and Ragone-Calvo, 
1996; Ford, 1996). Perkinsus marinus secretes multiple ECP into the culture medium, 
and thereby provides an excellent model to investigate the mechanisms of protozoan 
virulence. Several medium formulations containing a variety of supplements including 
yeastolate, fetuin, fetal bovine serum, bovine serum albumin, and oyster hemolymph and 
tissue homogenates have been employed in P. marin us culture (Gauthier and Vasta, 
1993; Kleinschuster and Swink, 1993; LaPeyre et al., 1993; Dungan and Hamilton, 1995; 
Gauthier et al., 1995; LaPeyre and Faisal, 1997; Macintyre et al., 2003). The expression 
profile of the ECP can be selectively altered by these media constituents, allowing a 
greater ability to study regulation of potential secreted virulence factors, including several 
serine proteases (LaPeyre and Faisal, 1995b; Macintyre et al., 2003). Chemically defined 
and protein-free media are of particular value in the production of antisera against 
potential extracellular virulence factors, as they eliminate the need to include potentially 
immunogenic non-parasite proteins along with the parasite antigens during immunization. 
Perkinsus marinus can be cultured in such a defined medium, ODRP-3, which is made 
from a base containing commercially available amino acid, vitamin, and defined lipid 
supplements (LaPeyre and Faisal, 1997). ECP are harvested from these media 
supernatants and are typically concentrated by ultrafiltration (LaPeyre et al., 1995; 
Garreis et al., 1996; LaPeyre et al., 1996; Oliver et al., 1999; Oliver et al., 2000). 
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Attempts have been made to produce antisera against P. marinus cells and/or ECP 
in both rabbits ( Choi et al., 1991; Dungan and Roberson, 1993; Ottinger et al., 2001) and 
mice (Dungan and Roberson, 1993); however, such immunizations have typically 
induced poor titers and a predominant IgM response. In addition, we have observed that 
immunization of mice with P. marinus ECP is associated with significant toxicity. Mice 
immunized with ECP in complete Freund's adjuvant (CFA) succumbed vvithin sixteen 
hours of immunization, apparently as a result ofhemorrhage. Immunization with 
Freund's incomplete adjuvant (FIA), while associated with less toxicity, generates a very 
poor immune response. Thus, determination of the cause of ECP toxicity and 
immunosuppression were viewed as crucial problems requiring resolution before further 
progress could be made toward production of antibodies useful for the study of parasite 
virulence. 
Materials and Methods 
Animals 
Six-week-old female BALB/cJ mice were purchased from Jackson Laboratories 
(Bar Harbor, ME) and were cared for in accordance with the 1996 National Research 
Council Guidelines for the Care and Use of Laboratory Animals. All immunizations 
employed a 1:1 emulsion of antigen with either CF A or FlA. 
In vitro propagation of Perkinsus marinus and production of ECP 
Perkinsus marinus isolate P-1 (LaPeyre et al., 1993) was seeded at 106 cells per 
mL in 50 mL of ODRP-3 media in a 75cm2 tissue culture flask and grown at 27°C under 
5% C02 for six weeks. The cells were removed from the culture by centrifugation and 
the supernatant passed through a 0.22J1m filter to remove any residual cells and debris. 
The culture supernatant was placed into lOkD molecular weight cutoff ultrafiltration 
concentrators (Centriprep-1 0, Millipore, Bedford, MA) and concentrated tenfold by 
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centrifugation at 2500 x gat 4°C. The buffer was exchanged by suspension of the ECP 
in phosphate buffered saline (lOOmM phosphate, 150mM NaCl, pH 7.4) andre-
concentration in the same Centriprep-1 0. The resultant culture supernatant ECP 
preparations (S-ECP) were stored at -80°C. 
Analysis of antibody titers 
82 
Assessment of the humoral response to hemolymph or ECP preparations was by 
enzyme-linked immunosorbant assay (ELISA). High protein binding ELISA plates 
(Costar 3590, Coming, Inc., Coming, NY) were coated with 25 to 1 OOng of antigen per 
well in SO!J-L of carbonate buffer (15mM Na2C03, 17.4mM NaHC03, pH 9.7), and 
residual unbound sites were blocked with 240!J-LiweH of 1% bovine serum albumin 
(BSA) in Tris buffered saline with Tween-20 (TTBS; 50mM Tris, 150mM NaCl, lmM 
EDTA, 0.1% Tween-20, pH 7.5). Fifty !J-L of serial 1:5 dilutions of a 1:50 dilution of 
mouse serum in 1% BSA in TTBS were then assayed in duplicate. The bound IgG was 
detected using SO!J-L of a dilution of peroxidase-labeled Fc-specific goat-anti-mouse IgG 
secondary antibody (#115-035-008, Jackson Immunoresearch Laboratories, Inc., West 
Grove, P A), and quantified by colorimetric detection of the rate of conversion of 2,2'-
azinobis(3-ethylbenzthiazoline-sulfonic acid) (ABTS). Titers were calculated as the 
dilution corresponding to 50% of the maximum rate plateau (Butler, 1994). 
Immunization with heat or phenylmethylsulfonyl fluoride treated S-ECP 
As P. marinus ECP contain a high level of serine protease activity (LaP eyre and 
Faisal, 1995b; LaP eyre et al., 1995), inactivation of such activity by heat or the serine 
protease inhibitor phenylmethylsulfonyl fluoride (PMSF) was conducted to determine if 
this inactivation would decrease toxicity or enhance immunogenicity. S-ECP were heat-
inactivated by incubation for 3 minutes in a boiling water bath. Serine protease 
inactivation was accomplished by incubation in 2mM PMSF. The unreacted PMSF was 
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allowed to degrade through approximately twenty half-lives prior to immunization 
(James, 1978). One mouse per treatment was immunized with 50~J,g of untreated S-ECP, 
heat-treated S-ECP or PMSF-treated S-ECP in FIA in divided intraperitoneal and 
subcutaneous depots. The anti-S-ECP response was analyzed by ELISA at four weeks 
post-immunization as described above. ELISA wells were coated with 100ng S-ECP, 
and secondary antibody was applied at a 1: 1000 dilution. 
Western blots were used to determine the pattern of reactivity in each of the 
mouse sera. Twenty ~J,g of untreated S-ECP were separated under non-reducing 
conditions by sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-P AGE) 
according to the method of Laemmli (Laemmli, 1970). Molecular weights were 
estimated using biotinylated broad-range molecular weight markers (Bio-Rad 
Laboratories, Hercules, CA). The separated proteins were blotted onto polyvinylidene 
difluoride (Immobilon-P, Millipore, Bedford, MA) in tris-glycine-methanol buffer 
(25mM Tris, 192mM glycine, 20% methanol, pH 8.3), and the blot was blocked with 
TTBS and cut into sections. Individual sections were probed with sera from mice 
immunized four weeks prior with untreated S-ECP, heat-treated S-ECP, or PMSF-treated 
S-ECP, at a dilution of 1:500. Secondary detection was by a peroxidase conjugated Fc-
specific goat-anti-mouse IgG at a 1:10000 dilution. Markers were detected with a 1:3000 
dilution of peroxidase-conjugated streptavidin (Sigma, St. Louis, MO). Reactive bands 
were visualized by film (Kodak Biomax MR -1) exposure using enhanced 
chemiluminescence reagents (ECL, Amersham Biosciences, Piscataway, NJ), and the 
blot was stained for total protein using colloidal gold (Bio-Rad Laboratories, Hercules, 
CA). 
Assessment of immunosuppression by S-ECP 
To ascertain whether the lack of a humoral response to the complete array of S-
ECP was due to immunosuppression, the impact of S-ECP on the antibody response to an 
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equally diverse, yet immunogenic set of proteins, oyster hemolymph, was determined. 
Three mice per group were immunized with 50J!g of cell-free oyster hemolymph from P. 
marinus negative oysters, 50J!g ofS-ECP, or SOJ!g ofS-ECP co-emulsified with 50J!g of 
hemolymph in FIA in divided intraperitoneal and subcutaneous depots. Anti-hemolymph 
titers were assayed by ELISA at weeks four and eight post immunization as described 
above. ELISA wells were coated with 25 ng of oyster hemolymph protein, and 
secondary antibody was applied at a 1:5000 dilution. Anti-S-ECP titers were similarly 
assayed, with S-ECP coated at SOng/well, and using a 1:1000 dilution of secondary 
antibody. At week 10, all mice, as well as three naive mice, were immunized with 50J!g 
of hemolymph in FIA. Four weeks later, anti-hemolymph titers were retested on all mice 
in a manner identical to that described above. 
Separation of Pluronic F-68 from ECP protein antigens 
Pluronic F-68 (PF68), along with other media components, were removed from 
potential protein antigens by ion exchange chromatography using DEAE-coupled 
Sepharose CL-6B equilibrated in 20mM piperazine (pH 9.7). An aliquot of S-ECP was 
extensively dialyzed against distilled/deionized water at 4°C using lOkDa molecular 
weight cutoff dialysis tubing. The dialyzed S-ECP were then mixed 1:1 with 40mM 
piperazine pH 9. 7 and applied to the column at 2mL!min. The column was washed with 
five column volumes of piperazine buffer, and the bound ECP components were eluted 
using piperazine buffer with 2M NaCl. The eluate was extensively dialyzed against 
distilled/deionized water and concentrated in the dialysis tubing by reverse osmosis using 
polyethylene glycol. 
Immunization of mice with DEAE-purified ECP (D-ECP) 
Initially, a single mouse was immunized with 50jlg ofDEAE-purified ECP (D-
ECP) emulsified in CF A, and closely monitored for toxic effects. This mouse was 
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subsequently boosted with 20j..tg at four weeks and 1 Oj..tg at eight weeks in FlA. After 
confirmation of a lack of toxicity in the initial mouse, two additional mice per group were 
immunized with lOOj..tg, 50j..tg, or 25j..tg ofD-ECP in CFA and boosted after four weeks 
with either 10 or 20j..tg ofD-ECP in FIA. Anti-D-ECP response was titered by ELISA, as 
described above, after the second boost for the initial test mouse and after the first boost 
for all other mice. ELISA wells were coated with SOng D-ECP and secondary antibody 
was applied at a 1:1000 dilution. Western blots against D-ECP were also completed as 
described above, with the sera tested at a 1 :200 dilution using a Surf-blot apparatus (Idea 
Scientific Company, Minneapolis, MN). 
Isolation and assessment of immunomodulatory media components 
Hemolymph (25j..tg/mL) from P. marinus-free oysters was spiked with each of 
four media treatments. Treatments included complete ODRP-3 medium, ODRP-3 
medium excluding the commercial defined lipid supplement (lipid-free medium), lipid-
free medium with 22j..tg/mL Tween-80, or lipid-free medium with lmg/mL Pluronic F-68 
(PF68). The concentrations ofTween-80 and PF68 mimicked their respective 
concentrations in the complete media containing the commercial defined lipid mix. All 
of the above were then concentrated tenfold in 1 OkDa molecular weight cutoff Centriprep 
ultrafiltration devices following the protocol for S-ECP preparation (above). Three mice 
per group were immunized with 50j..tg of hemolymph proteins from each of the treatments 
and controls. Controls included 50j..tg of untreated hemolymph, 50j..tg hemolymph 
combined with 50j.lg D-ECP and 50j..tg hemolymph combined with 50j.lg BSA. All 
immunizations were administered in FIA in divided subcutaneous and intraperitoneal 
depots. Anti-hemolymph ELISA reactivity was titered at four and eight weeks after 
immunization according to the method described above, with the exception that the plates 
were blocked with TTBS without BSA. 
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Quantification of Pluronic F-68 in ECP preparations 
Complete ODRP-3 medium was made excluding phenol red, due to its potential 
interference in the colorimetric assay. As with standard cultures, Perkinsus marinus was 
grown in the medium for six weeks prior to harvest of the culture supernatant. The 
culture supernatant was divided and processed in parallel by ultrafiltration concentration 
and DEAE column purification. PF68 concentration was estimated using a modification 
of the methods ofGhebeh et al. (1998). A standard curve ofPF68 was created using 
dilutions of an aqueous solution ofPF68, spanning concentrations from 0.1 to 2.0 
mg/mL. Two hundred J.LL of each standard, test sample, or 1: 10 dilution of test sample 
were placed into triplicate 1.6 mL microfuge tubes. One hundred J.LL of cobalt 
thiocyanate (3% cobalt nitrate, 20% ammonium thiocyanate in distilled/deionized water), 
200J.LL of ethyl acetate, and 80J.1L of absolute ethanol were added to each tube. The tubes 
were then vortexed and centrifuged at 10000 g for 60 seconds. The upper ethyl acetate 
and middle aqueous layers were removed, and the sediment and tube walls were rinsed 
twice with 200f..LL of ethyl acetate. The sediment was then dissolved in 2 mL of acetone. 
The absorbance of all test and standard tubes was measured spectrophotometrically 
against an acetone blank at an absorbance of328nm, and the concentration ofPF68 was 
determined by interpolation to a least squares fit of the standard curve. 
Results 
Heat and PMSF treatments do not substantially enhance S-ECP immunogenicity 
No anti-S-ECP titer could be calculated by ELISA in sera from mice immunized 
with untreated, heat-treated, or PMSF-treated S-ECP. There was a rate of change in the 
absorbance that was slightly higher than background at the highest concentrations of the 
serum produced against PMSF-treated S-ECP (Fig. IA). By western blot, the serum 
against untreated S-ECP did not appear to detect any proteins despite extended film 
exposure. Serum against heat-treated S-ECP recognized seven bands, however the 
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reactivity was very weak. Serum against PMSF-treated S-ECP predominantly recognized 
a single band, with weak recognition of two other bands (Fig. 1B). 
S-ECP suppresses the lgG response 
The admixture of S-ECP with hemolymph caused a suppression of the anti-hemolymph 
humoral response (Figs. 2A, 2B). Mean anti-hemolymph IgG titers of sera from mice 
immunized with both S-ECP and hemolymph were approximately 325 times lower at 
both four weeks and eight weeks than sera from mice administered hemolymph alone. 
The anti-S-ECP titers in sera from mice immunized with S-ECP alone or S-ECP with 
oyster hemolymph were unmeasurable, with reaction rates near zero at all concentrations. 
Thus, the presence of oyster hemolymph did not have any adjuvant effect or otherwise 
enhance the immune response to S-ECP. Following a week 10 hemolymph 
reimmunization of all three groups plus immunization of a naive group, the mean titer of 
sera from mice immunized with hemolymph and S-ECP was found to be similar to sera 
from mice immunized with hemolymph alone (Figs. 3A, 3B). Sera from naive mice had 
a mean anti-hemolymph titer nearly twice that of mice immunized with S-ECP ten weeks 
prior to hemolymph exposure (Figs. 3A, 3B). 
The presence of Pluronic F-68 or media additives suppresses the lgG response 
In an attempt to ascertain whether PF68 or other components may contribute to 
immunosuppression, mice were immunized with hemolymph concentrated with ODRP-3 
medium, lipid-free medium, lipid-free medium with PF68, lipid-free medium with 
Tween-80, or ECP depleted of media components by ion exchange chromatography (D-
ECP). Ion exchange purification of ECP on DEAE-Sepharose CL-6B did not visually 
alter the protein profile as visualized by SDS-PAGE (data not shown), but removed 
essentially all of the PF68, while ultrafiltration retentates (S-ECP) had significantly 
concentrated surfactant (Table 1 ). The mean anti-hemolymph IgG response was 
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diminished at weeks four and eight in the groups immunized with antigen in the presence 
oflipid-containing media, PF68, or D-ECP (Figs. 4A, 4B). In addition to the above 
groups, the mean titer in the group immunized with antigen spiked with lipid-free 
medium was reduced at week eight (Fig. 4B). 
DEAE-purified ECP has enhanced immunogenicity 
Although D-ECP appears to be independently immunosuppressive to 
heterologous antigens, as evidenced by the suppression of the antibody response to 
hemolymph antigens, it was nonetheless more immunogenic than S-ECP. This may have 
been due to the ability to administer the D-ECP in the presence of CF A without any overt 
toxicity. In all D-ECP immunized mice, anti-D-ECP titers were greater than the best titer 
achieved using S-ECP (Fig. 5A). The number of proteins recognized and the intensity of 
recognition by the sera generated against D-ECP was markedly improved over that 
generated by S-ECP, with recognition of a majority of the ECP proteins visualized by 
colloidal gold protein stain (Fig. 5B). There was no apparent association between 
increased levels of immunogen in the primary (i.e. 25, 50 or 1 OOj.!g) or booster (i.e. 10 or 
20j.!g) immunizations and the titer at week eight. 
Discussion 
Production of polyclonal antisera or a panel of monoclonal antibodies which 
detect distinct ECP components generated in vitro, can facilitate the study of the 
mechanisms of induction and secretion of potential virulence factors. Attempts to 
produce such tools for the study of P. marinus ECP have met with little success, 
primarily due to failure of the animals to mount an adequate immune response under 
immunization conditions that do not produce acute morbidity or mortality. The initial 
attempts to rectify this problem were aimed at general inactivation of potentially toxic 
molecules by heat treatment or inactivation of proteases (Fig. 1 ). These attempts were 
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Figure 1. 
A. ELISA titration of week four sera from individual mice immunized with 50J.tg S-
ECP (Ill), 50J.tg heat-treated S-ECP (.._),or 50J.tg PMSF treated S-ECP (8) in 
FlA. ELISA wells were coated with 1 OOng of S-ECP and blocked with 1% BSA 
in TTBS. Each serum was serially diluted (1 :5) in 1% BSA in TTBS and assayed 
in duplicate. Secondary antibody was a 1:1000 dilution of peroxidase-labeled 
goat-anti-mouse IgG. 
B. Western blot of20J.tg ofuntreated S-ECP using a 1:500 dilution of sera from mice 
immunized with untreated, heat-treated and PMSF-treated S-ECP. Secondary 
detection was by a 1:10000 dilution of peroxidase-labeled goat-anti-mouse IgG. 
Total protein stained with colloidal gold and enhanced chemiluminescence 
immunoblots of serum from mice immunized with 50J.tg S-ECP, 50J.tg heat-
treated S-ECP, or 50jlg PMSF treated S-ECP. Molecular weights (left) are in 
kDa. 
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Figure 2. 
ELISA titration of week four (A) and week eight (B) IgG-specific anti-hemolymph 
response of mice (three per treatment) immunized with S-ECP (•), S-ECP + 
hemolymph (A), or hemolymph alone (1111111). ELISA wells were coated with 25ng of 
hemolymph and blocked with 1% BSA in TTBS. Each serum was serially diluted 
(1 :5) in 1% BSA in TTBS and assayed in duplicate. Secondary antibody was a 
1:5000 dilution of peroxidase-labeled goat-anti-mouse IgG. 
The maximum reaction rates of 0.13 OD( 405)/min (week four) and 0.135 
OD(405)/min (week eight) used to calculate titer are marked by dotted lines. The 
titer was calculated as the inverse of the dilution corresponding to 50% ofthe 
maximum reaction rate plateau. 
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Figure 3. 
A. ELISA titration of week 14 IgG-specific anti-hemolymph response after week 10 
hemolymph challenge of mice previously immunized with S-ECP (0), S-ECP + 
hemolymph (Aa.), hemolymph alone (111), or primary immunization of naive mice 
( 0 ). ELISA wells were coated with 25ng of hemolymph and blocked with 1% 
BSA in TTBS. Each serum was serially diluted (1 :5) in 1% BSA in TTBS and 
assayed in duplicate. Secondary antibody was a 1:5000 dilution of peroxidase-
labeled goat-anti-mouse IgG. The maximum reaction rates of0.17 OD(405)/min 
for mice initially immunized with hemolymph and for naive mice, and 0.13 
OD(405)/min for mice initially immunized with S-ECP +Hemolymph and S-ECP 
alone used to calculate titer are marked by dashed and dotted lines, respectively. 
The titer was calculated as the inverse of the dilution corresponding to 50% of the 
maximum reaction rate plateau. 
B. Calculated (0) and mean(+) titers of week 14 IgG-specific anti-hemolymph 
primary or memory response in mice initially immunized with hemolymph, S-
ECP +hemolymph, S-ECP, or na'ive mice. 
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Sample PF68 concentration (mg/mL) 
ODRP-3 Medium 0.92 
U np~~'?~S.S.~~-~~!~~E~~S.!:l2~J.P:C!:t_§l!J:! ~"- __ .. "· ------·--·---------- .. ·--"····-- ......... 1. .. .. 13. 
Pre-DEAE dialyzed supernatant 0.88 
Final DEAE ECP (D-EC]J) <0.1 
Ultrafiltration filtrate <0.1 
Final ultrafiltration retentate (S-ECP) 6.50 
Table 1. Concentration ofPF68 in ODRP-3 medium, culture supernatants and ECP 
preparations. S-ECP and D-ECP were brought to the same volume prior to PF68 
quantification. 
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Figure 4. 
Calculated ELISA titers (mean± standard error) of week four (A) and week eight (B) 
IgG-specific anti-hemolymph response in the presence of no supplement, BSA, lipid-
free medium, ODRP-3 medium, Tween-80, PF68, or D-ECP. ELISA wells were 
coated with 25ng ofhemolymph and blocked with TTBS. Each serum was serially 
diluted (1 :5) in TTBS and assayed in duplicate. Secondary antibody was a 1 :5000 
dilution of peroxidase-labeled goat-anti-mouse IgG. The titer was calculated as the 
inverse of the dilution corresponding to 50% of the maximum reaction rate plateau. 
Note: One mouse in the D-ECP plus hemolymph group died on the second day 
after immunization, likely due to complications secondary to the injection. 
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Figure 5A. 
ELISA titration of sera from mice immunized with D-ECP, four weeks after final 
boost. ELISA wells were coated with 50ng ofD-ECP and blocked with 1% BSA in 
TTBS. Each serum was serially diluted (1 :5) in 1% BSA in TTBS and assayed in 
duplicate. Secondary antibody was a 1:1000 dilution of peroxidase-labeled goat-anti-
mouse IgG. The immunization schedule for the mice is shown in the inset table. 
*-These sera(+) are from animals immunized with S-ECP FIA, and are included 
for comparison. 
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Figure 5B. 
Western blot of 20J.!g of D-ECP using 1 :200 dilutions of sera from mice immunized 
with D-ECP or S-ECP. Secondary detection was by a 1:10000 dilution of peroxidase-
labeled goat-anti-mouse IgG. Colloidal gold total protein stain and enhanced 
chemiluminescence exposure. Molecular weights (left) are in kDa. *-These sera 
(+)are from animals immunized with S-ECP FIA, and are included for comparison. 
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unsuccessful in increasing the IgG titer, but did result in the detection of some proteins by 
western blot, implying that the treatments enhanced immunogenicity. The alterations in 
response caused by heat treatment may have been due to increased availability of linear 
epitopes on ECP proteins following heat denaturation, which could then be recognized on 
the denatured proteins on the western blot. The reason for the increased level of 
recognition of certain untreated ECP proteins by sera from mice immunized with PMSF-
treated S-ECP is not known. Sulfonylation of the active site serine residue during 
protease inactivation may have rendered a segment of those proteins more immunogenic, 
implying that the newly recognized bands may be proenzymes. The molecular weight of 
the newly recognized band at approximately 33 kDa coincides with the molecular weight 
of a protease whose activity can be selectively upregulated in the presence of host tissues 
(Macintyre et al., 2003); however, it is not known if these are the same protein. 
Given the complexity of P. marinus ECP, it was not felt that structural factors 
normally associated with poor immunogenicity, such as glycosylation or high protein 
solubility, were adequate to explain the globally poor immune response. The diminution 
in anti-hemolymph IgG titer caused by co-emulsification with S-ECP appears to have 
confirmed this by demonstrating that S-ECP is capable of actively suppressing the 
immune response (Fig. 2A). The disparity in mean titer continues through the eighth 
week (Fig. 2B), which may indicate continued immunosuppression or an initial 
disruption in the immune response at the time of primary immunization. The former is 
supported by the continued effect of S-ECP administration on anti-hemolymph primary 
response ten weeks after initial immunization. The latter is supported by the similarity in 
the anti-hemolymph titer following the week ten hemolymph boost, despite the presence 
or absence of S-ECP in the initial immunization. 
The similarity in the titers following the week 10 hemolymph boost between mice 
initially immunized with hemolymph in the presence or absence ofS-ECP is partially a 
function of the apparent difference in the number of recognized epitopes (Fig. 3A). This 
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is evidenced by a lower maximum reaction rate plateau, indicating that fewer hemolymph 
epitopes are recognized by those mice that initially received admixed S-ECP. A simple 
explanation for this effect could be the destruction of epitopes by proteases or other 
components within the S-ECP. This possibility is rendered less likely by the similar 
diminishment in maximum reaction rate seen in mice administered hemolymph ten weeks 
after S-ECP when compared with either naive mice or mice exposed previously to 
hemolymph in the absence ofS-ECP (Fig. 3A). This leaves the more intriguing 
possibility that the S-ECP, via its general immunosuppressive activity, caused a reduction 
in the expressed antibody repertoire. Such reductions in repertoire diversity have been 
observed in mice in association with depressed T -cell activity (Doenhoff et al., 1979; 
Dekruyff et al., 1980). 
In summary, there appear to be two separate mechanisms for the ECP-mediated 
immune suppression. The first is the presence of an immunomodulatory surface-active 
agent, PF68, present in the defined lipid concentrate and co-concentrated with proteins 
during preparation ofS-ECP from the culture supernatant. The second is 
immunosuppression by constituents of P. marinus secreted products. 
PF68 is used in suspension culture of animal and insect cells because of its ability 
to reduce cell death due to shear, and increase recombinant protein production by 
interaction with the phospholipid membrane (Palomares et al., 2000). PF68 is present in 
the chemically defined lipid component (#11905, Gibco, Grand Island, NY) of the 
ODRP-3 mediun1 at a concentration of 100g/L and, thus, in the final media at lg/L. The 
8.4kDa PF68 copolymer molecule is co-concentrated with the ECP proteins during 
ultrafiltration processing of the culture supernatant, despite the 1 OkDa molecular weight 
cutoff ofthe filtration membrane. Quantification ofPF68 demonstrated a 5.8-fold 
concentration ofPF68 with a tenfold volumetric concentration (Table I). This could 
potentially be due to association of the PF68 with proteins in solution, to steric inability 
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of the PF68 molecule to pass through a membrane pore, or to micellar structures created 
by exceeding the critical micellar concentration. 
PF68 has been associated with numerous immunomodulatory effects. It inhibits 
neutrophil random migration, chemotaxis, and adhesion (Lane and Lamkin, 1986; Lane 
and Krukonis, 1988). Micelles produced by PF68 can cause neutrophil activation and 
initiate superoxide production, and can render those cells refractory to further activation 
(Ingram et al., 1992). PF68, when administered on the same day as immunization with 
sheep erythrocytes, enhances the Arthus reaction and suppresses the delayed-type 
hypersensitivity reaction (Triolo et al., 1989). PF68 causes hemolysis in vitro, but only in 
concentrations greater than 40 mg/mL (Lowe et al., 1995). In vitro exposure of human 
monocytes to PF68 caused a 3.4-fold increase in procoagulant activity (Janco et al., 
1985). PF68 has also been shown to inhibit platelet aggregation in whole human blood 
(Edwards et al., 1997). It is unknown whether the procoagulant and/or platelet effects of 
PF68 are related to the hemorrhages observed in mice immunized with S-ECP in CF A. 
The dose ofPF68 administered to mice during immunization with 50J.!g S-ECP is 
calculated to be approximately 0.08 glkg (Table I). This is far lower than the intravenous 
or intraperitoneal LDso in mice of 5.5 glkg and> 10 g/kg, respectively (Pluronic MSDS). 
It is therefore unlikely that the toxicity seen during S-ECP immunization can be 
attributed to direct toxic effects ofPF68. This does not, however, preclude the possibility 
that PF68 may interact with constituents of CF A, FIA, or ECP to increase their acute or 
chronic toxicity. 
The pluronic series of polyoxyethylene/polyoxypropylene block copolymers, such 
as PF68, have a wide range of effects on the interaction between aqueous and lipid 
phases. Some have been shown to have adjuvant effects, with the degree of adjuvancy 
dependent on several factors, including molecular weight and hydrophile lipophile 
balance (HLB) (Hunter et al., 1981; Snippe et al., 1981; Hunter and Bennett, 1984; 
Hunter et al., 1991). Hunter et al. (Hunter et al., 1981) found that block copolymers with 
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the best adjuvant properties are those with a HLB below two. No pluronic copolymers 
tested with HLBs greater than two have adjuvant properties (Hunter et al., 1981 ). The 
adjuvant properties oflow-HLB pluronics appear to be due to their ability to retain, 
orient, and present antigens to the immune system on the surface of oil droplets present in 
the emulsion, with a depot of antigen remaining within the oil which is capable of surface 
replenishment (Hunter et al., 1981 ). This contrasts with water-in-oil emulsions such as 
CF A and FIA, where antigens are present in an aqueous phase contained within oil 
droplets (Hunter et al., 1981 ). Pluronics with HLBs greater than two not only fail to 
retain antigen within the oil phase of the emulsion, but can actually reduce the amount of 
antigen in that phase below what would have been present in the absence of surfactant 
(Hunter et al., 1981 ). Emulsions containing high HLB pluronics are unable to prolong 
the retention of antigen after injection into mouse footpads, indicating failure to form an 
antigen depot, and those animals produced little to no specific antibody (Hunter et al., 
1981). 
PF68 has an extremely high HLB of29 and its presence in the S-ECP preparation 
may partially destabilize the Freund's adjuvant emulsion. This destabilization may limit 
the retention of antigen at the immunization depot, and could thus account for the low 
titers and predominant IgM response. In combination with the other deleterious immune 
effects previously described, it is likely that the presence ofPF68 is partially responsible 
for the poor immune response in the mouse. Mouse anti-hemolymph titers are decreased 
when the hemolymph is administered in the presence of PF68, either as a constituent of 
the defined lipid supplement, or when it is added to the lipid-free medium (Fig. 4). When 
PF68 is included in the immunogen, its suppressive effect seems to be somewhat 
diminished by the presence oflipids in the media prior to concentration. Admixture of 
lipid-free medium to hemolymph is associated with a diminished response compared to 
control hemolymph or hemolymph with BSA, though only at the week 8 time point. 
Surprisingly, the addition of another high HLB non-ionic surfactant, Tween-80 
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(HLB=15), to the lipid-free medium was not associated with the same decreases in the 
mean titer seen with PF68. It is possible that its presence did not affect the Freund's 
emulsion at the concentration present in the media preparation. Alternatively, the 1310 
Da Tween-80 molecules may not have concentrated with the proteins during 
ultrafiltration. 
The most striking immunosuppression was caused by ECP depleted ofPF68 by 
DEAE ion exchange chromatography (D-ECP) (Figs. 4A, 4B). The cause of this 
suppression is not understood, but is currently under investigation. Determination of the 
mechanism of suppression of the immune response in mice may have implications in the 
study of the mechanisms of oyster disease caused by P. marinus. Oyster defense is 
composed of innate immune mechanisms such as phagocytosis, encapsulation, and 
production of reactive oxygen species and lysosomal enzymes. If it can be determined 
that the deleterious immune effects of ECP in the mice are due to suppression of similar 
innate mechanisms which then impact the humoral adaptive immune response (e.g. 
inhibition of phagocytosis by macrophages with failure of antigen presentation), the 
mouse model may serve as an effective tool in the screening of fractionated ECP for 
molecules with immune/defense effects. Furthermore, characterization of molecules with 
such a marked effect on humoral immunity may be valuable in the understanding of other 
parasitic protozoan diseases. 
While the suppression of the humoral immune response caused by PF68 was not 
nearly as great as that caused by D-ECP, the compounding of these suppressive factors, 
coupled with the inability to use CF A due to toxicity, was responsible for the failure of 
previous attempts to produce polyclonal antiserum with a high antigen specific IgG titer, 
and a panel of monoclonal antibodies. Immunization of mice with D-ECP in CF A 
followed by boosts in FIA has been associated with increased anti-ECP IgG titers and 
with a dramatic increase in the number ofECP components detected by western blot (Fig. 
5B). 
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This research demonstrates the potential problems associated with the production 
of an immunogen in the presence of a common media component. PF68 has an 
immediate effect on cells, and can affect changes not only in the fluidity and resistance of 
the plasma membrane, but in cellular metabolism and protein expression (Palomares et 
al., 2000). PF68 also remains associated V~rith the cell membrane even after removal from 
PF68-containing media (Palomares et al., 2000). Its presence has the potential to cause 
artifactual findings in assays of immune cell function, particularly those involved in 
innate immunity, such as macrophages, neutrophils, and invertebrate hemocytes. The 
removal of PF68 may be critical for the production of antibodies toward antigenic 
mixtures, especially those with intrinsic immunosuppressive factors. 
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Chapter 5 
Potential novel epitopes in the extracellular products of oyster-product-
supplemented Perkinsus marinus cells are not detected by subtractive immunization 
Abstract 
The extracellular products (ECP) of the oyster parasite Perkinsus marinus may 
contain virulence factors, including serine proteases. Supplementation of P. marinus 
growth medium with oyster products has been shown to alter the infectivity of the 
parasite and cause subtle changes in the pattern of ECP produced. A subtractive 
immunization technique was used in an attempt to create monoclonal antibodies to 
proteins unique to the ECP produced following parasite exposure to oyster products. 
While control mice maintained the ability to respond to an unrelated antigen, no 
detectable serum titer against novel ECP epitopes was detected in the experimental mice. 
Two separate attempts to produced discriminatory hybridomas also failed to produce any 
clones secreting ECP-specific antibody. 
Introduction 
The protozoan oyster parasite Perkinsus marinus secretes a complex set of 
extracellular products (ECP) during in vitro culture. These products have been 
demonstrated to adversely affect hemocyte function, including random and directed 
migration (Garreis et al., 1996) and production of reactive oxygen intermediates 
(Anderson, 1999) as well as decrease the titer of agglutinins and lysozyme in oyster 
plasma (Garreis et al., 1996). Feeding oysters P. marinus ECP incorporated into 
liposomes increases the intensity of experimental infections (LaPeyre et al., 1996). 
108 
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Serine proteases contained within the ECP have been suggested as a possible virulence 
factor (LaPeyre and Faisal, 1995; LaPeyre et al., 1995; Tall et al., 1999), and have been 
shown to degrade oyster plasma proteins (Oliver et al., 1999). 
In an attempt to create an in vitro culture medium which more closely duplicated 
the in vivo environment, oyster products including plasma, whole oyster homogenate, and 
homogenates of selected organs and tissues have been examined for use as culture 
supplements. Supplementation with whole oyster homogenates alters P. marinus cell 
size, differentiation, reproductive mechanism, and the constituents of the P. marin us 
ECP, in particular the pattern of secreted serine pro teases (See this dissertation, Chapter 
3; Macintyre et al., 2003; Earnhart et al., 2004). Furthermore, supplementation is 
associated with increased infectivity in experimental infections (Earnhart et al., 2004). 
While the modulation of infectivity and pattern of ECP serine protease secretion 
do not correlate, it is not known if there are other secreted products which are upregulated 
in response to medium supplementation, and which might be associated with increased 
infectivity. Due to the complexity ofthe ECP secreted by P. marinus, and the 
preponderant similarity between the products secreted in the presence or absence of 
supplementation, a more sensitive method was needed to study subtle differences in the 
content of the ECP produced by supplemented cells. 
Modulation of the murine humoral immune response with the DNA alkylating 
agent cyclophosphamide (Dong et al., 1995; Bauer and Povirk, 1997) has been used to 
enhance the ability to distinguish between similar molecules, to increase the likelihood of 
an immune response against non-immunodominant epitopes, and to bias the humoral 
response toward differences between two complex sets of antigens (Matthew and 
Sandrock, 1987; Pukhalsky et al., 1990; Williams et al., 1992; Brooks et al., 1993; 
Sleister and Rao, 2001; Sleister and Rao, 2002). Mechanistically, cyclophosphamide 
kills all replicating cells, including any B-lymphocytes induced to proliferate by specific 
antigen recognition. This deletion of reactive lymphocytes effectively tolerizes the 
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animal to that antigen set. The subsequent response to an antigen set containing minor 
protein or epitopic differences is then skewed toward recognition of the novel epitopes. 
This method could allow the detection of subtle differences between P. marinus ECP 
from cells grown in the presence or absence of oyster supplements and allow further 
investigation into the significance of these upregulated constituents. 
Materials and Methods 
Animals 
Six-week-old female BALB/cJ mice from the VIMS breeding colony were used 
all experiments. All mice were cared for in accordance with the 1996 National 
Research Council Guidelines for the Care and Use of Laboratory Animals. All 
immunizations were administered in divided intraperitoneal and subcutaneous depots and 
employed a 1:1 emulsion of antigen with Freund's incomplete adjuvant (FIA). 
Perkinsus marinus cultures and extracellular product purification 
Perkinsus marinus isolate P-1 (LaP eyre et al., 1993) was seeded at 106 cells per 
mL in 50 mL ofODRP-3 (LaPeyre and Faisal, 1997) medium in 75 cm2 tissue culture 
flasks and grown at 27°C under 5% C02 for six weeks. The cultures were centrifuged, 
then filtered to 0.22 J!m to remove any residual cells and debris. The ECP was 
concentrated and purified of media components by ion exchange chromatography as 
previously described (Earnhart and Kaattari, 2003), and dialyzed against several changes 
of phosphate buffered saline (PBS; lOOmM phosphate, 150mM NaCl, pH 7.4). 
For production ofECP from homogenate-pulsed marinus, cells were grown for 
six weeks in ODRP-3 medium supplemented with 0.3 mg/mL whole oyster (C. virginica, 
Taylor Resources, Inc., Shelton, WA) homogenate (Earnhart et al., 2004), then 
extensively washed with, andre-cultured in unsupplemented ODRP-3 medium for six 
weeks. The ECP was purified as described above from the latter culture supernatants, 
Reproduced with permission of the copyright owner.  Further reproduction prohibited without permission.
111 
and designated pulsed ECP (pECP). Differences between the two ECPs were assessed 
by gelatin-substrate zymography (Earnhart et al., 2004) and silver stained SDS-PAGE. 
Subtractive Immunization 
Six mice (A, B, C, D, K, L) were immunized with 50 J.!g each ofECP in FIA in 
divided intraperitoneal and subcutaneous depots (Table 1 ). Two control mice (E, F) were 
administered a similar volume of PBS in FlA. Four of the ECP-immunized mice (C, D, 
K, L) and the PBS-control mice (E, F) were administered cyclophosphamide 100 mg/kg 
in PBS intraperitoneally on days 1, 3, and 7 following immunization. Two ECP-
immunized mice (A, B) were administered cyclophosphamide 100 mg/kg in PBS on days 
3 and 7 only. On day ten, mice A, B, C, D, E, and F were immunized with 50 !J,g pECP 
in FIA in divided intraperitoneal and subcutaneous depots. To assess the response of 
non-subtracted mice to the antigens, naive mice were similarly immunized with 50 Jlg of 
ECP (G, H) or 50 J.!g pECP (I, J). To demonstrate the preservation of 
immunocompetence following subtraction, two subtracted mice (K, L) and two naive 
mice (M, N) were administered 50 J.!g ofbovine serum albumin (BSA) in FIA. 
Thirty days after the last immunization, serum from all mice was titered by 
ELISA. The anti-ECP and anti-pECP IgG titers were assessed in mice A-J. High protein 
binding ELISA plates (Costar 3590, Coming, Inc., Coming, NY) were coated with 100 
ng of ECP or pECP per well in 100 J.!L of carbonate buffer {15mM N a2C03, 17 .4mM 
NaHC03, pH 9.7), and residual unbound sites were blocked with 240 J.!Liwell of 1% BSA 
in Tris buffered saline with Tween-20 (TTBS; 50mM Tris, 150mM NaCl, lmM EDTA, 
0.1% Tween-20, pH 7.5). Serial fivefold dilutions of mouse serum in TTBS were applied 
in duplicate wells and incubated for 1 hour at room temperature. Detection of bound 
IgG was accomplished with a 1 : 1000 dilution of an F c-specific goat -anti -mouse IgG 
(#115-035-008, Jackson Immunoresearch Laboratories, Inc., West Grove, PA), and 
quantified by the colorimetric detection of the rate of conversion of 2,2' -azinobis(3-
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Table 1. Subtractive immunization mouse designation and immunization schedule. 
A,B 50 llg ECP 100 mg/kg, days 3, 7 50 11gpECP 
C,D 50 !lg ECP 100 mg/kg, days 1, 3, 7 50 11gpECP 
E,F PBS 100 mg/kg, days 1, 3, 7 50 11gpECP 
G,H 50 llg ECP 
I, J 50 11gpECP 
K,L 50 llg ECP 100 mg/kg, days 1, 3, 7 50 llgBSA 
M,N gBSA 
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ethylbenzthiazoline-sulfonic acid) (ABTS). The anti-BSA titer of all mice was measured 
similarly, with BSA coated at 100 ng/well, and the unbound sites blocked with TTBS. 
Hybridoma production 
On day 32, mouse C was sacrificed for hybridoma production. On day 49, mouse 
D was boosted with 30 Jlg pECP intraperitoneally in FIA and 10 Jlg pECP intravenously, 
and sacrificed for hybridoma production on day 52. For each fusion, the spleen was 
removed and the splenocytes were fused with the SP2/0 fusion partner at approximately a 
10:1 ratio using 50% polyethylene glycol, resuspended in 10 mL ofDMEM, and added to 
136 mL of supplemented DMEM (Anonymous, 1986) with 20% FCS and 1% OPI plus 
50 mL of SP2/0 conditioned medium and 4 mL of 50X azaserine/hypoxanthine (A9666, 
Sigma, Inc.). The fused cells were aliquoted at 200 JlL per well into ten 96-well plates. 
After 12 days, each culture supernatant was screened for anti-pECP activity by 
ELISA. ELISA wells were coated for 1 hour with 200 ng of pECP protein in carbonate 
buffer, and blocked with 240 J.LLiwell of 1% BSA in TTBS . Ninety J.LL of a 1: 10 culture 
supernatant dilution was transferred to the ELISA plates, incubated for one hour, washed, 
and the bound IgG detected with a 1:1000 dilution of peroxidase-conjugated, goat-anti-
mouse IgG antibody, and quantified by colorimetric detection of the conversion of 
ABTS. 
Results 
The silver stained SDS-P AGE demonstrated the expected minor differences 
between the ECP and the pECP, with several band differences between the two 
preparations (Fig 1 ). Gelatin zymography demonstrated upregulated low molecular 
weight proteases in the pECP. These proteases were in low concentration relative to the 
high molecular weight forms, and extended incubation was necessary for their clear 
visualization (Fig. 2). 
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Mice administered cyclophosphamide on days 1, 3 and 7 maintained tolerance to 
ECP throughout the course of the experiment (mice C, D) (Fig. 3). Those tolerized only 
on days 3 and 7 failed to maintain adequate tolerance to ECP (mice A, B). Mice which 
received the cyclophosphamide regimen in the absence oftolerogen (mice E, F) were 
able to respond appropriately to a subsequent administration of pECP. Furthermore, mice 
which were tolerized to ECP were still competent to respond to the unrelated antigen, 
BSA (mice K-N) (Fig. 4). There was, as expected, considerable cross-reactivity of sera 
from mice administered ECP versus pECP (mice G-J). 
There was no obvious difference between anti-ECP and anti-pECP titers in the 
subtracted mice; however, since the differences between the two ECPs were expected to 
be minimal, splenic lymphocytes from the two tolerized mice (mice C, D) were fused to 
attempt production of discriminatory hybridomas. Despite an excellent rate ofhybridoma 
production of 1 to 2 per well, none secreted antibody specific for any pECP component, 
as measured by ELISA. 
Discussion 
Despite the technically successful subtraction of a complex tolerizing antigen set 
with maintenance of the ability to respond to a novel antigen, the subtractive 
immunization failed to resolve any novel antigens, either by screening of serum or fused 
splenocytes. There are several possible reasons for this failure. First, there may not be 
any difference between the ECPs at the epitope level. The apparent differences in the 
ECP may represent differences in processing of a protein common to both ECPs, or may 
be due to differences in the rate or mechanism of degradation of ECP in the culture 
medium. Second, it is possible that the changes may be in proteins which are present in 
subimmunogenic concentrations. This is a particular possibility in the case of the serine 
proteases, which are present in extremely low concentration despite the high level of 
activity detected by gelatin zymography. Previous efforts at affinity purification of the 
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Figure 1. Silver stained SDS-PAGE (10% acrylamide resolving, 4% acrylamide 
stacking, under non-reducing or reducing conditions) of 5 !J,g of P. marinus extracellular 
products :from cells previously grown in unsupplemented medium (ECP) or medium 
supplemented with whole oyster homogenate (pECP). 
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Figure 2. Gelatin substrate SDS-PAGE zymogram (0.2% gelatin, 10% acrylamide 
resolving, 4% acrylamide stacking, under non-reducing conditions) of P. marinus 
extracellular products from cells previously grown in unsupplemented medium (ECP) or 
medium supplemented with whole oyster homogenate (pECP). Gels were washed three 
times for ten minutes with 2.5% Triton-X-100 to renature the proteins, then incubated for 
two or sixteen hours at 3 7°C in 0.1 M Tris pH 8.0. Gels were stained in 0.1% Coomassie 
Brilliant Blue G-250. 
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Figure 3. 
Subtractive immunization mouse designation and immunization schedule (a), and ELISA 
titration ofigG-specific anti-ECP (b), or anti-pECP (c) response. ELISA wells were 
coated with 100 ng of antigen and blocked with 1% BSA in TTBS. Each serum was 
serially diluted (1 :5) in 1% BSA in TTBS and assayed in duplicate. Secondary antibody 
was a 1: 1000 dilution of peroxidase-labeled goat-anti-mouse IgG, and detection was by 
the chromogenic conversion of ABTS. 
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Figure 3. 
a 
A,B 50 iJ,gECP 100 mg/kg, days 3, 7 50 iJ.gpECP 
C,D 50 iJ.g ECP 100 mg/kg, days 1, 3, 7 50 iJ.gpECP 
E,F PBS 100 mg/kg, days 1, 3, 7 50 iJ.gpECP 
G,H 50 iJ.g ECP 
I, J 50 iJ.gpECP 
K,L 50 ~J.gECP 100 mglkg, days 1, 3, 7 50 iJ.gBSA 
M,N 50 ~J.g BSA 
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Figure 4. 
Subtractive immunization mouse designation and immunization schedule (a), and ELISA 
titration of IgG-specific anti-BSA (b) response. ELISA wells were coated with 100 ng of 
BSA and blocked with TTBS. Each serum was serially diluted (1 :5) in TTBS and assayed 
in duplicate. Secondary antibody was a 1:1000 dilution of peroxidase-labeled goat-anti-
mouse IgG, and detection was by the chromogenic conversion of ABTS. 
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Figure 4. 
a 
Mouse Primary Cyclophosphamide Secondl!!Y 
A,B 50 flg ECP 100 mg/kg, days 3, 7 50 J.!gpECP 
C,D 50 flg ECP 100 mg/kg, days 1, 3, 7 50 ~J.gpECP 
E,F PBS 100 mglkg, days l, 3, 7 50 J.!gpECP 
G,H - - 50 flg ECP 
I, J - - 50 ~J.gpECP 
K,L 50 J.!gECP 100 mglkg, days l, 3, 7 50 flgBSA 
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ECP proteases by bacitracin affinity chromatography (van Noort et al., 1991; Faisal et al., 
1999) have yielded large increases in activity, but have failed to concentrate the proteases 
to the point where the protein bands are visible by silver stain, implying that even in 
concentrated preparations, they are present in sub-nanogram quantities (Earnhart, 
unpublished results). Alterations in protein expression that occur at this level, while 
probably biologically significant, may remain undetectable to the murine immune system, 
even under ideal circumstances. The failure to elicit an immune response could also be 
due to an intrinsic property of the protein which renders it non-immunogenic, such as the 
presence of glycosylation moieties which are similar to those found in the mouse. 
A third possibility is that the ability of the mouse to respond to particular antigens 
is diminished by some constituent of the ECP. Previous studies have shown that co-
administration of ECP with a highly immunogenic antigen mixture (oyster plasma) 
severely diminishes the plasma-specific titer (Earnhart and Kaattari, 2003). While the 
mice did retain the ability to respond to BSA following immunization and subtraction, the 
second administration of pECP following the subtraction may have limited any ability of 
the mouse to respond to novel antigen. The mechanism of the diminishment of the 
humoral response is not known, however, there is evidence in previous studies that P. 
marinus ECP may act as a mitogen (Earnhart, unpublished results). An effort was made, 
therefore, to delay administration of cyclophosphamide in two of the mice until day three, 
to allow polyclonal activation and mitogenesis to subside prior to subtraction of antigen 
specific cells. The failure of these mice to maintain tolerance suggests that ifECP does 
act as a mitogen, it does not affect the B-lymphocytes. Furthermore, it implies that the 
antigen specific B-cells have entered a non-replicative stage by day three. Since the 
ELISA screening assessed IgG secretion, those cells were still able to later undergo class 
switching, implying the presence of competent T-lymphocyie help. The continued ability 
of these cells to function adequately does not support the possibility that the failure to 
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detect novel antigen in the subtractive immunization was due only to ECP-mediated 
immunosuppression. 
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Subtractive immunization is a powerful tool to selectively target upregulated 
antigens in a complex mixture. The failure to distinguish novel antigens provided 
important information regarding alterations in P. marinus ECP constituents by medium 
supplementation. With regard to the alterations in the protease profile, for example, there 
are indications of downregulation of some high molecular weight proteases concurrent 
with the upregulation of the low molecular weight forms. If these proteins are antigenic 
in the mouse, the subtractive immunization results suggest that the high molecular weight 
forms may be multi-unit forms of the smaller proteases. This organization may be 
important in the regulation of protease secretion, stability, or activity. Production of 
monoclonal antibodies to the shared ECP components may elucidate the relationships and 
regulation ofECP constituents in standard and supplemented cultures. 
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Chapter6 
Monoclonal antibody analysis of Perkinsus marinus extracelhda.r products 
Abstract 
The protozoan oyster parasite Perkinsus marinus releases a complex set of 
extracellular products (ECP) during in vitro culture. These products have been 
previously implicated in parasite virulence, and their expression can be altered by 
medium supplementation with oyster homogenate. Little is known regarding ECP 
function, regulation, or mechanism of storage and release. Perkinsus marinus ECP were 
purified from a protein-free medium and used to produce a panel of five monoclonal 
antibodies. Several of the antibodies recognized series of proteins implying that the ECP 
may originate from comparatively few parental molecules. The ECP are secreted by 
several pathways, including the release of one product from the cell wall, and two other 
products from two morphologically distinct intracellular compartments. Antibodies 
against separate epitopes on one protein provided information about possible protein 
structure. A sandwich ELISA format allowed sensitive quantification of that protein and 
showed significantly reduced protein expression in homogenate supplemented cultures. 
Imrnunoaffinity purification has allowed tandem mass spectroscopic amino acid 
sequencing of that protein. Another antibody was used to characterize the Perkinsus cell 
wall. This antibody specifically bound to trophozoite and tomont walls, and was used to 
investigate the morphological and antigenic changes in these walls during thioglycollate-
induced formation of prezoosporangia. It was also used to confirm that homogenate 
supplementation can induce formation of prezoosporangia. This antibody labeled P. 
marinus cells in fixed oyster tissue in a species-specific manner. 
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Introduction 
Perkinsus marinus is a protozoan parasite of the eastern oyster, Crassostrea 
virginica, and has been partly responsible for the decline in oyster populations along the 
east coast of the United States (Burreson and Ragone-Calvo, 1996; Ford, 1996). 
Perkinsus marinus is an alveolate protozoan and has been demonstrated by phylogenetic 
analyses to be basal to the apicomplexans and the dinoflagellates, though it appears to be 
more closely related to the latter (Fong et al., 1993; Goggin and Barker, 1993; Siddall et 
al., 1995; Reece et al., 1997; Siddall et al., 1997). The in vivo life cycle of P. marinus 
begins with a small, immature trophozoite that enlarges over time into a "signet ring" 
form, so named for its large vacuole and offset nucleus. This mature trophozoite may 
then undergo binary fission, or may differentiate into a tomont structure, in which 4 to 64 
or more immature trophozoites are formed by palintomic fission within the parental cell 
wall (Perkins, 1996). Perkinsus marinus can also form motile biflagellate zoospores, 
again by palintomic fission within a differentiated parental trophozoite, the 
zoosporangium. Zoospores exit the zoosporangium through a discharge tube and pore 
structure (Perkins, 1996). 
During in vitro culture in a protein-free, chemically defined medium (ODRP-3; 
LaP eyre and Faisal, 1997), cellular proliferation is apparently solely by binary fission, 
and no zoosporulation is seen (Earnhart et al., 2004). Trophozoites can be induced to 
form prezoosporangia by incubation in fluid thioglycollate medium for 7 to 10 days (Ray, 
1952; Ray, 1966; Choi et al., 1989; Bushek et al., 1994; Fisher and Oliver, 1996). 
Subsequent transfer to sea water has been used to induce further differentiation into 
zoosporangia with zoospore production (Perkins and Menzel, 1966). Currently, however, 
and for unknown reasons, prezoosporangia (hypnospores) appear unable to form mature 
zoospores in vitro (Kleinschuster et al., 1994; Perkins, 1996). Supplementation of 
ODRP-3 medium with oyster tissue homogenates may induce a partial transition to the 
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prezoosporangium stage without thioglycoHate incubation, as evidenced by the 
appearance of enlarged cells with thickened cell walls (Earnhart et al., 2004). 
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The mechanisms by which P. marinus causes disease are not clear, though there is 
evidence that extracellular products (ECP) may play a role in virulence. Perkinsus 
marinus ECP have been shown to blunt the defensive generation of reactive oxygen 
intermediates by oyster hemocytes (Volety and Chu, 1995; Anderson, 1999). ECP and, 
in particular, the serine protease components, decrease random and chemotactic oyster 
hemocyte migration (Garreis et al., 1996), lysozyme activity, and plasma agglutinin titer 
( Garreis et al., 1996), and increase experimental infection level after oral administration 
of liposome-encapsulated ECP (LaP eyre et al., 1996). Oyster plasma proteins are also 
susceptible to cleavage by these proteases (Oliver et al., 1999). The secretion pattern of 
the serine proteases can be modulated by supplementation of ODRP-3 medium with 
homogenized oyster tissues (See this dissertation, Chapter 3; Macintyre et aL, 2003; 
Earnhart et al., 2004), though this modulation has not been definitively linked to changes 
in parasite virulence . Perkinsus marinus ECP are highly immunosuppressive in mice, 
indicating that there may be an effect on some basic component of innate immunity 
(Earnhart and Kaattari, 2003). 
Assessment of induction, expression levels, mechanisms of elaboration, and 
functions of possible P. marinus ECP virulence factors in ECP requires sensitive and 
specific methods of detection and purification. Attempts have been made to produce 
antibodies, mostly as polyclonal antisera, using whole cell immunogens (Dungan and 
Roberson, 1993; Romestand et al., 2001), lysed cells (Choi et al., 1991; Montes et al., 
2002), or extracellular products (Ottinger et al., 2001 ). Although these antibodies have 
been successfully used to label P. marinus in vivo (Dungan and Roberson, 1993), identify 
a major cell wall component (Montes et al., 2002), and quantify in vitro proliferation 
(Rornestand et al., 2001) as well as in vivo parasite load (Ottinger et al., 2001), there have 
been problems with specificity, with antibodies failing to identify some parasite life 
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stages (Choi et al., 1991) or crossreacting with other microorganisms or with oyster 
tissues (Dungan and Roberson, 1993; Dungan et al., 2000; Ottinger et al., 2001; Bushek 
et al., 2002). The goal ofthe current study was to produce monoclonal antibodies for 
characterization of one or more P. marinus ECP, including quantification, determination 
of storage and release mechanisms, and purification to allow amino acid sequencing. 
Materials and methods 
In vitro propagation of Perkinsus marinus and production of ECP 
Perkinsus marinus isolate P-1 (LaP eyre et al., 1993) was seeded at 106 cells per 
mL in 50 mL ofODRP-3 (LaPeyre and Faisal, 1997) medium in 75 cm2 tissue culture 
flasks and grown at 27°C under 5% C02 for six weeks. The cultures were centrifuged 
and filtered to 0.22 j.liD to remove cells and debris. The ECP were purified and 
concentrated by ion exchange chromatography as previously described, and dialyzed 
against several changes of phosphate buffered saline (PBS) (Earnhart and Kaattari, 2003). 
Immunization and hybridoma production 
Six-week-old female BALB/cJ mice were purchased from Jackson Laboratories 
(Bar Harbor, ME) and were cared for in accordance with the 1996 National Research 
Council Guidelines for the Care and Use of Laboratory Animals. All immunizations 
employed a 1: 1 emulsion of antigen with either Freund's complete ( CF A) or incomplete 
(FIA) adjuvant. The mouse used for hybridoma production was immunized with 50 ~g 
ECP in CF A, followed by FIA boosts with 20 ~g on week 4 and 10 ~g on week 8. On 
week 12, the mouse was given a final 5 ~g boost in FIA intraperitoneally and a 5 ~g 
intravenous injection of antigen without adjuvant. Three days later, the spleen was 
removed and the splenocytes were fused with the SP2/0 fusion partner at approximately 
an 8:1 ratio using 50% polyethylene glycol, resuspended 10 mL ofDMEM, and added 
to 136 mL of supplemented DMEM (Anonymous, 1986) with 20% FCS and 1% OPI plus 
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50 mL ofSP2/0 conditioned medium and 4 mL of 50X azaserinelhy'Poxanthine (A9666, 
Sigma, Inc.), and ali quoted at 200 JlL per well into ten 96-well plates. 
After 12 days, a 1:10 dilution of each culture supernatant was screened for anti-
ECP activity by ELISA. ELISA wells (Costar 3590, Corning, Inc., Corning, NY) were 
coated for 1 hour with 25 ng of antigen in carbonate buffer, and blocked with 240 
J-LLiwell of 1% bovine serum albumin (BSA) in Tris buffered saline with Tween-20 
(Earnhart and Kaattari, 2003). The culture supernatant dilution was incubated for one 
hour, washed, and the bound IgG detected with a 1:1000 dilution of peroxidase-
conjugated, goat-anti-mouse IgG antibody (#115-035-008, Jackson Immunoresearch 
Laboratories, Inc., West Grove, PA), and quantified by colorimetric detection ofthe 
conversion of 2,2' -azinobis(3-ethylbenzthiazoline-sulfonic acid) (ABTS). 
All ELISA positive colonies were rescreened by immunoblot. Twenty Jlg of ECP 
were separated on preparative SDS-P AGE gels (Laemmli, 1970), and transferred to 
PVDF membranes. The blots were blocked with TTBS, and screened with 1:10 dilutions 
of culture supernatant using a Surfblot apparatus (Earnhart and Kaattari, 2003). 
Secondary detection was by peroxidase-conjugated, goat-anti-mouse IgG. Reactive 
bands were visualized by film exposure using enhanced chemiluminescence reagents 
(Biomax MR-1, Eastman Kodak, Rochester, NY; ECL, Amersham Biosciences, 
Piscataway, NJ). 
Selected hybridomas were cloned two to three times by limiting dilution (Harlow 
and Lane, 1988) and expanded for production of antibodies by ascites formation in 
pristane-primed mice (Harlow and Lane, 1988). Antibody was purified from the ascites 
fluid by protein-A conjugated Sepharose beads (153-6159, Bio-Rad Laboratories) and the 
IgG subisotype was determined by ELISA (IS02, Sigma, Inc.). To differentiate between 
antibody recognition of protein or carbohydrate epitopes, 200 ng ECP was treated with 
periodate in an ELISA format as previously described (Woodward et al., 1985). 
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Antibodies were assessed for utility in a sandwich ELISA format using a matrix 
screening fonnat. Two hundred ng of each antibody were coated onto ELISA plates in 
carbonate buffer, and the plates were blocked with 1% BSA in TTBS. All wells were 
then incubated with 500 ng P. marinus ECP for 1 hour. All possible combinations of 
antibodies were tested using NHS-biotin labeled antibodies (Rosenberg, 1996) to detect 
the bound ECP. Biotinylated antibodies (200 nglwell) were incubated for 1 hour, and 
detected by 1 : 1000 dilution of horseradish peroxidase conjugated streptavidin and 
colorimetric detection using ABTS. 
Immunoaffinity purification and de novo amino acid sequencing 
Two mL of protein-A-conjugated Sepharose beads were equilibrated in the 
manufacturer's binding buffer and added to 6.5 mg of purified antibody in 8 mL of 
binding buffer. The beads were incubated with end-over-end mixing for 90 minutes, 
washed twice with 20 mL of binding buffer, resuspended in 10 mL of 20 mM 
dimethylpimelimidate in binding buffer for 30 minutes, then incubated for two hours with 
0.2 M ethanolamine, pH 8. Residual non-covalently bound IgG was removed by washing 
the beads in 100 mM glycine, pH 3. 
For antigen purification, the antibody-coated beads were equilibrated in PBS and 
packed by gravity into a 5 mL column. Two hundred J.lg ofECP were treated with 2 mM 
phenylmethylsulfonyl fluoride to inactivate the endogenous serine proteases, diluted to 
10 mL in PBS, and run through the column by gravity. The column was washed with 30 
mL of PBS, and the bound antigen eluted with 100 mM glycine, pH 2, collected in 200 
fractions, and neutralized with 10 J.!L of 1 M sodium phosphate, pH 8. Fractions 
containing protein were pooled and concentrated by ultrafiltration (Microcon-1 0). The 
purity of the product was assessed by reducing and non-reducing SDS-P AGE. 
The antigen purified by antibody 1B3 was subjected to two dimensional 
electrophoresis (Invitrogen, Carlsbad, CA), with or without pi markers, using pH 3-10 
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IPG strips, and a 4-16% acrylamide second dimension. One gel was stained using a mass 
spectroscopy-compatible silver stain (SilverQuest, Invitrogen), and a spot was excised for 
tandem mass spectroscopy amino acid sequencing at Eastern Virginia Medical SchooL 
Quantification ofpl07/p102 in a sandwich ELISAformat 
ELISA wells were coated with 200 ng of antibody 5G9 in carbonate buffer, and 
blocked with 1% BSA in TTBS. Perkinsus marinus cultures were grown for four weeks 
in 75 cm2 flasks in ODRP-3 medium supplemented with 0.25 mg/mL of tissue 
homogenate from Crassostrea ariakensis oysters or C. virginica oysters from Louisiana, 
Tangier Sound (Chesapeake Bay, Virginia), the CROSBreed program, or Washington 
state. Control cultures were unsupplemented. The cells from these cultures had been 
used in a prior study of infectivity (Earnhart et al., 2004). For titration of p 107 /p 102, 
each culture supernatant sample was compared with a standard ECP. This standard ECP 
was determined to contain 10 J.lg/mL of p 1 07/p 102 by titration of activity against a 
known quantity of affinity purified p 1 07/p 102 protein in a manner identical to that 
described below. 
Each culture supernatant, negative control unseeded medium, and standard P. 
marinus ECP was titered by serial twofold dilutions in 1% BSA in TTBS in duplicate 
wells and incubated for one hour. The plates were then washed and incubated with 200 
ng ofbiotinylated 1 B3 for 1 hour, followed by a 1 hour incubation with 100 J.!L of a 
1: 1000 dilution of horseradish peroxidase-conjugated streptavidin. The rate of 
peroxidase-catalyzed conversion of ABTS substrate was measured 
spectrophotometrically. The quantity ofpl07/p102 was determined by fitting a 
sigmoidal curve to the rate data from each dilution series using a four-parameter logistic 
equation, and interpolation of concentration at the value corresponding to 30% of the 
reaction rate plateau of the standard ECP for that plate (SigmaPlot, SPSS, Inc., Chicago, 
IL) (Arkoosh and Kaattari, 1990). 
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To confirm that the oyster homogenate did not interfere with antigen binding, 
ECP-spiked homogenate samples from three different oyster species were assessed. 
Whole tissue homogenates from Crassostrea gigas, C. virginica, and C. ariakensis were 
adjusted to 3.0 mg proteinlmL and spiked with an equal volume of standard ECP 
containing 20 J.Lg/mL of p 1 07/p 102. Serial dilutions of each spiked homogenate were 
made in duplicate using both TTBS and 1.5 mg/mL homogenate as diluents. These 
dilutions were assayed and pl07/pl02 quantified using the 5G9/biotinylated 1B3 ELISA 
described above. 
Fluorescence immunostaining 
Perkinsus marinus cells grown in ODRP-3 medium were harvested after one and 
eight weeks of culture and 106 cells were applied to slides (Superfrost plus, Fisher 
Scientific) by cytospin. The cells were air dried, blocked with 1% BSA in PBS for one 
hour, incubated in a 1:1000 dilution of each monoclonal antibody for one hour, washed 
three times in PBS, incubated in a 1 :64 dilution of a fluorescein-conjugated Fc-specific 
goat-anti-mouse IgG (F8264, Sigma, Inc.) for one hour, and again washed. Perkinsus 
marinus hypnospores (prezoosporangia) were created by incubation of cells in 
thioglycollate medium with 20% (v/v) chemically defined lipid supplement (#11905, 
Gibco, Grand Island, NY) (Ray, 1952; Chu and Lund, 2004). After 10 days of 
incubation, the cells were pelleted by centrifugation and stained with antibody 5A2 as 
described above. Another 106 cells were stained with Lugol's iodine solution. The cells 
in both experiments were photographed using a Nikon DXM1200 digital camera or an 
Olympus D1000 35mm camera on an Olympus BX51 microscope. 
Immunogold electron microscopy 
Perkinsus marinus cells from four-week-old unsupplemented cultures, from 
cultures supplemented with 0.3 mg/mL oyster (C. virginica W A) homogenate, from cells 
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incubated in thioglycoHate as described above, or from thioglycollate-incubated cells 
transferred for one week into artificial sea water were fixed in matched-osmolality 1% 
glutaraldehyde/4% paraformaldehyde for 1 hour. The fixed cells were washed once in 
0.1 M sodium cacodylate, enrobed for 1 hour in 2% agar I 0.1 M sodium cacodylate, and 
dehydrated through a graded ethanol series in 10% increments, with 15 minutes per step 
and two changes at the 1 00% level. The temperature was lowered to and maintained at -
20"C after the 30% step. The dehydrated cells were infiltrated with Lowicryl HM20 for 
36 hours, and the blocks were polymerized with long-wave UV light (360 nm, 15 W at 1 
meter). Sections were cut at 90 nm on a Reichert-Jung ultramicrotome and mounted on 
gold grids coated with carbon-stabilized Formvar. 
The sections were blocked with 0.5% BSA in PBS for 30 minutes, transferred to a 
1 :250 dilution of antibody 5A2 in blocking solution, incubated for 1 hour, and washed 
five times in PBS. Negative controls were included that omitted primary antibody. The 
sections were then incubated for 1 hour in a 1 :250 dilution of 10 nm colloidal gold-
conjugated goat-anti-mouse IgG antibody (G-7652, Sigma, Inc.), washed five times in 
PBS, incubated for 5 minutes in 1% glutaraldehyde to fix the label, washed with ddH20, 
air dried, stained for 15 minutes with saturated uranyl acetate, and examined on a Zeiss 
CEM 902 transmission electron microscope. 
Immunohistochemistry 
Infected and uninfected oysters were fixed in neutral buffered formalin and 
embedded in paraffin. Six Jlm sections were cut, mounted onto slides (Superfrost plus, 
Fisher Scientific), deparaffinized in xylene, and rehydrated through a graded ethanol 
series. Sections were blocked in PBS with 3% BSA for one hour, incubated in a 1 :500 
dilution of each monoclonal antibody for one hour, washed three times in PBS, incubated 
in a 1:250 dilution of peroxidase-conjugated goat-anti-mouse IgG for one hour, and again 
washed. Control slides omitted the primary or both antibodies. The bound antibodies 
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were localized by the peroxidase-mediated conversion of aminoethylcarbazole to a 
colored product. The sections were counterstained in a 1% solution of Fast Green. 
Results 
Monoclonal antibody production 
134 
Thirty-eight clones from ELISA positive wells were initially expanded. After 
further screening and selection, nine hybridomas were cloned. Of those nine, several 
recognized the same protein(s), and were assessed for their utility in a sandwich-type 
ELISA format. Five monoclonal antibodies, each with a different epitope specificity, 
were chosen for further investigation (Fig. 1; Table 1). None of the combinations of 
antibodies with similar immunoblot reactivity reacted with different epitopes, precluding 
their use in a sandwich format. However, the immunoblot-negative antibody 1B3 did 
react with the same protein as antibody 5G9 (Fig. 2). 
Several of the antibodies, despite their monospecificity, recognized series of 
proteins by immunoblot (Fig. 1 ). Periodate oxidation of carbohydrates did not alter 
antibody recognition, indicating that the epitopes recognized are likely not carbohydrates 
(Fig. 3). Rather than elimination of activity, there was an increase in the maximum rate 
of change in substrate conversion after periodate treatment for both antibodies 1B3 and 
5G9, which may represent improved access to the protein epitope following oxidation of 
the carbohydrates. 
Immunoaffinity purification and de novo amino acid sequencing 
Imrnunoaffinity purification of proteins recognized by antibodies SG9 and 1 B3 
demonstrated that both recognize a protein doublet of 107 and 102 kDa (p 107 /p 1 02), 
which concurred with the immunoblot results for antibody 5G9 (Fig. 1 ); however, in 
addition to those shared bands, antibody 1B3 purified an 81 kDa protein (Fig. 4). Under 
reducing conditions, there is an intense 42 kDa band in both purifications. 
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Using two dimensional electrophoresis ofthe 1B3 purification product, it was 
determined that the immunopurified 42 kDa band was heterogeneous and composed of 
approximately eight spots encompassing a wide range of isoelectric points (pi) (Fig. 5). 
Protein spots occurred at a pi of 4.9, and in the range of pi 6.5 to 7.3, with the most 
prominent spot occurring at a pi of 6.85. The protein also displayed some minor 
molecular weight variation, with two series of spots occurring in a range of 
approximately 1 kDa. The most intensely staining spot (Fig. 5) was selected for de novo 
amino acid sequencing by tandem mass spectrometry. The DeNovoX software package 
provided numerous short amino acid sequences (Table 2); however, BLAST searches for 
short, nearly exact matches of the amino acid sequences did not yield consistent protein 
similarities. 
Quantification ofpl07/pl02 in a sandwich ELISAformat 
Since antibody 1B3 recognized an 81 kDa protein in addition to the antigens 
recognized by 509 (Fig. 4), it was necessary to use the more restrictive 509 as the 
capture antibody in the sandwich ELISA. This eliminated the possibility of blockade of 
detection ofp107/pl02 by the 81 kDa protein (Fig.2). There were marked differences in 
the level of p 1 07 present in whole oyster homogenate-supplemented versus 
unsupplemented P. marinus cultures (Fig. 6a). While the unsupplemented ODRP-3 
culture had a concentration similar to that of the standard ECP, all supplemented cultures 
demonstrated depressed levels of the p 107 protein. This effect was less pronounced in 
the cultures supplemented with homogenate from C. virginica oysters from Washington 
state. The combination of standard ECP with culture supplements did not demonstrate 
any problem with blocking or epitope destruction (Fig. 6b ). In all cases, the measured 
level of p 107 in the spiked sample was similar to or slightly greater than the expected 
value of 200 ng/mL. 
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Fluorescence immunostaining 
Antibody 1B3 stained apparently internal vesicular structures within the 
marinus cells; however, these structures were only seen in the one week old cultures, and 
then only in a subset of cells (Fig. 7a). The 5G9 antibody, which detects a subset ofthe 
proteins recognized by 1B3 did not stain any structure at either the one- or eight-week 
time point. At both time points, antibody 9El2 primarily stained somewhat round, as 
well as more diffuse, filamentous, intracellular structures (Fig. 7b, c). Antibody 5A2 
brightly stained the cell exterior at both time points (Fig. 7d, e). An apparent internal 
wall forming during cell division was visible in some cells, indicating that the antigen is 
present even at the earliest stages of wall formation (Fig. 7f). The 5Hll antibody did not 
stain any structure at either time point. 
Perkinsus marinus cells incubated in lipid-supplemented FTM displayed a range 
of sizes (Fig. 7f, g). The smallest cells were similar in size to unincubated trophozoites. 
These cells stained brightly with antibody 5A2, and did not stain with Lugol's iodine 
solution. At the other size extreme were extremely enlarged cells with thickened cell 
walls having the appearance of prezoosporangia. The walls of these cells stained darkly 
with Lugol's iodine, but stained very weakly with antibody 5A2. Where staining 
occurred, it often appeared to be patchy. There were also cells which were of 
intermediate size, and of intermediate staining intensity. These cells had somewhat 
thickened cell walls which stained lightly with Lugol's iodine. They displayed more 
intense staining with antibody 5A2 than did the prezoosporangia, but again the antigen 
appeared to be distributed in patches, in contrast to the homogenously bright stain seen in 
trophozoites. There was no fluorescent staining in any of the control treatments. 
Immunogold electron microscopy 
Trophozoites from unsupplemented P. marinus cultures, as well as trophozoites 
and tomonts from supplemented cultures, were tested by immunogold labeling for 
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reactivity with antibody 5A2. Antibody 5A2 strongly labeled the cell wall of 
trophozoites from both unsupplemented and homogenate-supplemented cultures, as well 
as tomont structures in the latter (Fig. 8). Trophozoites from unsupplemented cultures 
typically had a thin layer of somewhat loosely adherent cell wall material which was 
5A2-reactive, and which became separated from the cell wall during fixation (Fig. 8a). 
Trophozoites from supplemented cultures were typically larger, and had a somewhat 
thicker, heavily labeled cell wall (Fig. 8b). 
Cells in supplemented cultures frequently replicated by palintomic fission within 
the cell wall of a parental trophozoite. Antibody 5A2 labeled both the parental wall as 
well as the newly formed walls of the internal daughter trophozoites in this tomont 
structure (Fig. 8c). Enlarged trophozoites resembling prezoosporangia were occasionally 
found in the supplemented cultures. These cells had a two-layered wall, with a heavily-
labeled external wall that appeared fibrillar and loosely attached to a lightly-labeled, 
more dense internal cell wall (Fig. 8d). Minimal labeling was observed in negative 
controls, with typically one to two beads per P. marinus cell cross-section. 
Prezoosporangia created in thioglycollate medium frequently had a two-layered 
cell wall morphology. Many cells had a thick, dense, lightly-labeled internal wall with an 
outer, patchy layer of heavily labeled, fibrillar wall material (Fig. 9a). Where this outer 
wall material was completely removed, only the outermost surface of remaining wall was 
moderately labeled (Fig. 9b ). In some cases, the entire heavily-labeled outer cell wall 
appeared to have detached from the inner cell wall structure as a sheet (Fig. 9c). 
Following incubation in artificial sea water to initiate palintomic division into 
zoosporangia containing prezoospores, loosely-adherent, heavily labeled outer wall 
fragments remained over a thinner, lightly-labeled inner wall (Fig. 9d) in a pattern 
identical to that seen in prezoosporangia. In contrast with the cells created during 
palintomic replication of trophozoites in tomonts (Fig. 8d), the prezoospore walls did not 
label (Fig. 9d). 
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Figure 1. 
Immunoblot (a) of30 J.tg ofECP under non-reducing conditions using 1:1000 dilutions of 
purified monoclonal antibodies. Secondary detection was by a 1:10000 dilution of 
peroxidase-labeled goat-anti-mouse IgG. Reactivity was detected by enhanced 
chemiluminescence and film exposure, and total protein was stained with colloidal gold. 
Molecular weights (right) are in kDa. 
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Table 1. Proteins from P. marinus ECP recognized by individual monoclonal antibodies. 
Antibody Sub-isotype Proteins recognized (kDa) 
1H3 lgG1 22 
9E12 lgG1 31, 24,22 
5A2 IgG3 235,107,90, 74,61,54,50,41,28 
5G9 IgG1 107, 102 
1B3 IgG1 107,102,81 
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Figure 2. 
Assessment of antibody utility in a sandwich ELISA format. ELISA plates were coated 
with 200 ng of antibody 509 (a) or 1B3 (b), blocked, incubated with 1% BSA in TTBS, 
and incubated with P. marinus ECP (5 Jlg/mL) for 1 hour. After washing, biotinylated 
antibodies (200 ng/well) were incubated for 1 hour, and detected by 1:1000 dilution of 
horseradish peroxidase conjugated streptavidin and colorimetric detection using ABTS. 
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Figure 3. 
ELISA of periodate-treated and control ECP. ECP was coated onto plates at 2 !lg/mL, 
and residual sites blocked with TTBS. The treated plate was treated for 1 hour with 5 
mM periodate in 50 mM acetate buffer, pH 4.5. Control plate was incubated in acetate 
buffer. Both plates were then incubated for 30 minutes in 50 mM sodium borohydride in 
PBS, and washed with TTBS. Serial dilutions of each antibody were made in duplicate, 
and incubated for 1 hour at room temperature. Secondary detection was with a 
peroxidase-conjugated goat-anti-mouse IgG antibody. 
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Figure 4. 
Silver stained SDS-P AGE (12% resolving, 4% stacking) under non-reducing and 
reducing (~-mercaptoethanol) conditions of the ECP affinity purification product using 
antibodies 1B3 and 509. Molecular weights are in kDa. 
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Figure 5. 
Two dimensional separation of protein affinity purified by antibody 1B3, using a 3-10 pi 
range first dimension and a 4-16% gradient tris-tricine polyacrylamide gel second 
dimension. Isoelectric points were estimated by using pi markers run concurrently with 
p107/pl02 in a separate gel (not shown). Molecular weights (left) are in kDa. Mouse 
IgG heavy chain (IgG HC) and light chain (IgG LC) are present due to minor leakage of 
antibody 1 B3 from the affinity column during elution. The protein spot selected for de 
novo amino acid sequence analysis by tandem mass spectrometry is designated with an 
asterisk (*). 
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Table 2. Selected p42 tandem mass spectrometry de novo amino acid sequences. 
Amino acid sequence Relative probability 
TPW ASLGLSLHR 95.1 
TPLVLSSS 71.3 
MLFYEHYQ 47.5 
SPTTTEDWYLS 42.4 
yyyyyy 28.4 
QTPLVL 28.1 
ENAGLK 22.8 
LLFGGD 22.0 
LAMRMPP 19.6 
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Figure 6. 
Quantification ofpl07/pl02 (a) in unsupplemented medium (ODRP-3) or the same 
medium supplemented with 0.25 mg/mL whole oyster homogenate derived from 
Crassostrea ariakensis (Ca), or from populations of C. virginica from Louisiana (CvLA), 
Tangier sound, Virginia (CvTG), the CROSBreed program (CvXB) or Washington state 
(CvWA). Quantification ofpl07/pl02 (b) from homogenates of C. ariakensis (Ca), C. 
gigas (Cg), or C. virginica (CvWA) spiked with 10 !lg/mL ofp107/pl02 in standard 
ECP. ELISA plates were coated with 200 ng of antibody 5G9 and blocked with 1% BSA 
in TTBS. Serial twofold dilutions of each sample were made with homogenate (gray 
bars) or TTBS (hatched bars) and assessed in duplicate. The bound antigen was then 
detected by incubation with 200 ng/well ofbiotinylated antibody 1B3 followed by 
incubation with a 1:1000 dilution of peroxidase-conjugated streptavidin. The titrated 
rates of conversion of ABTS by each sample were compared with a standard ECP for 
quantification of p 107 /p 102. 
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Figure 7. 
Immunofluorescent staining of 1 week old (a, b, d) and 8 week old ( c, e) P. marinus cells 
grown in ODRP-3 medium, or 8 week old cultures incubated in lipid-supplemented 
thioglycollate medium for 10 days (f, g). Antibodies 1B3 (a), 9El2 (b, c), and 5A2 (d, e, 
f) were applied at a 1: 1000 dilution to P. marin us cells which had been applied by 
cytospin to slides, dried, and blocked with 1% BSA in TTBS. Following three washes, 
the bound monoclonal antibodies were detected with a 1 :64 dilution of fluorescein-
labeled goat-anti-mouse IgG antibody. Cells which were incubated in thioglycollate were 
washed with PBS, blocked with 1% BSA in PBS, incubated with a 1: 1000 dilution of 
antibody 5A2, washed, incubated in a 1:200 dilution offluorescein-labeled goat-anti-
mouse IgG, washed, and resuspended in PBS (f). Some thioglycollate incubated cells 
were washed in PBS, then stained with Lugol's iodine (g). Cells were photographed 
using a fluorescein filter set (a-f) or phase contrast microscopy (g) at an original 
magnification of lOOOX (a-e) or 400X (f, g). In thioglycollate cultures (f, g), 
prezoosporangia are marked with an asterisk (*), trophozoites which are partially 
enlarged are marked with arrowheads, and non-enlarged trophozoites with arrows. 
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Figure 7. 
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Figure 8. 
Immunogold electron microscopy of P. marinus trophozoites (a, b), tomont (c), and 
thick-walled trophozoite (d) which were grown in unsupplemented ODRP-3 medium (a) 
or the same medium supplemented with 0.3 mg/mL of whole oyster tissue homogenate 
(b, c, d). Arrows indicate the antibody 5A2 reactive cell wall, which in some cases (a) is 
separated from the plasma membrane (open arrowhead). Non-5A2-reactive cell wall (d) 
which resembles a prezoosporangium wall is indicated by a closed arrowhead. Sections 
were blocked in 0.5% BSA in PBS and incubated in a 1:250 dilution of antibody 5A2. 
Following washes, the monoclonal antibody was labeled with a 1:250 dilution of goat-
anti-mouse IgG antibody coupled to lOnm colloidal gold beads which appear as black 
dots on the photomicrographs. The label was fixed with glutaraldehyde, and the sections 
were counterstained with uranyl acetate. All bars = 0.1 11m. 
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Figure 9. 
Immunogold electron microscopy of P. marinus prezoosporangia formed by 
thioglycollate incubation (a-c), or zoosporangia by thioglycollate and artificial sea water 
incubation (d). Arrows indicate the 5A2-reactive cell wall which, if present, is loosely 
attached (b, d) or completely separated (c) from the non-labeled prezoosporangium or 
zoosporangium wall (arrowhead) which overlies the plasma membrane (open arrowhead). 
The cell walls of forming zoospores (d) are not labeled by antibody 5A2 (open arrow). 
Sections were blocked in 0.5% BSA in PBS and incubated in a 1:250 dilution of antibody 
5A2. Following washes, the monoclonal antibody was labeled with a 1:250 dilution of 
goat-anti-mouse IgG antibody coupled to 1 Onm colloidal gold beads which appear as 
black dots on the photomicrographs. The label was fixed with glutaraldehyde, and the 
sections were counterstained with uranyl acetate. Bars are 0.5 Jlm (a, b, d) or lJlm (c) 
Jlm. 
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Figure 10. 
Immunohistochemical detection of P. marinus. Tissue sections from the gill (a, c) or 
digestive gland (b, d) of C. virginica oysters infected (a, b) or not infected (c, d) with P. 
marin us, or from P. atlanticus-infected Ruditapes decussatus gill (e) or H ematodinium 
perezi-infected Callinectes sapidus hemolymph (f). Tissue sections were deparaffinized 
in xylene, rehydrated through an ethanol series, blocked with 3% BSA in TTBS, and 
incubated for 1 hour in a 1:500 dilution of purified antibody 5A2. Following three 
washes, the bound antibody was labeled with a 1 :250 dilution of a peroxidase-coupled, 
Fc-specific goat-anti-mouse IgG. The section was again washed three times, and the 
peroxidase label was visualized by the chromogenic conversion of aminoethylcarbazole. 
The sections were counterstained with 1% Fast green for contrast. 
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Immunohistochemistry 
Only antibody 5A2 labeled P. marinus in fixed, embedded oyster tissue sections. 
In these sections, both single trophozoites as well as multicellular tomonts were clearly 
visible, and the staining ofthese cells was both intense and specific (Fig. lOa, b). No 
reactivity was seen in uninfected oyster tissues (Fig lOc, d). There was also no 
crossreactivity with Perkinsus at/anticus (Fig. 1 Oe) or with the dinoflagellate 
Hematodinium perezi (Fig. 1 Of). 
Discussion 
Perkinsus marinus secretes a complex set of extracellular products by apparently 
disparate mechanisms, including release from the cell wall and secretion from vesicles 
(Fig. 7). It is not known how the ECP present in vesicles are transported extracellularly, 
though there is evidence ofboth lomasome-type membranous bodies occurring near the 
cell wall, as well as micropores which open to the wall (Sunila et al., 2001). The pattern 
of recognition by monoclonal antibodies indicates that the numerous ECP may originate 
from a much smaller number of parental molecules (Fig. 1 ). The single epitope 
specificity of antibody 5A2, for example, is able to recognize at least nine different 
molecular weight forms, 9El2 and 1B3 three forms each, and 5G9, two forms. While 
antibody 5Hll recognized a single band, its failure to label any cellular structure may 
indicate that it is simply a degradation product of another parent molecule. In no case 
does the detection of multiple bands appear to be due to shared glycosylation moieties 
(Fig. 3). 
The protein detected by antibodies 5G9 and 1B3 is detected in situ only in 
vesicular structures at early time points, possibly only while the culture is actively 
replicating. Even then, it is only detected in a subset of cells and, in situ, only by 
antibody 1B3 (Fig. 7a). There are several possible explanations for this behavior. Both 
antibodies recognize epitopes which are apparently dependent on protein conformation, 
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rather than the linear amino acid sequence; 1B3 does not recognize denatured protein, 
and neither antibody detects the protein following disulfide reduction. This likely 
explains the failure to detect this protein in fixed cell preparations and tissues. Structural 
alterations of the protein may take place within the secretory vesicles or following release 
from the cell which affect antibody detection. The intracellular recognition of antigen by 
1B3 may result from detection of an immature protein form. Irnrnunoaffinity purification 
of the ECP products recognized by 1B3 demonstrates that, in addition to the pl07/pl02 
doublet recognized by both antibodies, there is recognition of an 81 kDa protein. While 
the structure of p 107 /p 102 is not clear, under reducing conditions the affinity purification 
products of antibodies 1 B3 and 5G9 appear as a band of approximately 42 kDa mass. 
This presents the possibility that p81 is a dimeric form of p42, and is the form detected by 
1B3 in situ. It is uncertain how this protein then assembles into the 107 kDa form 
detectable by both antibodies, since there are no other protein bands visualized on 
reducing SDS-P AGE to account for the added mass. In this model, 5G9 recognition is 
dependent on the structure of the fully assembled molecule. 
When the p42 subunit ofp107/pl02 is subjected to two dimensional 
electrophoresis (Fig. 5), there is evidence of minor mass variation, and post-translational 
modification. The approximate 1 kDa mass variation could be due to a difference in 
protein structure or glycosylation, and may account for the formation of the doublet under 
non-reducing conditions. The major isoelectric point variations may be due to 
differences in phosphorylation or to the presence of charged sugar residues on the 
molecule (Mann and Jensen, 2003). If these isoelectric differences are due to 
phosphorylation, this may indicate differences in protein activation among the various 
isoforms. 
The function of the p 107 /p 102 molecule is not known, and the peptide sequences 
from tandem mass spectroscopic analysis did not allow functional prediction. Due to its 
apparent production during log-phase in vitro growth (Fig. 7a), it may play a role in the 
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early infection process, or stimulation of cell division. Perkinsus marinus cells grow 
more rapidly when exposed to conditioned medium; presumably due to the presence of a 
secreted growth factor (Gauthier and Vasta, 1995; Bushek et al., 2000). The amount of 
07/p 102 present in culture supernatants is depressed when the cultures are grown in the 
presence of whole oyster homogenates (Fig. 6a), or homogenates of individual oyster 
tissues or organs (See this dissertation, Chapter 3). This may be due either to destruction 
or modification of the protein during or after its secretion into the culture medium, or to 
dowmegulation of expression of that protein under those medium conditions. The 
preservation of detection of the protein in ECP-spiked homogenates indicates that the 
latter is more likely (Fig. 6b ). Dowmegulation of protein expression in the presence of 
homogenates could be the consequence of an oyster defense mechanism, especially if the 
protein is a virulence factor. This seems less likely, however, given the increased 
infectivity of cells grown in supplemented medium (Earnhart et al., 2004). An alternative 
explanation is that p 107 /p 102 is not downregulated in the presence of supplements, but 
upregulated in their absence. The p 1 07/p 102 protein may be secreted under the stressful 
condition of culture in an unsupplemented, protein-free medium. If true, it may be 
involved in nutrient transport or scavenging of scarce nutrients such as iron (Gauthier and 
Vasta, 1994). 
In contrast with the time-dependent, vesicular location of the p 1 07/p 102 antigen 
recognized by antibody 1B3, the immunofluorescent staining pattern of antibody 9E12 
demonstrated a markedly different pattern of intracellular processing or storage. The 
protein recognized by 9E12 was apparently constitutively produced, and the pattern of 
staining indicated that it was present within large intracellular compartments joined by a 
filamentous network, possibly representing the endoplasmic reticulum and/or Golgi 
complex (Soltys et al., 1996). This localization could not be confirmed ultrastructurally. 
The failure of antibody 9El2 in immunogold staining was likely due to the inability of 
the epitope to withstand fixation and embedding. It is not known whether the three 
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molecular weight forms (Fig. 1) are the result of extracellular cleavage or if they are 
related proteins. The decreasing amount of material with decreasing molecular weight 
seems, however, to indicate that the two lower molecular weight forms are the products 
of degradation of the parent molecule (Fig 1 ). 
Antibody 5A2 recognizes a series of proteins, the largest of which has a molecular 
weight similar to the Perkinsus wall protein, PWP-1, described by Montes et al. (2002). 
Antibodies against PWP-1 labeled the walls of mature trophozoites, immature 
trophozoites encased within a parental tomont wall, and the thickened wall of 
prezoosporangia. In this study, antibody 5A2 labeled both trophozoite and tomont cell 
walls (Fig. 7d, e) but did not label the apparently structurally dissimilar cell wall of the 
prezoosporangia (Fig. 7f). As the trophozoites enlarged in thioglycollate medium, there 
was a change in the cell wall structure such that it stained with Lugol's iodine (Fig. 7g) 
(Ray, 1952). As this transition occurred, the amount of 5A2 label was greatly reduced, 
and its distribution was patchy (Fig. 7f), apparently due to shedding ofthe loosely 
attached 5A2-positive cell wall layer with the formation of a new cell wall. These 
findings were confirmed ultrastructurally. Shedding of the outermost cell wall material 
appeared to occur to some extent in trophozoites (Fig 8a, b), and cells transitioning to the 
prezoosporagium stage almost completely released this outer layer from the underlying 
waH, leaving only occasional adherent patches (Fig. 9). A similar immunogold staining 
pattern was seen in trophozoites grown in the presence of oyster homogenate, with the 
walls of some cells having a two-layered morphology consisting of the fibrillar, 5A2-
positive outer wall covering a more electron dense, lightly labeled inner wall (Fig 8d). 
Oyster tissue supplementation has been noted to alter cell morphology to more closely 
resemble the prezoosporangium stage induced by thioglycollate incubation, including 
cellular enlargement and formation of a thickened cell wall (Earnhart et al., 2004). The 
formation of an antigenically dissimilar inner wall during supplementation supports the 
contention that oyster product supplements causes a partial transition to the 
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prezoosporangium life stage, and may offer insights into the in vivo signals or conditions 
required for this transition. The antigenic differences between these walls may also 
explain the failure of some antibodies created using prezoosporangium antigen to detect 
other P. marinus life stages (Choi et al., 1991; Dungan and Roberson, 1993). 
Despite the binding similarities between the anti-PWP-1 antibody and 5A2, there 
are marked epitope differences, assuming they label the same parental protein. While the 
anti-PWP-1 antiserum recognized both P. atlanticus and P. marinus protein (Montes et 
al., 2002), antibody 5A2 was specific for the wall of P. marinus. Furthermore, despite 
polyspecific recognition by the anti-PWP-1 antiserum, there was only a single 233kDa 
band recognized by immunoblot, in contrast with the series of bands recognized by 5A2. 
The detection of a protein series by antibody 5A2 may indicate either an incidental or 
functional degradation of a parent molecule. PWP-1 protein has been demonstrated to be 
resistant to proteolytic degradation by the serine protease trypsin (Montes et al., 2002), 
suggesting that the apparent processing of the protein detected by 5A2 is due to a 
protease with a specific ability to degrade this structural wall protein. Perkinsus marinus 
secretes numerous serine proteases into the culture medium (LaPeyre and Faisal, 1995; 
LaPeyre et al., 1995; Garreis et al., 1996; Faisal, Schafhauser et al., 1999), some of which 
can be modulated by the environment in which the cells are grown (See this dissertation, 
Chapter 3; Macintyre et al., 2003; Earnhart et al., 2004). It is possible that one or more 
of these proteases functions in the processing of cell wall components. Faisal et al. 
(1999) demonstrated that the cyclopeptide protease inhibitor bacitracin was able to inhibit 
P. marinus in vitro growth, indicating that the appropriate functioning ofthe serine 
proteases is critical for parasite survival. 
The proteolytic processing of wall components to forms having immune-
modulatory or other virulence activities occurs in bacterial pathogens, as well as in other 
protozoan parasites. The bacterial fish pathogen Renibacterium salmoninarum regulates 
its major extracellular product, p57, by cleavage of a cell-bound form, and subsequent 
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degradation into a series of fragments by endogenously produced serine prot eases 
(Rockey, Gilkey et al., 1991; Rockey, Turaga et al., 1991; Wiens et al., 1999). The 
malarial parasite Plasmodium falciparum proteolytically alters cell surface proteins 
during maturation (Rosenthal et al., 1987; Braun-Breton and Pereira da Silva, 1988) and 
addition of protease inhibitors, while not altering the cleavage of the parental molecule, 
diminishes the rate ofloss of the antigens into the culture medium (Lyon and Haynes, 
1986). Diffuse staining in the tissues surrounding the cells indicates that the 5A2 antigen 
is not confined to the P. marinus walls during active infection, but may be shed into 
tissues (Fig. 1 Oa, b). This pattern is similar to the diffuse immunofluorescent staining 
noted by Dungan and Roberson (1993) in infected tissue sections stained with a 
polyclonal antiserum. 
The biochemical composition of the P. marinus cell wall is not known, but may 
have similarities with the glycoprotein exoantigens of the apicomplexan Cryptosporidium 
parvum (Riggs et al., 1997), the secreted glycoprotein of Toxoplasma gondii (Zhang et 
al., 2001), and to the glycoprotein cell wall found in some yeasts (Nelson et al., 1991). 
Yeast cell walls are composed of several types of carbohydrate and mannan glycoproteins 
(Nelson et al., 1991 ). In Leishmania parasites, mannan is a virulence factor critical for 
parasite survival within macrophages (Ralton et al., 2003). The major surface 
glycoproteins of Trypanosoma cruzi are ligands of the mannose-binding proteins in the 
human host and may function as mediators of adhesion with host cells (Kahn et al., 1995; 
Kahn et al., 1996). 
Perkinsus marinus ECP has been found in previous studies to be highly 
suppressive of the murine humoral immune response (Earnhart and Kaattari, 2003). If 
the marinus cell wall has functional similarities to the mannan cell wall in the yeasts, 
this could offer a possible explanation for the immunomodulatory effects of P. marinus 
ECP in both the mammalian and the oyster systems. Mannose, along with several other 
sugars, has been documented by lectin labeling to occur on the P. marinus cell surface 
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(Brown and Faisal, 1998; Gauthier et al., 2002). Mannans have several 
immunomodulatory activities, some of which may impact on oyster defense functions. 
These include induction of prostaglandin E2 secretion by monocytes, induction of 
suppressor T -lymphocytes, suppression or induction of proliferation of B-lymphocytes, 
suppression ofT-lymphocyte proliferation, alteration of normal cytokine responses, 
interference with leukocyte homing, activation of complement, and inhibition of 
myeloperoxidase activity (Mikami et al., 1982; Wright et al., 1983; Podzorski et al., 
1989; Nelson et al., 1991; Krizkova et al., 2001). Garreis et al. (1996) described several 
dysfunctions in the oyster defense system which appeared to be mediated by the ECP of 
P. marinus, including a reduction in both random and chemotactic migration of 
hemocytes, and a decrease in the titer of agglutinins and lysozyme in the plasma. There 
is also an abrogation by P. marinus cells and ECP of the oyster hemocyte 
myeloperoxidase-mediated (Austin and Paynter, 1995) reactive oxygen species response 
(Volety and Chu, 1995; Anderson, 1999). If the release of these cell wall components is 
mediated by the degradation of the 5A2 parental antigen, the appearance of degradation 
products may signify activation of a virulence mechanism. 
An understanding of the mechanisms ofECP regulation, storage, and secretion 
offers new insights into potential virulence mechanisms of this protozoan parasite. Both 
the constitutive expression and release, and the storage and time-dependent release of 
products indicates the diversity of functions that the ECP likely mediate. The in vitro 
study of these dynamics in host product-supplemented medium has demonstrated altered 
expression of the p 107 /p 102 protein as well as the formation of a structurally and 
antigenically distinct cell wall. Previous studies have shown increased parasite 
infectivity under these conditions, making these changes particularly interesting. The 
ability of P. marinus to survive and replicate within oyster hemocyte phagosomes 
indicates that there are one or more mechanisms by which P. marinus subverts the host 
defense. The ECP storage in and release from the cell wall, potentially by the action of 
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specific serine proteases, is conceptually an efficient means by which to mediate that 
survival. The sloughing and loose adherence to the plasma membrane of the trophozoite 
cell wall may indicate that it is less a structural component than a mediator of the host-
parasite relationship. The loss of 5A2 antigen detection in the more stable, and likely 
structurally important prezoosporangium wall further supports this possibility. 
Increasingly, the ECP appear to be an important target not only for investigations of 
virulence mechanisms, but in the study of basic processes in this protozoan parasite. 
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Summary 
The modulation of Perkinsus marinus morphology and function through in vitro 
culture with host-derived supplements has demonstrated new aspects ofthe complexity of 
the host-parasite relationship. Despite the complexity of these interactions, this research 
has shown that parasite functions likely mediated by host signals can be selectively 
modulated by host-derived extracts and studied in vitro. The most promising of these 
supplement-induced alterations is the reversal of in vitro culture-induced attenuation. 
The concurrent study of attenuated and virulent forms of a clonal isolate is an ideal tool 
for the investigation of potential virulence factors and activities. This, combined with the 
development of specific antibodies to precisely track and quantify some of the 
supplement-induced changes, has provided new information regarding the regulation of 
extracellular proteins, pro teases, the sources of potential extracellular product (ECP) 
virulence factors, the inductive environment required for transition from binary to 
palintomic parasite reproduction, the regulation of parasite proliferative rate, and the 
host-induction of, and structural changes associated with, the transition from trophozoite 
to zoosporangium. 
The reversal of parasite attenuation was accomplished by medium 
supplementation with oyster plasma or whole oyster homogenates. Increased infectivity 
was specifically induced by oyster tissues, though it was not related to the disease 
susceptibility of the oyster from which the supplement was derived. This implies that 
any differences in host susceptibility to the parasite are independent of the mechanisms 
involved in regulation of parasite infectivity. Supplementation also elicited other changes 
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in the parasite, including the protease secretion pattern, parasite size, and morphology. 
None of these changes, however, absolutely correlated with the increased infectivity. 
The complex set of phenotypic changes caused by supplementation appeared, in some 
cases, to be differentially modulated by homogenates derived from different oyster 
populations or species. There were also variations in infectivity, morphology, and 
protease production in different P. marinus cell lines. While these experiments did not 
seek to address co-adaptation between local host and parasite populations, these 
combined differences could indicate this possibility. 
The proliferative, morphological, and ECP changes caused by medium 
supplementation were elicited to varying degrees by each supplement derived from 
specific organs or tissues. This tissue-specific modulation of parasite functions may play 
an important role in the regulation of parasite growth, life stage transition, and other 
functions. Parasite proliferation was reduced by medium supplementation, with two 
exceptions. Plasma-supplemented cultures had somewhat reduced proliferation, but not 
to the same extent seen with other supplements, while supplementation with adductor 
muscle was associated with proliferation exceeding that of the control cultures. The 
parasite multiplies rapidly within oyster hemocytes and in the interstitial spaces of the 
open circulatory system, and exposure to plasma or the highly vascularized adductor 
muscle may induce a proliferative response in the parasite. Alternatively, there may be, 
in plasma and adductor muscle, a lack of down-regulatory signals for proliferation which 
occur in the other oyster tissues. This hypothesis is supported by the reduction in 
proliferation from control levels that occurs in the presence of other tissue supplements. 
Downregulation of proliferation in the presence of large amounts of certain degraded 
tissues may represent a parasite adaptation to prolong host survival. 
The proliferative response is not, however, the only measure of parasite growth in 
culture. Supplementation, especially with whole oyster homogenate, also caused marked 
cellular enlargement. This enlargement was specifically induced by oyster products and 
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was similar to the induction of increased infectivity, in that it was independent of host 
susceptibility. At lower supplementation levels, the increase in cell size was not 
sufficient to counteract the effect of decreased proliferative rate on the aggregate cell 
volume; however, at some moderate to high supplementation levels, there is a net 
increase in this aggregate volume, indicating some form of parasite growth or 
transformation, even at drastically reduced proliferative rates. While this effect was 
noted to some extent in cultures supplemented with homogenate of Crassostrea 
ariakensis or C. gigas, the aggregate cell volume was never as great as with C. virginica 
supplements, probably due to progressive loss of culture viability at higher supplement 
doses. The ability to maintain lower parasite burden and aggregate parasite volume in C. 
ariakensis and C. gigas may partially explain the increased tolerance of P. marinus 
infection in these oyster species. 
A subset of the cells in C. virginica-supplemented cultures appeared by light 
microscopy to have a thickened cell wall. This, combined with the drastic size change, 
was thought to resemble the transition to prezoosporangia typically induced by 
thioglycollate incubation of trophozoites. The morphologic similarity between the 
supplemented and thioglycollate treated cells was further supported by the binding 
pattern of a trophozoite wall-specific monoclonal antibody during immunogold electron 
microscopy. The transition to an antigenically and structurally distinct cell wall form was 
found in both situations, indicating medium supplementation can be used to more 
carefully investigate the signals or conditions that induce this life stage transition. This 
stage is typically seen in vivo only in moribund oysters; therefore, rather than a specific 
inductive molecule, it is logical to assume that the parasite may simply be affected by a 
large amount of degrading oyster tissue, possibly by the concentrations of free lipids or 
amino acids, or by the alteration in the reduction-oxidation state in the local environment. 
Thioglycollate itself is a reducing agent and creates an anaerobic condition during 
incubation. The size and structural changes elicited by whole oyster homogenate could 
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not be replicated by supplementation with any specific oyster tissue, even when the 
supplement was derived from the digestive gland and gonad, which is essentially the bulk 
of the oyster. Combinatorial studies may be helpful in elucidating the exact requirements 
for induction of this transition. 
Supplementation also caused a remarkable change in the mechanism of in vitro 
proliferation. Unsupplemented cultures replicate, apparently exclusively, by binary 
fission. Culture medium supplementation, especially with homogenates of whole oyster 
and digestive gland/ gonad, resulted in the bulk of replication occurring by palintomy 
within parental tomonts. Tomonts are very commonly seen in infected tissue sections, 
and thus appear to be the normal replicative mechanism. The transition to binary fission 
in the absence of host products is puzzling, but may be due to the small size ofthe cells in 
unsupplemented cultures. While palintomy, by definition, does not require a proportional 
increase in cytoplasmic volume prior to karyokinesis and cytokinesis, there may be an 
absolute limit to the cytoplasmic volume that enables multiple fission. The cellular 
enlargement that occurs with supplementation may thus enable the parasite to revert to its 
normal reproductive mechanism. 
The extracellular products of P. marinus have been shown to be 
immunomodulatory in both the oyster and, in this research, the mouse. While the 
mechanism of immune dysfunction is not clear, it may be due to modulation of shared 
innate immune mechanisms. The availability of monoclonal antibodies for affinity 
purification will allow investigation of the effects of isolated ECP components on innate 
immune function. Antibodies produced against ECP have shown that they are 
heterogeneous in their manner of storage and secretion. This implies heterogeneity of 
function. There are clearly modulations in ECP during culture supplementation, and 
some of these may play a role in the supplement-induced alteration of virulence. The 
failure of subtractive immunization techniques to distinguish novel ECP antigens from 
cells exposed to oyster supplements may indicate that any role ofECP in increasing 
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infectivity and virulence may be due simply to alterations in the expression level of an 
ECP component. This type of alteration is clearly seen in quantification of the p 1 07/p 102 
protein; with any medium supplementation, there is apparent downregulation of protein 
production. This also occurs with some serine proteases during medium 
supplementation. In many cases when there is increased low molecular weight protease 
activity, there is also decreased expression of some high molecular weight proteases. 
While each of these proteins may be independently regulated, it is also possible that the 
upregulated low molecular weight proteases are simply modifications of extant proteins 
caused by the medium supplementation conditions. The available panel of monoclonal 
antibodies has already demonstrated that the pattern of ECP is deceptively complex. 
Many of the molecules present may be degraded components of relatively fewer parental 
molecules. 
If the low molecular weight proteases are formed by processing ofhigher 
molecular weight forms, there are apparently very specific culture conditions required to 
initiate and stabilize those changes. Supplementation with whole C. virginica 
homogenate, while the most reliable method for low molecular weight protease 
induction, is not always effective, and there is an effect of dose with all supplement types. 
When supplementing with individual organs, both adductor and heart muscle 
homogenates effectively induced low molecular weight proteases, but the optimal 
inductive concentration varied widely between these two muscular tissues. The induction 
by those tissues also did not appear to be associated with the high molecular weight 
downregulation often seen with whole oyster supplemented cultures. This implies that 
the low molecular weight proteases are induced molecules, rather than products of 
processing within the ECP, and may have a specific function associated with the in vivo 
correlate of those medium conditions. In addition, the results of non-zymographic 
assessment of protease activity indicate that there may be other proteases induced by 
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interesting, as these tissues are a primary entry point for the parasite. 
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This research has provided some of the initial information necessary for 
determination of mechanisms of infectivity and parasite alteration ofhost defense 
responses. It has investigated potential in vitro correlates of host-induced modulation of 
parasite infectivity, reproduction, morphology, life stage transition, and protein and 
protease secretion. Progress has also been made toward resolution of the exact 
mechanisms of induction involved in those changes, with candidate molecules in some 
cases resolved to the tissue level. In addition, it has provided a number of antibody tools 
for the continued study of the host-parasite interaction, both in vitro and in vivo which 
will facilitate the tracking and quantification of molecules of potential importance to the 
diseases process. 
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